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ABSTRACT 
The use of antibiotics in poultry growth and disease control has led to antibiotics resistant 
problem in human beings, which is a big concern among consumers. With the necessity for 
judicious use of antibiotics in poultry production, alternative strategies to improve disease 
resistance in poultry production are necessary. The research is more inclined towards using the 
natural products available to grow healthier and antibiotic free meat animals. In the context of 
exploring natural and sustainable resource of alternative to antibiotics, the biochemical milieu of 
eggshell membranes (ESM) were analyzed by using mass spectrometry techniques including 
matrix assisted laser desorption ionization and liquid chromatography coupled with tandem mass 
spectrometry (MALDI-TOF-MS and LC-MS/MS). We found more than 300 proteins and the 
abundant among them are lysozyme, ovotransferrin, ovocleidin, clusterin, ovokeratin 
ovodefensin and many more. These proteins are not only antimicrobial in nature, but also many, 
play a vital role in metabolic and developmental processes. A series of experimental trails were 
done in which chickens by feeding ESM supplemented diet. Our initial experiments showed that 
feeding 0.5% levels of eggshell membrane not only improved the body weight of chickens, but 
also modulated immunoglobulin parameters and stress levels. Further experiments were done to 
see the effect of ESM under endotoxin challenged conditions in which 5 week old chickens fed 
with ESM supplemented or control diet were challenged with Salmonella lipopolysaccharide. 
Our results showed significant difference in body weight loss, pro and anti-inflammatory genes, 
and serum corticosterone levels in control versus ESM fed chickens. ESM supplemented diet not 
only helped to restore the body weight loss due to LPS injection but it also helped to provides 
better tolerance to endotoxin challenges as indicated by splenic cytokine profiles of the chickens. 
In view of the need for alternatives to antibiotics in meat animal production, exploring the 
potential of egg byproducts as nutritional modulator of immunity during post hatch period 
appears logical. 
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1Introduction 
The emergence of antibiotics resistant bacteria and their link to prophylactic use of antibiotics as 
growth promoter in meat producing animals has prompted the search for alternatives to 
antibiotics. Products such as probiotics, prebiotics, bacteriophages fecal extracts, yolk antibodies, 
and organic acids have been used to satisfy this need. However, there is no uniformity of the 
nature and the mechanisms of action of these products. Ideally, a suitable product may be that 
which would not only protect animals from diseases but also not affect the growth potential and 
production values of the animals. Deploying the potential of immune system to protect the 
animals from disease may help. Vaccination against specific pathogens have been the examples 
of such choice.  However, there is no general vaccine that might provide overall resistance 
against most common health problems of poultry. Besides, nonspecific immune activation is 
energy expensive which can affect production values.  Should it be possible to program the 
immune system to protect the individual, in the concept of allostatic modulation, may be an 
option.  The immunity of neonates specifically, the newly hatched poultry is not completely 
developed and plastic hence, it is not only vulnerable to infections but also may be trainable to 
protect birds against disease without interfering with their growth and wellbeing.. Nutrition 
modulation is considered one of the effective means to train the immune system and make the 
animals more immunocompetent.  The experiments in this dissertation examines some of these 
concepts using egg shell membrane, a byproduct of poultry industry that contains a variety of   
bioactive proteins and peptides, to affect immunity and health outcomes of post hatch poultry 
measured through selective physiological parameters.  
2The studies are divided in two parts. The first part deals with the identification of the proteins 
and peptides of fresh harvested eggshell membranes (ESM) by using the mass spectrometer, 
Matrix Assisted Laser Desorption Ionization Mass Spectrometry (MALDI-MS/MS), High 
Pressure Liquid Chromatography (HPLC) and Liquid Chromatography-Tandem Mass 
Spectrometry (LC/MS/MS) techniques. Based on the qualitative data of protein profiles of the 
eggshell membranes, the biological effects of the ESM was evaluated on post hatch chickens 
under both normal and endotoxin challenge conditions. 
 Chapter 2 discuses about the proteomic aspect of eggshell membranes and all the techniques and 
procedures used to identify and characterize the protein and peptides present in eggshell 
membranes by using “top down/bottom up” MALDI and ESI mass spectrometry approaches.  
Chapter 3 discuses about the nutritional aspect of the eggshell membranes harvested form fresh 
unfertilized eggs and their immunomodulatory effect on growth and performance of chickens at 
3 weeks of age. 
Chapter 4 discusses about the proteomic characterization of eggshell membranes obtained from 
hatchery waste. Chapter 5 is about the ameliorating effect of eggshell membranes in conditions 
of endotoxin challenge. We explored whether these membranes when give as a supplement to the 
post hatch chickens can provide resistance and tolerance to the stressful conditions at a later 
stage.  
3Chapter 1: 
Immunity and antibiotics alternative in the context of poultry health and wellbeing: a 
literature review 
4Introduction 
Production of healthy livestock is integral to food safety, animal wellbeing, and sustainable 
agriculture. The emergence of antimicrobial resistant bacteria has been a worldwide concern and 
squarely blamed on the prophylactic use of antibiotics in meat animal industry where it is used as 
growth promoter [1-6]. The use of antibiotics is not only implicated in producing antibiotics 
resistant pathogenic bacteria but it also upsets the regular microflora [7-10]. However, the 
restriction in the prophylactic use of antibiotics also increases the chance of bacterial diseases 
and causes food safety problems that could potentially cripple the poultry and meat industry. 
Hence, there has been increasing research focus on finding alternatives to antibiotics that would 
provide resistance to microbial disease while maintaining the production values [11]. The quest 
to improve immunity and disease resistance of meat producing animals and poultry thus raises 
questions on options to modulate, and assess immunity This review addresses some of these 
issues particularly in the context of poultry production. 
Alternatives to antibiotics 
The consumer’s concern and demand for antibiotic free food leads to the focus of modulation of 
the avian immune system particularly using nutritional approaches which not only can increase 
the production of poultry but also fulfill consumer’s demand for antibiotic free food at the same 
time [12]. But the major concern in adding the alternative to antibiotics is that the product should 
be equally potent to promote the growth and also keep the animal free from disease. The cost to 
impact ratio on health status of an animal is another big issue that needs to be addressed when 
using an alternative to antibiotics [1, 13]. Of a number of methods that have been proposed or are 
on trial are vaccines, antimicrobial peptides [14-16] (exogenous or induced), bacteriophages, 
probiotics[17], prebiotics, different phytochemicals (essential oils, saponins) [18] and 
5recombinant cytokines (recombinant intact and/ or modified synthetically to enhance efficacy) 
[13].  All these are geared to improve endogenous resistance, modulate immunity directly or 
indirectly to reduce the burden of harmful agents that affect growth, wellbeing, and food security 
of meat animals.  
Examples of Alternatives: 
Vaccines 
The first and foremost method, which revolutionized the history of immunomodulation, was 
vaccination discovered by Edward Jenner that has changed the face of medical research. Vaccine 
is a preparation from attenuated form of a pathogen, which stimulated the immune system and 
develops the memory to kill the microorganism encountered later in the life. By exposing the 
immune system to a harmless form of pathogen it can be made more alert and ready for a 
vigorous response in times of real pathogen attack. The biggest contribution of vaccine is 
complete eradication of smallpox [19], and a significant decrease of measles, mumps and rubella 
worldwide in human medicine. Vaccines can be an easy solution to many challenges faced by 
poultry industry today [20]. Salmonella vaccines along with other preventative strategies are one 
of the effective measures, which holds a promising future for control of food borne pathogens in 
poultry products [21]. A greater success is achieved in developing coccidiosis vaccines by 
injecting the chicken with Eimeria oocysts at posthatch stage [22]. Newcastle disease was 
completely eradicated with the application of a Newcastle virus vaccine, which was initially 
done by means of slaughtering and sanitary measures [23].  
Antimicrobial proteins and peptides 
Antimicrobial peptides (AMP) are endogenous or exogenous low molecular weight 
proteins, which can provide protection against a wide range of microbes including bacteria, fungi 
6and viruses. They are cationic in nature and create pores on the bacterial cell wall and control 
microbial growth (6). AMP’s also known as “natural antibiotics” have numerous applications for 
therapeutic, nutraceutical, and biotechnological industries [24]. Antimicrobial peptides specially 
derived from food products are safer for human consumption. Most of them are explored mainly 
in milk, egg and rice [25, 26]. Lysozymes, defensins and transferrins that are present in milk and 
egg are also important molecules of our innate immune cells such as neutrophils and 
macrophages [27, 28]. Lysozyme is well known for its efficacy against gram-positive bacteria 
and is extensively used in food industry as natural source of food preservative, which increases 
the shelf life of food [29]. Transferrins, such as lactotransferrin and ovotransferrin present in 
milk and egg respectively help to fight against infections by chelating iron and thus inhibiting the 
growth of bacteria by limiting the availability to this essential component needed for bacterial 
growth [30]. Nissin, an antimicrobial peptide produced by lactococcus lactis, is widely used to 
increase the shelf life of the food by preventing the spoilage done by pathogenic bacteria [31]. 
The advantage of AMP over the synthetic antibiotics is that the bacteria are less resistant to the 
them as compared to the latter [24]. Advances in our understanding of the mechanism of action 
of AMP’s will open up new avenues for developing novel and therapeutic applications.  
Bacteriophage  
A bacteriophage is a virus that lyses the bacterium, invade and kill it by disrupting its metabolic 
system. Bacteriophage therapy has been reported to be an effective alternative to antibiotic in 
vancomycin resistant enterococcus infection in the mouse model [32]. In contrast to antibiotics 
the mode of antimicrobial action by bacteriophage does not lead to the development of resistance 
mechanisms in bacteria. Because of the specific mode of action, the use of phage against the 
targeted bacteria is safe for the beneficial microbiota [33]. The use of bacteriophages in the food 
7industry to eliminate food born pathogens has also gained considerable recognition [34].  The 
‘phage biocontrol’ approach is safe and effective at both the pre-harvest and post-harvest stage of 
controlling food borne pathogens and has the potential to be considered as the most effective 
methods for food safety in the future [35]. 
Probiotic and prebiotic 
Changing of the gut microbiota through dietary means has been a subject of much discussion. 
The gut biology is an important area especially in agriculture animals. The use of probiotic and 
prebiotic in the treatment of various metabolic disorders is gaining momentum in past few years. 
The term probiotics is defined “as a live microbial feed supplement which beneficially affects the 
host animal by improving its intestinal balance” [36]. By the mechanism of competitive 
exclusion, for colonization sites and the production of compounds, which are toxic for 
pathogenic bacteria, probiotics inhibit bacterial growth and help to maintain the intestinal flora 
[37]. Prebiotics, similarly are defined as “ a nondigestible food ingredient that beneficially affect 
the host by selectively stimulating the growth and / or activity of one or limited number of 
bacteria in the colon” [38]. The use of prebiotics and probiotics not only for increasing the 
productivity but also for disease prevention in poultry production is deemed an effective 
alternative to antibiotics to satisfy the consumer’s unmet demand of healthy and diseases free 
meat. [39] 
Herbal Products 
The extract from various plants such as thyme, eugene, oregano have been shown to inhibit the 
growth of pathogenic bacteria such as Salmonella, Escherichia coli and Clostridium in vitro as 
well as in birds [40]. Essential oils (EO) extracted from different parts of the plant stimulate the 
digestive tract by promoting the formation of digestive enzymes in the gut. They also exert their 
8antimicrobial effect by creating the pores in the lipid bilayer of the cell membrane, which makes 
the cell leaky and disturbs the metabolism of the bacteria and leads to its death [41]. The 
applications of antimicrobial activity of EOs are not limited to meat and meat products but also 
apply to vegetables, rice, and dairy products. However the usage of EOs can sometimes add a 
flavor and distinct kind of aroma to the meat, which is a limiting factor from the consumer’s 
sensory point. Due to its increasing applications in the food industry, Eos are gaining great 
attention for future research, that would provide more insights into their mechanism of action 
and also address safety concerns [42].  
However, there is a lack of consistency regarding the findings of the effects these 
additives have on the various health parameters that are measured to prove their efficacy. The 
systematic investigation of the effect of additives on the various aspects of the immune system is 
needed to convince the commercial producers to completely rely on these products. By keeping 
in mind that the immune system is an integrated system, which cannot be determined by solely 
measuring one, or few parameters will help us to avoid unintended consequences in the near 
future [43, 44]. Rather than interpreting for results with individual markers if we try to 
congregate the related markers together and see their mass effect, and focus on their consistency 
it will help make a better conclusion [45].  
 Immunomodulation 
Immunomodulation is the manipulation or adjustment of the immune system to improve 
resistance to disease. It includes all possible means of altering the immune system such as 
immunosuppression or enhancement based on the necessities of the prevailing health conditions. 
Immunomodulation helps to alleviate the existing pathological condition and control the damage 
done by it. In case of autoimmune problems, where the immune system attacks self-components, 
9the main target is to suppress it or reduce its activity which otherwise can result in 
immunopathology. In the same token, immunocompromised individuals can be susceptible to 
infections and become victims of pathogenic attacks more easily, the enhancement of immunity 
and protection against deadly infections [46]. Hence a well-balanced immunity against pathogen 
can protect the individual against disease and improve well-being. 
Nutrition immunomodulation  
Well-balanced nutrition is one of the main factors which can help in optimizing the function of 
the immune system [47]. Immunonutrition, even though it is an emerging science, roots back to 
1880s where the effect of malnutrition was seen on the growth of lymphoid organs [48]. The 
immune system and nutrition are catalogued in such a way that excess or lack of a nutrient 
debilitates its function [49-51]. Excess or deficiency of essentials in the diet can make the 
immune system vulnerable to several infections, which not only worsens the quality of life but 
also decrease its expectancy. Even though there is a fundamental understanding of how innate 
and adaptive immune systems interact for the clearance of pathogens, there is a need to 
investigate further when trying to modulate the immune system to improve the quality of life. 
The immune system operates under normal conditions for maintenance, but at the time of 
pathogenic attack its dietary requirements change. It undergoes cell proliferation to increase the 
number of leukocytes to make its army ready for the defense against the attack. There is also an 
intensive demand of nutrition for the synthesis of acute phase proteins by the liver [52]. The 
nutrient requirements of the immune system can also change with the type of infection an 
individual encounters. By inferring the nutritional cost of the immune system it will be easy to 
manipulate the essential components in the diet to manage the loss of production during infection 
[52, 53]. Significant effort is made to improve immunity and disease resistance through 
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nutritional means. Nutrition based epigenetic programming during the neonatal and perinatal 
period may increase the efficiency of the immune system to fight against the infection [54, 55].  
Nutritional immunomodulation is seen as a panacea to deal with the immune system 
problems. With the dietary interventions it is possible to fine-tune the immune system and make 
it better to fight with infectious agents. Since the ancient time the use of many plant products 
such as green tea, turmeric, fish oil, vitamin D have proven to have a therapeutic and 
ameliorating effects against sickness [56]. The idea of immunomodulation is not to overwhelm 
the system by adding or deleting an ingredient in the diet but to provide a means for optimal 
functioning and analyzing its consequences on the immune system. The main target of the 
change in dietary elements is to see its beneficial and long lasting effects on the system, which 
can make it more competent and resistant to infections.  
There are several factors, which needs to be carefully considered while designing the experiment 
for nutritional modulation to avoid study-to-study variation. Age, sex, genetics, eating, stress and 
many more factors, which vary in different subjects, can bring inconsistency in the results [44]. 
Interactive factors of Immunity  
Immune response is subject to endogenous control such as physiology, age, genetics and even 
psychosomatic dispositions [57, 58]. Exogenous factors such as environment and nutrition can 
also affect or permanently modulate the immune system, [59-61]. In the context of food animal 
production the most relevant ones are genetics and nutrition although a variety of other factors 
such as housing and hygiene may play roles in immune system function and in the animal’s 
disposition to disease. The genetic variation influences the inflammatory response of an 
individual to a given challenge. With mutations and single nucleotide polymorphism there is 
greater probability of having variations in the synthesis of inflammatory mediators.  
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The relationship between neural, endocrine, and immune system are still unraveled. The 
neuroendocrine-immune interactions have been studied in the context of stress and inflammation 
[62]. Stress activates the hypothalamic pituitary (HPA) axis affecting the release of 
corticotrophin and glucocorticoids [63]. Glucocorticoids produced by adrenal gland have 
profound effects on the immunological functions and the deregulation in the HPA axis greatly 
affects the effector mechanism of the immune system. Stress hormones, glucocorticoids and 
catecholamine influence immunity. The immunosuppressive effects of high levels of corticoids 
influence the levels of cytokines produced by lymphocytes [64, 65].The nervous system and 
immune system also cross talk via the HPA axis. The cytokines released by the sentinel cells in 
the event of inflammation such as interleukins and TNF-a can affect neuroendocrine system and 
be can be affected by it. Recent studies have also shown that the sympathetic nervous system 
such as the vagus nerve that innervates the spleen is known to influence immunity [66, 67]. 
Under inflammatory conditions the vagus nerve stimulates the immune cells in the spleen 
resulting in the production of acetylcholine that dampens the production of cytokines [68, 69]. 
Other evidence suggest the mutual influence of nervous and immune system and certain 
neurotransmitters directly modulate the response of the cells of immune system [70]. T cells and 
macrophages express β adrenergic receptors, and T cells produce acetylcholine and the 
stimulation by vagus nerve also causes acetylcholine production that alters the resident immune 
cell functions of spleen and liver, and their ability to produce specific cytokines [71]. The gut 
harbors the second largest neural network and several neuropeptides that have been shown to 
possess antimicrobial, and immunomodulatory activities, and play important roles in the 
development of self-tolerance [72]. Many of these peptides produced during persistent and 
chronic stress suppress the immune system and affect the outcome of a disease [73, 74]. 
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The immune system is relatively plastic at the time of birth and is vulnerable to infections 
that can permanently alter its potential to respond to stressful situations later in life [75]. Early 
life programming also known as imprinting of the immune system through the neuro-endocrine 
axis have been speculated to influence immunity over the span of life [76, 77]. The enteric 
endocrine and nervous system also help chemosensing of nutrients which in turn can influence 
immunity [78]. 
The above discussions posit that allostatic modulation of immunity by way of 
conditioning may be a reasonable option for programming the immune system for a balanced 
response to protect against infection without the loss of productivity and wellbeing. Epigenetic 
programming as a concept in physiology is not new. Susceptibility to infection are modulated by 
epigenetic control of immune cells such as DNA and histone modifications [79]. Wild animals 
generally show better immune responses to antigens as compared to captive animals because of 
their exposure to variety of challenges from the environment [80]. In order to enhance the 
chances of survival, their immune system is differently programmed since birth, thus they are 
more tolerant to endotoxin challenges [81]. Perinatal malnutrition is known to have profound 
neuroimmunomodulating effects in mammals to the extent that many metabolic and 
inflammatory diseases develop as a result [82]. Hence a better understanding of diet and neuro-
immuno interactions may help achieve the objective for restricted use of antibiotics. 
Conclusion 
It is apparent that the postnatal (posthatch) immune system is amenable to modulation. Immune 
system not only can communicate with the brain and endocrine system, the chemicals such as 
proteins and peptides produced by those systems also regulate it. The embryonic and fetal factors 
exert control in training and pruning the system that is retained as immune memory to be 
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expressed at the time of need. Both resistance and tolerance to microbes may be manifestations 
of this memory. The programming of the immune system during posthatch period may be critical 
which brings us to next set of issues such as what are the tools to accomplish such a feat? Could 
it be the maternal factors such as milk in mammals or wild diets and environmental contaminants 
including bacteria, viruses, and parasites that can confer broad variety of resistance and 
immunity, which will benefit survival and wellbeing? Such accomplishments can be engineered 
to apply to a large-scale scenario for example, poultry production where the birds need to be 
competent to resist infection without sacrificing their growth potential and performance. There is 
also more need for research on how do we evaluate the effect of dietary nutrients, to determine 
its impact on the immune system in terms of not only evading the pathogen but also protecting 
the tissue from self-destruction  
Thus while making a conclusion for the modulating effect of nutrients their sustainability and 
effects on the host’s susceptibility to pathogens should be considered. 
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ABSTRACT 
Eggshells are poultry industry byproducts with potential for use in various biological and 
agricultural applications. We have been interested in the membranes underlying the calcareous 
shell, as a feed supplement, which showed potential to improve immunity and performance of 
post hatch poultry. Therefore, to determine their protein and peptide profiles, we extracted the 
eggshell membranes (ESM) from fresh unfertilized eggs with methanol and guanidine 
hydrochloride (GdHCl) to obtain soluble proteins for analysis by mass spectrometry. The 
methanol extract was subjected to matrix assisted laser desorption ionization (MALDI), 
electrospray ionization (ESI), high performance reverse phase liquid chromatographic separation 
(HPLC) and tandem mass spectrometry (MS/MS) to determine its peptide and protein profiles. 
The GdHCL extract was subjected to ESI-HPLC-MS/MS following trypsin digestion of 
reduced/alkylated proteins. Nine proteins from the methanol extract and >275 proteins from the 
GdHCl extract were tentatively identified. The results suggested the presence of several 
abundant proteins from egg whites, such as, ovoalbumin, ovotransferrin, and lysozyme as well as 
many others associated with antimicrobial, biomechanical, cytoskeletal organizational, cell 
signaling, and enzyme activities. Collagens, keratin, agrin, and laminin were some of the 
structural proteins present in the ESM. The methanol soluble fraction contained several clusterin 
peptides and defensins particularly, 2 isoforms of gallin.  The ratios of the 2 isoforms of gallin 
differed between the membranes obtained from brown and white eggs. The high abundance of 
several anti-microbial, immunomodulatory, and other bioactive proteins in the ESM along with 
its potential to entrap various microbes and antigens may make it a suitable vehicle for oral 
immunization of post hatch poultry, and improve their disease resistance. 
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INTRODUCTION 
With over 90 billion eggs produced annually in the USA(USDA, 2014),  the egg shells constitute 
a significant byproduct of the poultry industry with potential for use in various agricultural and 
biomedical applications(Anton, et al., 2006; Cordeiro and Hincke, 2011; Kovacs-Nolan, et al., 
2005; Mine and Kovacs-Nolan, 2006). The egg shell consists of a calcareous outer crust 
underlined by two layers of proteinaceous membranes which enclose a composite chemical 
milieu of egg whites and yolk, and provide both physical and biological protection to embryo 
(Ahlborn, et al., 2006; Hincke, et al., 2012). Understanding the protein and peptide constituents 
of the egg shell membrane (ESM) may provide better insight into their roles in embryo 
development and protection, improve egg quality, and facilitate the utilization of this agricultural 
waste product.  In recent years there has been many studies of  the protein components of various 
avian egg compartments including the ESM as well as their biological significance (Mann, et al., 
2006),(Kaweewong, et al., 2013).  However, there are very few studies of egg membrane 
associated peptides. Whereas the proteins have both structural and functional bases within 
tissues, the peptides also play important roles in many biological processes such as signal 
transduction, transportation, and host defense(Brown and Hancock, 2006; Hu, et al., 2009; 
Soloviev and Finch, 2006). Therefore, the objective of this study was to profile the extractable 
peptide and protein composition of the inner eggshell membranes by using “top down/bottom 
up” MALDI and ESI mass spectrometry approaches.   
MATERIALS AND METHODS 
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Chemicals and reagents.  The following reagents and devices including Centricon YM-10 
filtration units (EMDMillipore.com), C18 Nu tips (Glysci.com), 1 kDa Dispodialyzer 
(Harvardapparatus.com), Spectra/Por membranes (Spectrumlabs.com), Biowide Pore C18 reverse 
phase HPLC column (15 cm x 4.6 mm, 5µm particle size, 300 Å pore size, Sigma-Aldrich, St. 
Louis, MO), C18 column (150 x 0.1mm, 3.5 µm particle size, 300 Å pore size, Zorbax SB 
(Agilent), BCA protein assay kit, Pierce C18 spin columns, MS grade trypsin (Fisher 
Scientific.com), peptide  calibration standard II (m/z 500-16000, Bruker Daltonics, Bremen, 
Germany), and 2-iodoacetamide (IAA) (MP Biomedicals, OH) were purchased from their 
respective vendors. All other reagents and supplies including 1, 4-dithiothreitol (DTT), 2, 5-
dihydroxybenzoic acid (DHB), and 1,5-diaminonaphthalene (DAN), were purchased from Sigma 
Aldrich (St. Louis, MO).   
Egg membrane harvest and extraction.  Egg shells from fresh unfertilized brown and white 
eggs were washed with deionized water inside with mild scrubbing to remove loosely adsorbing 
egg white proteins, and the membranes were peeled free of calcareous shells. Pooled or 
individual egg shell membranes (ESM) were again washed with excess deionized water by 
stirring for 2-3 h, blot dried with Whatman filter papers then chopped into small pieces for 
further processing. Figure 1 shows a flow chart of the general procedure of membrane extraction 
and processing. The pooled ESM were extracted by 2 methods (a) with 70% methanol containing 
0.1% acetic acid in and (b) with a buffer consisting of 4 M guanidine hydrochloride (GdHCl), 20 
mM EDTA, and 50 mM Na-acetate, pH 5.8.  The ESM fragments were extracted by stirring with 
10 volumes of respective solutions for 24 hours at 4oC.  The extracts were centrifuged at 21,000 
g for 15 min, and the clear supernatant dialyzed against excess 50 mM ammonium carbonate 
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solution using 1,000 Da Spectra/Por membranes with 3-4 changes. The membrane retentate of 
both extracts following dialysis were concentrated by lyophilization and resuspended in a smaller 
volumes of 50 mM ammonium bicarbonate to measure their protein concentrations by the BCA 
protein assay using bovine serum albumin (BSA) as the standard. The ESM harvested from 
individual brown and white ESM were similarly extracted with acidified methanol and screened 
by direct matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-
TOF-MS) (Kannan, et al., 2007; Kannan, et al., 2009).  The experiments were carried out in two 
separate trials to confirm the overall repeatability of the results.  
Direct MALDI-TOF MS of methanol extract.  The methanol extracts of individual or pooled 
membrane preparations were screened for their peptide profiles in the mass range of 1-20 kDa by 
direct MALDI-TOF-MS using 2 dihydroxybenzoic acid (DHB) as the matrix. The standard dry 
droplet method with 1:1 matrix: analyte ratio was employed to prepare spots on a Bruker ground 
steel MTP 384 MALDI target plate. To find the effect of reduction and alkylation, aliquots of 
samples in methanol were diluted with 3 volumes of 70% methanol containing 200 mM 
ammonium bicarbonate then treated with 10 mM DTT for 10 minutes in a boiling water bath, 
cooled to room temperature for 1 h followed by alkylation with 40 mM iodoacetamide for an 
additional 1 h in the dark.  The control samples were identically treated except that DTT was 
omitted from the reaction mixture.  Both control and reduced/alkylated samples were spotted on 
target plates along with calibrating Bruker peptide standard II in adjacent spots. The spectra were 
acquired using a Bruker Ultraflex II MALDI-TOF mass spectrometer (Bruker Daltonics GMBH, 
Bremen, Germany), operated in the positive-ion reflectron mode. The ammonium bicarbonate 
dialysate of the methanol extract was similarly, subjected to reduction/alkylation then dried with 
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a Centrivap evaporator (Labonco) to reduce the volume, desalted, and spotted for MALDI-TOF-
MS. The TOF analyzer was calibrated with peptide standard II. Accurate mono isotopic peptide 
masses were determined by MALDI-TOF-MS using combinations of external and internal 
calibration procedures, and spotting with equal volumes of α-cyano-4-hydroxycinnamic acid 
(HCCA) matrix, prepared in 0.1% FA, 50:50 water/ACN (Kannan, et al., 2013). The LIFT-
MS/MS was performed on selected peaks to determine their identity. 
Reverse phase HPLC purification of peptides in methanol extract. The dialyzed methanol 
extract was passed through a 10 kDa Centricon filter to exclude high molecular weight proteins 
in order to purify some of the peaks observed in MALDI-TOF-MS.  The filtrate with ≤10 kDa 
peptides was evaporated with Centrivap, re-dissolved in 0.1% formic acid, centrifuged at 21,000 
g, and the supernatant subjected to reverse phase HPLC purification. The chromatographic 
separation was done on a BiowideC18 reverse phase column attached to an Agilent 1100 HPLC 
interfaced with an ESI mass spectrometer. Several major peptide fractions based on the ESI-MS 
multiply charged mass spectra corresponding to m/z 4484 and 4597, 2157, 3231, 2878, 2804, 
2641, and 1902 peaks, were collected, pooled from replicate runs, and concentrated by 
evaporative drying for further characterization as described below. 
Peptide identification by MALDI-TOF-MS and MS/MS (LIFT-TOF/TOF). The peptide 
fractions were reconstituted in smaller volumes of 50 mM ammonium bicarbonate and checked 
for homogeneity by MALDI-TOF-MS then reduced and alkylated with DTT and iodoacetamide 
as described above followed by trypsin digestion for 24 h at 37oC. The tryptic peptides were 
desalted with C18 Nu tips, spotted on MALDI target plates with saturated HCCA as described 
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above, and the spectra collected in both MALDI-TOF (MS) and LIFT-TOF/TOF (MS/MS) 
modes.  
MALDI-ISD (in source decay) analysis.  The m/z 4597 and 4484 peptide fractions were 
reconstituted in 0.1% formic acid and spotted mixed with a saturated solution of 1, 5 
diaminonaphthalene (DAN) prepared in 50% ACN containing 0.1% formic acid at 1:1 ratio of 
analyte: matrix then subjected to MALDI-ISD fragmentation (Fukuyama, et al., 2006; Kannan, 
Liyanage, Lay Jr, Packialakshmi, Anthony and Rath, 2013; Quinton, et al., 2007).  ISD spectra 
were acquired with a Bruker Reflex III MALDI-TOF mass spectrometer. The MALDI-ISD mass 
spectra were similarly analyzed with Bruker BioTools 3.1 to obtain sequence tags to search the 
NCBI Gallus data base using protein blast. Both these peptides, m/z 4484 and 4597, were also 
subjected to LIFT-TOF/TOF fragmentation for further confirmation of their identities. 
Comparative differences in selective peptides of brown and white ESM. The MALDI-TOF-
mass spectra of methanol extracts of individual brown and white egg membranes were screened 
to determine the relative spectral intensities of m/z 4597 and 4484 peptides in each preparation 
and the means of the cumulative results were compared using Student’s t test.  
LC-MS/MS analysis of methanol and guanidine extracted proteins.  Following the 
measurement of protein concentrations of 1 kDa membrane retentate of both methanol and 
GdHCl extracts as described earlier, approximately 10 µg of methanol extracted and 50 µg of 
GdHCl extracted proteins were dried by vacuum evaporation and reconstituted in 10 µl of 
ammonium bicarbonate, subjected to reduction and alkylation, and digestion with trypsin at a 
protein: trypsin ratio of 50:1 for 24 h at 37oC.  The tryptic digest was desalted using Pierce C18 
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spin columns and chromatographed on a capillary C18 column (150 x 0.1mm, 3.5 µm particle 
size, 300 Å pore size, Zorbax SB) attached to an Agilent 1200 series HPLC interfaced with a 
Bruker Amazon-SL quadrupole ion trap mass spectrometer and captive spray ion source. Tryptic 
peptides were separated at a solvent flow rate of 1.6 µL/min with 0 to 40 % gradient of 0.1% FA 
(solvent A) and ACN in 0.1% FA (solvent B) over a 320 minutes period. 
MALDI-TOF-MS data analysis.  All MALDI-TOF-MS data were processed using Bruker Flex 
Analysis 3.3 and Bruker BioTools 3.1 software.  Peptides were identified using LIFT-TOF/TOF 
data by searching the NCBI Gallus database using the MASCOT MS/MS ion search tool with a 
peptide mass tolerance of 200 ppm and MS/MS tolerance of 0.6 Da.  For MS and MS/MS data 
obtained from tryptic digests of the fractions corresponding to m/z 4597, 4484, 2157, 3231, 
2878, 2893, and 1902  were searched in the NCBI Gallus database as above but with trypsin, 
listed as the digestion enzyme.  Accurate monoisotopic peptide masses (± 0.1 Da) were used for 
peptide identifications.   
LC-MS/MS analyzed proteins. Peaks were picked in the LC-MS/MS chromatogram using 
Bruker default settings.  Bruker Proteinscape bioinformatics suite coupled with MASCOT 2.1 
was used to search NCBI Gallus protein database for identification of proteins. The parent ion 
mass tolerance and fragment ion mass tolerance, were both set at 0.6 Da.  A MASCOT decoy 
database search was performed with all the datasets.  A score threshold of 45 or above was used 
as a high probability match for protein identifications.  The proteins with only <1% false 
discovery rate (FDR) and at least 1unique peptide were reported.  Functional annotation for these 
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proteins was performed using the Software Tool for Researching Annotation of Proteins 
(STRAP) (Bhatia, et al., 2009). 
RESULTS 
MALDI-TOF-MS identification of methanol extracted proteins and peptides.   Figure 2 
shows a MALDI-TOF-MS of the methanol extract of ESM shown in the range between m/z 
1000-6000 range with  peaks corresponding to m/z 1616, 1902, 2001, 2157, 2641, 2797, 2878, 
2894, 3231, 4484, 4597, and 4778.  Some of the other peaks that occurred beyond 10,000 m/z 
was 14302 matching to the corresponding MW of chicken lysozyme. The methods used for 
identification of some of the peaks and their identities are summarized in Table 1. The peaks 
corresponding to m/z 4484, 4597, and 4778 showed a 348 Da mass difference upon reduction 
and alkylation suggestive of the presence of 3 disulfide bonds while several other peaks did not 
show any mass shifts (Figure 3). Reduction and alkylation, particularly under complete aqueous 
conditions, rendered the m/z 4484, 4597, and some other peptides insoluble with 0.1% FA 
indicated by the disappearance or observance of low intensities in MALDI signals.  Figures 4 
and 5 show the MALDI-ISD and MALDI-LIFT-TOF/TOF results for peptides m/z 4597 and 
4484. MALDI-ISD yielded a high confident sequence tag “YCSNTCSKTQI” based on observed 
c ions (N-terminus protected) from m/z 4597.  MASCOT sequence query and MS/MS search 
using MALDI-LIFT-TOF/TOF data and blast search against NCBI Gallus data base all, resulted 
in significant hit against the protein precursor named “gallin’ with a sequence  
“LVLKYCPKIGYCSNTCSKTQIWATSHGCKMYCCLPASWKW”, matching to m/z 4597.  
Almost same sequence, but without the N-terminal leucine (L) is a perfect match to m/z 4484. 
The peak at m/z 4778 although showed to have 3 disulfide bonds from MALDI-TOF-MS results 
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(Figure 3), its identification was not possible through these means most likely due to insufficient 
amounts of material. The LC-MS/MS data from the methanol extracted proteins however, 
suggested a high possible identity for this peptide to be gallinacin 10 as will be described later 
with LC-MS-MS results. The peaks at m/z 1902, 2001, 2157, and 3231, observed in direct 
MALDI-TOF-MS, were all identified as fragments of clusterin having the common sequence tag 
“TPPFGGFREAFVPPVQRVR” by MASCOT MS/MS ion search of the LIFT-TOF/TOF data 
using NCBI Gallus database (Figures 6-8 and S1 and S2). The results were also supported by 
bottom up identification that showed the presence of two common tryptic fragments 
corresponding to their respective protonated monoisotopic masses at m/z 878.4 (TPPFGGFR) 
and m/z 1042.5 (EAFVPPVQR), for each of those peptides, both derived from the same domain 
of clusterin (Figures 7 and S3-S4). Thus, the m/z 1902, 2001, 2157 and 3231 peaks were 
identified as “TPPFGGFREAFVPPVQR”, “TPPFGGFREAFVPPVQRV”, 
“TPPFGGFREAFVPPVQRVR” and “TPPFGGFREAFVPPVQRVRLVPPRRRLS,” 
respectively (Table 1). The peptides corresponding to peaks at m/z 2878 and 2894 were both 
identified by MALDI LIFT-TOF/TOF fragmentation as one phosphatase and actin regulator 
protein (PHACTR) with a sequence of “PPKRGLLPTNPPEAALPSKPPGDRTVTA” and a 
sporozoite surface protein 2-like with the sequence of  
“PNPIGLIGPIGPNVSNPIGLLGPNGPNAFS” (Figures 9 and 10, Table 1).   
LC-MS/MS identification of methanol and GdHCl extracted peptides/proteins.  Major 
proteins identified in methanol and GdHCl extracts are listed in Table 2 and Table S1. There 
were 9 proteins identified in the methanol extract and over 275 in GdHCl extract. Six of the 
methanol extracted proteins were identified in the GdHCl extract which included the proteins, 
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lysozyme, clusterin, gallin, and ovocleidin.  Since gallinacin 10 propeptide that contains 3 
disulfide bonds (Lynn, et al., 2004), was identified in the methanol extract, we presumed that this 
LC-MS/MS identified tryptic fragment “AGACPPTFTISGQCHGGLLNCCAK” could relate to 
the m/z 4778 peak, observed in MALDI-TOF mass spectrum.  The accurate protonated mono 
isotopic mass for the m/z 4778 peak was determined to be 4772.9 ± 0.3 Da using replicate 
MALDI-TOF-MS measurements. Combining the mass information with the 
“AGACPPTFTISGQCHGGLLNCCAK” sequence tag and MASCOT query lead to a significant 
match with the sequence corresponding to 
“DPLFPDTVACRTQGNFCRAGACPPTFTISGQCHGGLLNCCAKIPAQ” belonging to  
gallinacin 10(Lynn, Higgs, Gaines, Tierney, James, Lloyd, Fares, Mulcahy and O'Farrelly, 2004) 
with a score of 308, and an expect value 8.2e-027.  The sequence corresponding to the accurate 
mass for m/z 4778 peptide appeared to be 5 amino acids longer N terminally than the predicted 
sequence of the mature gallinacin 10 peptide(Lynn, Higgs, Gaines, Tierney, James, Lloyd, Fares, 
Mulcahy and O'Farrelly, 2004; Xiao, et al., 2004).  The 2 other proteins namely, an 
angiotensinogen isoform X7, and an uncharacterized protein LOC771972 isoformX1 though 
were also identified from LC/MS-MS analyses of the methanol extract (Table 2) could not be 
identified elsewhere.   
 
The guanidine extract containing 276 proteins with Mascot scores 45 or above were identified 
with one or more unique peptides. When the identification was done on the basis of a single 
unique peptide, the fragmentation score was sufficient to identify with 95% confidence 
(supplementary Table S1).  GO classification done using STRAP used 103 IDs (Figure 11) to 
access the likely function of the proteins based on the annotations in the database. Several high 
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abundant egg white associated proteins such as ovalbumin, ovotransferrin, lysozyme, 
ovomucoid, and ovoglobulin were present in ESM. A large repertoire of proteins associated with 
muscle associated and motor functions such as, titin, dynein, obscurin, myosin, and nebulin, and 
others with cytoskeletal organizational and anchoring functions (xin, golgin, spectrin, ninein), 
enzymes (kinases, helicase, protein ligase), enzyme inhibitors (ovomucoid), and signaling 
functions were identified in ESM.  Proteins such as collagens, keratins, laminins, agrin, and 
chondroitin sulfate that are structural components of the membrane were present in GdHCl 
extract. Similarly several antimicrobial proteins such as lysozyme, gallinacin, mucin, ovocalyxin, 
proteases and protease inhibitors were also identified. 
Differential expression of m/z 4597 and 4484 in brown and white ESM.  Figure 12 shows 
comparative profiles of m/z 4484 and 4597 peaks in ESM from brown and white eggs. 
Calculated by their peak intensities, the brown ESM had lower levels of m/z 4597 peptide 
relative to m/z 4484 isoform of gallin than the white ESM which had higher levels of m/z 4597 
and lower level of m/z 4484 peptide  (brown, 0.42±0.04; white,0.72±0.08, p<0.05, n=7). 
DISCUSSION 
Egg is a large haploid cell and fertilized eggs can give rise to a young organism. Hence, analysis 
of proteins in avian egg membrane is expected to reveal their role in nourishment, development, 
immune protection and structural strength. Our results show that the eggshell membranes contain 
many extractable proteins and peptides notwithstanding the fact that much of the membrane 
material remains insoluble even, under chaotropic extraction condition.  Many proteins identified 
in the ESM have previously been shown to be present in other compartments of the egg 
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(Gautron, et al., 2001; Kaweewong, Garnjanagoonchorn, Jirapakkul and Roytrakul, 2013; 
Miksík, et al., 2007).  Some of these included egg white proteins such as ovalbumin, 
ovotransferrin, lysozyme, clusterin, ovocleidin, ovoglycoprotein, ovomucoid, and ovoinhibitors 
that are considered to be highly abundant (Boschetti and Righetti, 2008; Mann, 2007a; Rose and 
Hincke, 2009).  The methanol extraction led to the recovery of  several peptides some of which 
turned out to be the fragments of clusterin, a secretory multifunctional glycoprotein associated 
with cytoprotective, and chaperon-like function(Jones and Jomary, 2002). It has been reported 
that clusterin protects against a wide range of environmental, microbial, and oxidative stress 
which the egg may naturally be exposed to.  However, the significance of different clusterin 
peptides, most of which appeared to be derived from one domain, is not understood. Two of the 
peptides identified in the methanol extract by MALDI-TOF-MS were derived from, a 
phosphatase and actin regulator (PHAR) protein and another, a sporozoite surface protein 2-like 
protein.  PHAR is involved in actin binding cytoskeletal organizing function associated with 
neuronal development of embryo (Allen, et al., 2004)although the significance of its presence 
along with many other signaling proteins in ESM, is not understood.  However, there were also 
many cytoskeletal organizational proteins identified in guanidine extracts of ESM.  The 
sporozoite surface protein 2-like (SSP2-like) protein is an orthologue of a protein present on the 
surface of several unicellular parasites (Tewari, et al., 2002).  It is an adhesive protein that can 
bind to extracellular matrix based on its function in malarial parasites (Behet, et al., 2014).  
Whether SSP2-like protein acts as a decoy protein protective against parasite invasion of egg is 
not known.  Other major peptides of note identified in the methanol soluble fraction, were 
lysozyme, a cationic, antibacterial protein which is one of the most abundant proteins present in 
all compartments of the egg and 3 other defensin-like peptides corresponding to m/z 4484, 4597, 
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and 4778 all of which showed to contain 3 disulfide bonds common to most avian beta defensins 
(AvBD)(Lynn, Higgs, Gaines, Tierney, James, Lloyd, Fares, Mulcahy and O'Farrelly, 2004; 
Zhang and Sunkara, 2014).  Two of these peptides, m/z 4484 and 4597, were of interest because 
they occurred at different proportions in white and brown ESM both of which were identified as 
gallins with the former being shorter by a single N-terminal amino acid leucine (L). The gallin, 
also known as ovodefensin, was identified by Mann(Mann, 2007b) as a meleagrin-like peptide in 
chickens although similar homologous peptides were identified in many other species of 
birds(Naknukool, et al., 2011; Odani, et al., 1989).  Gong et al.(Gong, et al., 2010a) identified 3 
isoforms of gallin in chicken oviduct suggesting the polymorphism resulted from gene 
duplication.  However, in ESM we detected only 2 isoforms of the same gallin in both white and 
brown eggs although they occurred in differential proportions. The peptide corresponding to m/z 
4778 was provisionally identified as gallinacin 10 containing 3 disulfide bonds(Lynn, et al., 
2007; Xiao, Hughes, Ando, Matsuda, Cheng, Skinner-Noble and Zhang, 2004; Zhang and 
Sunkara, 2014) that we deduced to match to the stretch of sequence   corresponding to 
“DPLFPDTVACRTQGNFCRAGACPPTFTISGQCHGGLLNCCAKIPAQ”. This sequence 
nested the predicted, mature sequence of   gallinacin 10 suggesting that the m/z 4778 peptide 
may be the mature peptide sequence of gallinacin 10 that is 5 amino acid longer than the 
predicted sequence(Lynn, Higgs, Gaines, Tierney, James, Lloyd, Fares, Mulcahy and O'Farrelly, 
2004; Xiao, Hughes, Ando, Matsuda, Cheng, Skinner-Noble and Zhang, 2004; Zhang and 
Sunkara, 2014).  The occurrence of gallinacin 10 in other egg compartments and uterine 
secretion have been reported(Mann, Macek and Olsen, 2006; Marie, et al., 2015).   
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The GdHCl extract included most of the proteins and peptides in the methanol extract. A 
functional annotation of them using the STRAP(Bhatia, Perlman, Costello and McComb, 2009), 
showed these proteins being largely associated with metabolic, regulatory, developmental, and 
binding activities. Collagens, keratin, laminin, agrin, ovoglycan, and chondroitin sulfate are most 
likely associated with structural ecomponents of the membrane whereas proteins such as titin, 
obscurin, and nebulin, that are associated with muscle biomechanical function(Meyer and 
Wright, 2013), presumably, provide biomechanical support and resilience to the membrane 
protecting the egg against drop damage.  There were numerous cytoskeletal organizational, 
anchoring, scaffolding, and tethering proteins (dynein, filamin, nesprin, ninein, xin, golgin, and 
aczonin), and glycoproteins related to adhesion and differentiation functions (protocadherin),  
metal and vitamin binding proteins (ovotransferrin, riboflavin-binding), enzyme proteins 
(kinases, helicase, ligase), and regulatory proteins, the functional significance of which in ESM 
are not understood. Many of these molecules although may have been acquired during the 
passage of egg (Sun, et al., 2013) in the reproductive tract, they could very likely be responsible 
for providing molecular coordination for the development of embryo.  
 
Many proteins identified in the ESM such as defensin, ovotransferrin, ovocalyxin, and lysozyme 
including some keratin peptides which have been shown to be antimicrobial conceivably provide 
protection against microbial invasion (Gautron, et al., 2011; Superti, et al., 2007; Tam, et al., 
2012; Zhang and Sunkara, 2014). Protease inhibitors and anti-proteases such as ovalbumin Y, 
ovomacroglobulin (ovostatin), ovomucoid, ovoglycan, also possess antimicrobial activities that 
are associated with defensive functions (Gautron, et al., 2007; Huopalahti, 2007; Mann and 
Mann, 2011; Mann and Mann, 2013).  Mucoid substance such as ovomucin and mucin similarly,  
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provide defense against virus(Lieleg, et al., 2012).  222Likewise, there are serine proteases 
which possess microbiocidal activities (Heutinck, et al., 2010) present in GdHCl extracts of 
ESM.  The shell membrane is an antimicrobial protein rich matrix that not only provides 
protection to the egg but also harbors other proteins associated with cellular development that 
can provide external cues to embryo development. 
 
Mann et al.(Mann, et al., 2007), using decalcified egg shell membrane, identified the presence of 
several phosphoproteins such as osteopontin and phosvitin which are implicated in eggshell 
calcification(Hincke, et al., 2010).  The conspicuous absence of these 2 proteins in the inner 
eggshell membrane in our study suggests that either the shell membrane proximal to egg white, 
is naturally low or deficient in these proteins since it does not undergo calcification or our search 
parameters precluded the identification of these phosphoproteins.  However, both ovocleidin-116 
(OC-116) and ovocalyxin, both of which are phosphoproteins and implicated in mineralization 
process were identified (Hincke, Nys and Gautron, 2010; Horvat-Gordon, et al., 2008) that 
suggests that there was no problem related to our methodology to identify osteopontin and 
phosvitin. 
 
In conclusion, our results show that the ESM is rich in a variety of proteins and peptides many of 
which are associated with different protective and supportive functions for embryo. Whereas the 
presence of many abundant proteins in the ESM are consistent with the literature, the differences 
in identification of some minor abundance proteins can also be attributed to other related issues 
such as extraction conditions, and post translational modifications as well as search parameters 
(Aebersold, 2009; Ahmed and Rice, 2005). Overall, the natural abundance of such a large 
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repertoire of bioactive proteins and peptides in ESM suggests that it can be a potent nutritional 
supplement to improve health and performance of post-hatch poultry(Makkar, et al., 2015b) in 
the same paradigm of mammalian milk.  
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AvBD, avian beta defensin; ESI, electrospray ionization; ESM, egg shell membrane; FA, formic 
acid; ISD, in source decay; GdHCl, guanidine hydrochloride; LC-MS, liquid chromatography 
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Table 1:  Identification of peptides or proteins corresponding to mass and the analytical methods 
m/z Sequence Protein Method of 
identification 
1902 TPPFGGFREAFVPPVQR clusterin MALDI LIFT-
TOF/TOF, PMF-
MS/MS 2001 TPPFGGFREAFVPPVQRV clusterin ALDI LIFT-
TOF/TOF, PMF-
MS/MS 2157 TPPFGGFREAFVPPVQRV
R 
clusterin ALDI LIFT-
TOF/TOF, PMF-
MS/MS 3231 TPPFGGFREAFVPPVQRV
RLVPPRRRLS 
clusterin ALDI LIFT-
TOF/TOF, PMF-
MS/MS 2878 PPKRGLLPTNPPEAALPS
KPPGDRTVTA 
phosphatase and 
actin regulator 
protein 
ALDI-TOF-MS, 
LIFT-MS-MS 
2894 PNPIGLIGPIGPNVSNPIGL
LGPNGPNAFS 
sporozoit  surface 
protein 2-like 
MALDI-TOF-MS,  
LIFT-MS-MS 
4484 VLKYCPKIGYCSNTCSKT
QIWATSHGCKMYCCLPA
SWKW 
gallin protein 
precursor 
MALDI-ISD, 
LIFT-TOF/TOF 
4597 LVLKYCPKIGYCSNTCSK
TQIWATSHGCKMYCCLP
ASWKW 
gallin protein 
precursor 
MALDI-ISD, 
LIFT-TOF/TOF 
4778 DPLFPDTVACRTQGNFCR
AGACPPTFTISGQCHGGL
LNCCAKIPAQ KIPAQ 
predicted  
gallinacin 10 
MALDI-TOF-MS, 
LC-MS/MS 
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Table 2.  List of proteins/peptides identified from methanol extract of eggshell membrane 
Accession Protein MW [kDa] Scores #Peptides 
1 gi|345100466 Chain A, Hen Egg 
White Lysozyme 
with A 
Isoaspartate 
Residue 
14.3 801.6 (M:801.6) 14 
2 gi|342165190 Ovocleidin-116; 
Short=OC-116; 
Flags: Precursor 
76.8 285.4 (M:285.4) 7 
3 gi|4325105 clusterin [Gallus 
gallus] 
51.3 109.6 (M:109.6) 3 
4 gi|293321591 Gallin protein 
precursor [Gallus 
gallus] 
4.9 90.8 (M:90.8) 2 
5 gi|212485 ovoinhibitor 
[Gallus gallus] 
51.9 90.6 (M:90.6) 2 
6 gi|513218610 PREDICTED: 
uncharacterized 
protein 
LOC771972 
isoformX1 [Gallus 
gallus] 
27.1 71.5 (M:71.5) 2 
7 gi|513175885 PREDICTED: 
angiotensinogen 
isoform X7 
[Gallus gallus] 
51.3 45.3 (M:45.3) 2 
8 gi|46487955 gallinacin 10 
prepropeptide 
[Gallus gallus] 
7.1 35.0 (M:35.0) 1 
9 gi|295982528 Chain P, Tcr 21.30 
in complex With 
MHC Class II-ag 
(11-27) 
2.0 33.4 (M:33.4) 1 
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Figure 1.  Flow chart of eggshell membrane (ESM) sample processing. 
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Figure 2.   Direct MALDI-TOF mass spectrum of 70% methanol extract of ESM spotted with 
dihydroxybenzoic acid (DHB) as the MALDI matrix; m/z values of all the annotated peaks 
shown between m/z 1,000-6,000 represent values closer to average masses rather than 
monoisotopic masses.    
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Figure 3.  MALDI-TOF mass spectra of methanol extract of ESM without (a) and with reduction 
and alkylation with DTT/ iodoacetamide (b).  Arrows show peaks that were modified by 
carbamidomethylation and the m/z values of all annotated peaks represent values closer to 
average masses rather than monoisotopic masses.  
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Figure 4.   MALDI-ISD-TOF-MS of LC purified m/z 4597 (a) and 4484 (b) peaks in Figure 2 
showing the N-terminus sequence tag obtained from the corresponding c fragment ions. 
MASCOT sequence query identified them as gallin precursors.  
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Figure 5.  MALDI LIFT-TOF/TOF fragmentation spectra for LC purified, reduced/alkylated (a) 
m/z 4597 (m/z 4943) and (b) 4484 (m/z 4833) peaks showing corresponding b and y ion 
fragments and their identifications gallin precursors. 
 
 
 
 
 
 
 
m/z500 1000 1500 2000 2500 3000 3500 4000 4500
     0
     2
     4
     6
     8
    10
Abs . Int. * 1000
a W
b L C* T Q I W A T S H G C*
y H S T A W I Q T K S C* T N
211.499
b 2
331.578
y  2
297.255
a 3
325.430
b 3
617.337
b 5
777.558
b 6
1114.839
b 9
1496.544
b 12
1846.016
y  14
1798.558
b 15
1982.747
y  15
2069.766
y  16
2171.920
y  17
2171.920
b 18
2241.929
y  18
2273.944
b 19
2427.989
y  19
2400.783
b 20
2541.045
y  20
2486.028
a 21
2514.123
b 21
2669.118
y  21
2672.385
a 22
2700.556
b 22
2770.564
y  22
2770.564
b 23
2898.073
y  23
2871.666
b 24
2986.305
y  24
2959.378
b 25
3144.924
y  25
3068.380
a 26
3096.898
b 26
3245.557
y  26
3152.899
b 27
3360.406
y  27
3313.748
b 28
3573.698
b 30
(a) 
m/z1000 2000 3000 4000
      0.0
      0.5
      1.0
      1.5
      2.0
      2.5
      3.0
      3.5
      4.0
Abs. Int. * 1000
a K Y
b K I T S H G C K M S W
a-17 V AS W K
b-17 AS
y V L S
203.8
y 1
56.1
a-17 1
182.7
a 2
211.0
b 2
334.2
y 2
316.1
a 3
342.3
b 3
326.2
b-17 3
475.9
a 4
664.1
b 5
735.1
a 6
887.7
b 7
887.7
y 7
1003.8
b 8
1367.0
b-17 11
1633.2
y 12
2661.2
b 22
2762.8
b 23
2849.3
b 24
2988.4
y 24
2988.4
b 25
3044.2
b 26
3248.0
y 26
3204.3
b 27
3333.8
b 28
3464.7
b 29
3418.5
a-17 29
3831.0
y 31
4062.7
b 33
4111.5
a-17 34
4138.9
b-17 34
4330.1
y 35
4183.7
a-17 35
4211.9
b-17 35
4271.7
a-17 36
4833.9&(y39)&
(b) 
&m/z!4597!!
m/z!4484!
Figure!5!
 46
Figure 6. MALDI LIFT-TOF/TOF fragmentation for peak observed at m/z 1902 in direct 
MALDI-TOF-MS shown in Figure 2.  MASCOT MS/MS ion search identified it as a part of 
clusterin 
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Figure 7. MALDI peptide mass finger print of purified m/z 1902 in direct MALDI-TOF-MS 
showing tryptic fragments m/z 878 and 1042. 
 
 
 
 
 
 
 
1042.5 
878.4 
1080.5 
834.4 916.4 998.5 
1129.5 1293.5 
1114.5 
981.4 
0 
1 
2 
3 
4 
5 
6 
4 
x10 
In
te
ns
ity
 [a
.u
.] 
600 700 800 900 1000 1100 1200 1300 1400 1500 m/z 
TP
PF
GG
FR
&
EA
PV
PP
VQ
R&
Figure'7'
m/z 
 48
Figure 8. MALDI LIFT-TOF/TOF fragmentation of peak at m/z 2157 observed in direct 
MALDI-TOF-MS  in Figure 1 and MASCOT MS/MS ion search showing the corresponding 
sequence ‘TPPFGGFREAFVPPVQRVR,’  identified as the clusterin  fragment.   
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Figure 9.  MALDI LIFT-TOF/TOF fragmentation of m/z 2878 peak (Figure 2) and MASCOT 
MS/MS ion search identification of as phosphatase and actin regulator protein with 
corresponding fragment sequence PPKRGLLPTNPPEAALPSKPPGDRTVTA. 
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Figure 10.  MALDI LIFT-TOF/TOF fragmentation of peak at m/z 2894 in direct MALDI-TOF-
MS (Figure 2) and MASCOT MS/MS ion search showing its identification as a part of 
sporozoite surface protein 2-like corresponding to the  sequence 
“PNPIGLIGPIGPNVSNPIGLLGPNGPNAFS”.  
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Figure 11. STRAP annotation of GdHCl extracted, LC/MS/MS identified proteins
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Figure 12. Profiles of m/z 4484 and 4597 peptides expressed in white and brown ESM; the 
minor peaks (arrow) are corresponding gallin isoforms with loss of H2O 
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Supplementary Figure and Table legends 
 
Figure S1. MALDI LIFT-TOF/TOF fragmentation for peak observed at m/z 2001 in direct 
MALDI-TOF-MS. 
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Figure S2. MALDI LIFT-TOF/TOF fragmentation for peak observed at m/z 3231 in direct 
MALDI-TOF-MS shown in Figure 2.  MASCOT MS/MS ion search showed identification as a 
part of clusterin with a sequence tag,   TPPFGGFREAFVPPVQRVRLVPPRRRLS  
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Figure S3. MALDI peptide mass finger print (PMF) of purified m/z 2001 in direct MALDI-TOF-
MS  
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Figure S4.  MALDI peptide mass finger print (PMF) of purified m/z 3231 shown by direct 
MALDI-TOF-MS  
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Supplement Table 1 List of proteins/peptides identified from GdHCl extract of eggshell 
membrane (ESM). 
Row Accession Protein 
MW 
[kDa] Scores 
#Peptide
s 
      1 gi|71274079 
Gallin protein precursor 
[Gallus gallus] 77.8 
2609.0 
(M:2609.0) 54 
2 gi|83754919 
Chain A, Crystal 
Structure Of Aluminum-
Bound Ovotransferrin At 
2.15 Angstrom 
Resolution 75.8 
2593.4 
(M:2593.4) 54 
3 gi|34811330 
Chain A, Crystal 
Structure Of S-
ovalbumin At 1.9 
Angstrom Resolution 42.9 
1698.2 
(M:1698.2) 34 
4 gi|440923753 
Chain C, Crystal 
Structure Of Uncleaved 
Ovalbumin At 1.95 
Angstroms Resolution 42.8 
1637.2 
(M:1637.2) 32 
5 gi|510032768 
ovalbumin-related 
protein X [Gallus gallus 
gallus] 45.4 
732.1 
(M:732.1) 17 
6 gi|229157 lysozyme 14.3 
700.1 
(M:700.1) 12 
7 gi|345100466 
Chain A, Hen Egg White 
Lysozyme With A 
Isoaspartate Residue 14.3 
697.4 
(M:697.4) 14 
8 gi|385145541 
ovalbumin-related Y 
[Gallus gallus] 43.8 
595.3 
(M:595.3) 16 
9 gi|513193913 
PREDICTED: titin 
isoform X2 [Gallus 
gallus] 3652 
523.8 
(M:523.8) 34 
10 gi|513188927 
PREDICTED: mucin-6 
[Gallus gallus] 291.1 
457.4 
(M:457.4) 15 
11 gi|4325105 clusterin [Gallus gallus] 51.3 
443.8 
(M:443.8) 11 
12 gi|129295 
RecName: 
Full=Ovalbumin-related 
protein X; AltName: 
Full=Gene X protein 26.3 
405.1 
(M:405.1) 9 
13 gi|162952006 
ovomucoid precursor 
[Gallus gallus] 22.4 
349.6 
(M:349.6) 8 
14 gi|223464 ovomucoid 20.2 
339.5 
(M:339.5) 8 
15 gi|513191195 
PREDICTED: beta-
microseminoprotein-like 12.1 
286.3 
(M:286.3) 6 
 58
[Gallus gallus] 
16 gi|352173 protein,riboflavin binding 25 
286.0 
(M:286.0) 6 
17 gi|63052 
unnamed protein product 
[Gallus gallus] 17.5 
272.1 
(M:272.1) 5 
18 gi|671865 
ovomacroglobulin, 
ovostatin [Gallus gallus] 164 
264.0 
(M:264.0) 8 
19 gi|7441632 ovocleidin - chicken 15.3 
240.7 
(M:240.7) 5 
20 gi|385145531 
ovoglobulinG2 type AB 
[Gallus gallus] 47.4 
239.1 
(M:239.1) 9 
21 gi|22218070 
ovoglycoprotein 
precursor [Gallus gallus] 22.3 
238.9 
(M:238.9) 5 
22 gi|342165190 
RecName: 
Full=Ovocleidin-116; 
Short=OC-116; Flags: 
Precursor 76.8 
221.1 
(M:221.1) 8 
23 gi|513167276 
PREDICTED: obscurin 
[Gallus gallus] 1158.7 
209.6 
(M:209.6) 13 
24 gi|212485 
ovoinhibitor [Gallus 
gallus] 51.9 
148.3 
(M:148.3) 4 
25 gi|513178501 
PREDICTED: dystonin 
isoform X4 [Gallus 
gallus] 920.1 
144.0 
(M:144.0) 10 
26 gi|513206786 
PREDICTED: 
ovoinhibitor [Gallus 
gallus] 57 
137.7 
(M:137.7) 4 
27 gi|513193378 
PREDICTED: dynein 
heavy chain 7, axonemal 
isoform X1 [Gallus 
gallus] 458.9 
133.7 
(M:133.7) 9 
28 gi|223059 
ovalbumin N term 
fragment 4.2 
130.7 
(M:130.7) 2 
29 gi|4204093 
egg white lysozyme 
[Gallus gallus] 4.9 
124.8 
(M:124.8) 4 
30 gi|363734560 
PREDICTED: mucin-5B 
isoform X1 [Gallus 
gallus] 233.4 
122.0 
(M:122.0) 6 
31 gi|61102692 Xin [Gallus gallus] 216.1 
116.5 
(M:116.5) 8 
32 gi|365813307 
Chain A, Crystal 
Structure Of Monoz-
Biotin-Avidin Complex 13.6 
113.3 
(M:113.3) 3 
33 gi|576329 
Chain A, Crystal 
Structure Of Vitelline 
Membrane Outer Layer 18 
112.0 
(M:112.0) 4 
  59 
Protein I (Vmo-I): A 
Folding Motif With 
Homologous Greek Key 
Structures Related By An 
Internal Three-Fold 
Symmetry 
34 gi|513180391 
PREDICTED: LOW 
QUALITY PROTEIN: 
transcription initiation 
factor TFIID subunit 1 
[Gallus gallus] 216.6 
109.6 
(M:109.6) 7 
35 gi|513195515 
PREDICTED: nebulin 
[Gallus gallus] 752.6 
107.4 
(M:107.4) 8 
36 gi|513206710 
PREDICTED: histone-
lysine N-
methyltransferase, H3 
lysine-36 and H4 lysine-
20 specific isoform X6 
[Gallus gallus] 290.2 
107.0 
(M:107.0) 6 
37 gi|513213183 
PREDICTED: golgin 
subfamily A member 1 
isoform X7 [Gallus 
gallus] 90.2 
106.7 
(M:106.7) 6 
38 gi|1334744 
spectrin alpha chain 
[Gallus gallus] 281.8 
105.3 
(M:105.3) 7 
39 gi|513229885 
PREDICTED: sperm 
flagellar protein 2 
[Gallus gallus] 270.1 
103.2 
(M:103.2) 7 
40 gi|102221132 
apolipoprotein B [Gallus 
gallus] 523 
102.6 
(M:102.6) 6 
41 gi|513217982 
PREDICTED: protein 
kinase C-binding protein 
1 isoform X22 [Gallus 
gallus] 132 
101.3 
(M:101.3) 6 
42 gi|513157185 
PREDICTED: golgin 
subfamily B member 1 
isoform X3 [Gallus 
gallus] 362.7 
100.6 
(M:100.6) 6 
43 gi|513190030 
PREDICTED: ninein 
isoform X15 [Gallus 
gallus] 233.4 99.6 (M:99.6) 7 
44 gi|6433844 aczonin [Gallus gallus] 560.4 99.2 (M:99.2) 6 
45 gi|513162168 
PREDICTED: uro-
adherence factor A 
isoform X1 [Gallus 
gallus] 245.5 97.2 (M:97.2) 6 
 60
46 gi|363727445 
PREDICTED: protein 
piccolo, partial [Gallus 
gallus] 401.4 96.1 (M:96.1) 6 
47 gi|363738135 
PREDICTED: LOW 
QUALITY PROTEIN: 
chromodomain-helicase-
DNA-binding protein 9 
[Gallus gallus] 322.2 96.0 (M:96.0) 6 
48 gi|63370 
unnamed protein product 
[Gallus gallus] 422.6 95.2 (M:95.2) 7 
49 gi|513217433 
PREDICTED: 
centrosome-associated 
protein CEP250 isoform 
X14 [Gallus gallus] 287.7 92.4 (M:92.4) 7 
50 gi|513187528 
PREDICTED: spectrin 
beta chain, non-
erythrocytic 5 [Gallus 
gallus] 453 92.3 (M:92.3) 6 
51 gi|157168357 
centromere protein F 
[Gallus gallus] 339.7 90.4 (M:90.4) 6 
52 gi|371928996 keratin 75 [Gallus gallus] 54.3 90.0 (M:90.0) 3 
53 gi|116669 
RecName: Full=Acetyl-
CoA carboxylase; 
Short=ACC; Includes: 
RecName: Full=Biotin 
carboxylase 262.6 89.9 (M:89.9) 6 
54 gi|513218156 
PREDICTED: death-
inducer obliterator 1 
isoform X4 [Gallus 
gallus] 223.5 89.8 (M:89.8) 5 
55 gi|293321591 
Gallin protein precursor 
[Gallus gallus] 4.9 88.4 (M:88.4) 2 
56 gi|513201109 
PREDICTED: vacuolar 
protein sorting-associated 
protein 13C isoform X2 
[Gallus gallus] 416.6 88.2 (M:88.2) 5 
57 gi|513240592 
PREDICTED: LOW 
QUALITY PROTEIN: 
histone-lysine N-
methyltransferase MLL2, 
partial [Gallus gallus] 575.9 87.7 (M:87.7) 6 
58 gi|356991167 
E3 ubiquitin-protein 
ligase HERC2 [Gallus 
gallus] 528.7 86.8 (M:86.8) 7 
59 gi|513214081 
PREDICTED: E3 
ubiquitin-protein ligase 602.8 86.0 (M:86.0) 7 
 61
RNF213 isoform X6 
[Gallus gallus] 
60 gi|513182967 
PREDICTED: rho 
GTPase-activating 
protein 24 isoform X5 
[Gallus gallus] 83.8 85.9 (M:85.9) 5 
61 gi|29837126 
SMC1 protein cohesin 
subunit [Gallus gallus] 142.9 85.4 (M:85.4) 5 
62 gi|513210403 
PREDICTED: LOW 
QUALITY PROTEIN: 
acetyl-CoA carboxylase 
2 [Gallus gallus] 266.2 85.0 (M:85.0) 6 
63 gi|513189629 
PREDICTED: nesprin-2 
isoform X1 [Gallus 
gallus] 803.8 84.9 (M:84.9) 6 
64 gi|392018 filamin [Gallus gallus] 275.7 84.8 (M:84.8) 5 
65 gi|363744378 
PREDICTED: DENN 
domain-containing 
protein 4C isoform X5 
[Gallus gallus] 211.5 84.3 (M:84.3) 4 
66 gi|513182982 
PREDICTED: rho 
GTPase-activating 
protein 24 isoform X10 
[Gallus gallus] 73.2 83.9 (M:83.9) 5 
67 gi|15341204 
cgABP260 [Gallus 
gallus] 280.3 82.9 (M:82.9) 5 
68 gi|513193268 
PREDICTED: A-kinase 
anchor protein 9 isoform 
X20 [Gallus gallus] 506.8 82.8 (M:82.8) 6 
69 gi|513227073 
PREDICTED: RNA 
exonuclease 1 homolog 
isoform X3 [Gallus 
gallus] 130.6 82.6 (M:82.6) 6 
70 gi|513181431 
PREDICTED: 
uncharacterized protein 
KIAA1210 isoform X5 
[Gallus gallus] 103.6 82.3 (M:82.3) 4 
71 gi|513210496 
PREDICTED: 
tetratricopeptide repeat 
protein 28 [Gallus gallus] 265.1 82.0 (M:82.0) 5 
72 gi|513182471 
PREDICTED: 
extracellular matrix 
protein FRAS1 isoform 
X2 [Gallus gallus] 439.3 81.6 (M:81.6) 4 
73 gi|513176503 
PREDICTED: nesprin-1 
isoform X6 [Gallus 1010.5 80.6 (M:80.6) 7 
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gallus] 
74 gi|513185495 
PREDICTED: Alstrom 
syndrome protein 1 
isoform X1 [Gallus 
gallus] 292.6 79.5 (M:79.5) 5 
75 gi|513196869 
PREDICTED: 
nucleoprotein TPR 
isoform X6 [Gallus 
gallus] 276.8 78.7 (M:78.7) 6 
76 gi|513176284 
PREDICTED: utrophin 
isoform X2 [Gallus 
gallus] 351.1 78.3 (M:78.3) 5 
77 gi|513221651 
PREDICTED: 
microtubule-actin cross-
linking factor 1-like, 
partial [Gallus gallus] 363 78.0 (M:78.0) 6 
78 gi|1020104 
melanotransferrin/EOS47 
[Gallus gallus] 80.9 77.9 (M:77.9) 4 
79 gi|7248371 
myosin heavy chain 
[Gallus gallus] 223.3 76.0 (M:76.0) 5 
80 gi|118090437 
PREDICTED: 
protocadherin Fat 1 
isoform X6 [Gallus 
gallus] 507.9 76.0 (M:76.0) 5 
81 gi|513195972 
PREDICTED: LOW 
QUALITY PROTEIN: 
abnormal spindle-like 
microcephaly-associated 
protein homolog [Gallus 
gallus] 398.3 75.8 (M:75.8) 6 
82 gi|299469458 
nuclear mitotic apparatus 
protein [Gallus gallus] 241.4 75.8 (M:75.8) 5 
83 gi|513178510 
PREDICTED: dystonin 
isoform X7 [Gallus 
gallus] 308.2 75.7 (M:75.7) 5 
84 gi|513202440 
PREDICTED: 
microtubule-associated 
protein 1A [Gallus 
gallus] 307.1 75.5 (M:75.5) 5 
85 gi|91208266 
RecName: 
Full=Cytospin-A; 
AltName: Full=SPECC1-
like protein; AltName: 
Full=Sperm antigen with 
calponin homology and 
coiled-coil domains 1- 124.8 75.2 (M:75.2) 5 
  63 
like 
86 gi|158186693 
A-kinase anchor protein 
9 [Gallus gallus] 455.2 75.1 (M:75.1) 5 
87 gi|363731544 
PREDICTED: dynein 
heavy chain 8, axonemal 
[Gallus gallus] 534.2 74.6 (M:74.6) 5 
88 gi|363737124 
PREDICTED: dedicator 
of cytokinesis protein 10 
[Gallus gallus] 249.7 74.4 (M:74.4) 3 
89 gi|513210175 
PREDICTED: 
kinetochore-associated 
protein 1 isoform X3 
[Gallus gallus] 251 73.9 (M:73.9) 4 
90 gi|513179159 
PREDICTED: 
intersectin-2 isoform X6 
[Gallus gallus] 172.2 73.7 (M:73.7) 4 
91 gi|513158331 
PREDICTED: 
centrosomal protein of 
290 kDa isoform X6 
[Gallus gallus] 288.8 73.4 (M:73.4) 5 
92 gi|62954540 
Ovocalyxin-36 precursor 
[Gallus gallus] 48.8 73.2 (M:73.2) 1 
93 gi|513204692 
PREDICTED: LOW 
QUALITY PROTEIN: 
dynein heavy chain 1, 
axonemal [Gallus gallus] 489.6 73.2 (M:73.2) 5 
94 gi|513183661 
PREDICTED: ankyrin-2 
[Gallus gallus] 447.9 72.8 (M:72.8) 5 
95 gi|478430999 
melanoma inhibitory 
activity protein 3 
precursor [Gallus gallus] 221.6 72.6 (M:72.6) 5 
96 gi|513218117 
PREDICTED: laminin 
subunit alpha-5 isoform 
X9 [Gallus gallus] 408.8 72.3 (M:72.3) 5 
97 gi|513160180 
PREDICTED: 
ELKS/Rab6-
interacting/CAST family 
member 1 isoform X7 
[Gallus gallus] 117.2 72.2 (M:72.2) 5 
98 gi|206597434 
collagen alpha-2(I) chain 
precursor [Gallus gallus] 128.8 71.9 (M:71.9) 5 
99 gi|50746309 
PREDICTED: rho 
GTPase-activating 
protein 10 isoform 2 
[Gallus gallus] 88.9 71.8 (M:71.8) 5 
100 gi|50745053 PREDICTED: structural 127.7 70.9 (M:70.9) 5 
  64 
maintenance of 
chromosomes protein 6 
isoform X2 [Gallus 
gallus] 
101 gi|363736045 
PREDICTED: telomere-
associated protein RIF1 
[Gallus gallus] 254.2 70.8 (M:70.8) 4 
102 gi|363737706 
PREDICTED: LOW 
QUALITY PROTEIN: 
unconventional myosin-
Vc [Gallus gallus] 202.8 70.2 (M:70.2) 4 
103 gi|116248042 
beta-defensin 11 [Gallus 
gallus] 11.6 70.1 (M:70.1) 1 
104 gi|513213292 
PREDICTED: myosin-3 
[Gallus gallus] 219 70.1 (M:70.1) 4 
105 gi|343469213 
MPDZ protein [Gallus 
gallus] 214.1 70.0 (M:70.0) 5 
106 gi|363739068 
PREDICTED: probable 
phospholipid-
transporting ATPase VB 
isoform X8 [Gallus 
gallus] 165.6 69.5 (M:69.5) 4 
107 gi|513180457 
PREDICTED: testis-
expressed sequence 11 
protein isoform X8 
[Gallus gallus] 101.4 69.4 (M:69.4) 4 
108 gi|513168024 
PREDICTED: sickle tail 
protein homolog isoform 
X16 [Gallus gallus] 156.7 69.2 (M:69.2) 4 
109 gi|513194213 
PREDICTED: bile salt 
export pump isoform X2 
[Gallus gallus] 148.5 68.2 (M:68.2) 4 
110 gi|513175708 
PREDICTED: LOW 
QUALITY PROTEIN: 
ryanodine receptor 2 
[Gallus gallus] 564.6 67.7 (M:67.7) 5 
111 gi|513190198 
PREDICTED: protein 
AHNAK2 [Gallus gallus] 389.1 67.3 (M:67.3) 5 
112 gi|363734923 
PREDICTED: 
cytoplasmic dynein 1 
heavy chain 1 [Gallus 
gallus] 525.5 67.2 (M:67.2) 4 
113 gi|2145309 TBP0 [Gallus gallus] 33.1 67.0 (M:67.0) 4 
114 gi|60544838 
gonad expressed 
transcript [Gallus gallus] 177.1 66.9 (M:66.9) 5 
115 gi|298542005 unnamed protein product 121.7 66.8 (M:66.8) 5 
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[Gallus gallus] 
116 gi|363728442 
PREDICTED: coiled-coil 
domain-containing 
protein KIAA1407 
homolog isoform X2 
[Gallus gallus] 106 66.4 (M:66.4) 4 
117 gi|513164437 
PREDICTED: ADP-
ribosylhydrolase like 1 
isoform X4 [Gallus 
gallus] 208.5 66.4 (M:66.4) 3 
118 gi|21623677 SPACR [Gallus gallus] 102.6 66.1 (M:66.1) 4 
119 gi|118093388 
PREDICTED: E3 
ubiquitin-protein ligase 
HECW2 [Gallus gallus] 176 65.9 (M:65.9) 3 
120 gi|513192568 
PREDICTED: WD 
repeat-containing protein 
96 [Gallus gallus] 204 65.8 (M:65.8) 4 
121 gi|513188813 
PREDICTED: protein 
unc-79 homolog isoform 
X29 [Gallus gallus] 262.5 65.7 (M:65.7) 4 
122 gi|513197226 
PREDICTED: 
bromodomain testis-
specific protein isoform 
X6 [Gallus gallus] 102.7 65.6 (M:65.6) 5 
123 gi|162417991 
protocadherin Fat 3 
precursor [Gallus gallus] 501.6 65.3 (M:65.3) 4 
124 gi|513225858 
PREDICTED: formin-
like 1 [Gallus gallus] 131.3 65.2 (M:65.2) 5 
125 gi|513208391 
PREDICTED: 
polycystin-1 isoform X3 
[Gallus gallus] 479.2 64.9 (M:64.9) 3 
126 gi|513229901 
PREDICTED: ATP-
dependent RNA helicase 
DHX29, partial [Gallus 
gallus] 148 64.7 (M:64.7) 4 
127 gi|513175724 
PREDICTED: LOW 
QUALITY PROTEIN: 
lysosomal-trafficking 
regulator [Gallus gallus] 426.9 64.6 (M:64.6) 5 
128 gi|513184797 
PREDICTED: 
biorientation of 
chromosomes in cell 
division 1-like isoform 
X3 [Gallus gallus] 325.3 64.6 (M:64.6) 4 
129 gi|513204547 
PREDICTED: stabilin-1 
[Gallus gallus] 268.7 64.5 (M:64.5) 4 
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130 gi|513166523 
PREDICTED: LOW 
QUALITY PROTEIN: 
teneurin-4 isoform X6 
[Gallus gallus] 311.5 64.4 (M:64.4) 4 
131 gi|253735708 
glutathione peroxidase 3 
precursor [Gallus gallus] 24.6 63.9 (M:63.9) 1 
132 gi|513170156 
PREDICTED: 
transcriptional repressor 
NF-X1 isoform X16 
[Gallus gallus] 119.4 63.8 (M:63.8) 3 
133 gi|513160161 
PREDICTED: 
serine/threonine-protein 
kinase WNK1 isoform 
X5 [Gallus gallus] 293.8 63.4 (M:63.4) 4 
134 gi|363744372 
PREDICTED: LOW 
QUALITY PROTEIN: 
mitogen-activated protein 
kinase kinase kinase 1 
[Gallus gallus] 170.3 63.2 (M:63.2) 4 
135 gi|513211039 
PREDICTED: DNA 
polymerase epsilon 
catalytic subunit A 
isoform X1 [Gallus 
gallus] 260.7 63.0 (M:63.0) 4 
136 gi|513187516 
PREDICTED: mitogen-
activated protein kinase-
binding protein 1 isoform 
X1 [Gallus gallus] 189.4 62.9 (M:62.9) 4 
137 gi|438007 
alpha-2-macroglobulin 
receptor [Gallus gallus] 506.8 62.9 (M:62.9) 4 
138 gi|363732080 
PREDICTED: BEN 
domain-containing 
protein 3 isoformX2 
[Gallus gallus] 87.6 62.7 (M:62.7) 3 
139 gi|513162558 
PREDICTED: glutamate 
receptor ionotropic, 
kainate 1 isoform X2 
[Gallus gallus] 102.1 62.4 (M:62.4) 4 
140 gi|60098865 
hypothetical protein 
RCJMB04_13m2 [Gallus 
gallus] 158.3 62.0 (M:62.0) 3 
141 gi|363740639 
PREDICTED: myosin 
heavy chain, skeletal 
muscle, adult isoform X1 
[Gallus gallus] 223.1 62.0 (M:62.0) 3 
142 gi|513181168 PREDICTED: 163.2 62.0 (M:62.0) 4 
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uncharacterized protein 
KIAA2022 isoform X7 
[Gallus gallus] 
143 gi|211121 agrin [Gallus gallus] 211.3 61.9 (M:61.9) 5 
144 gi|3184528 
T-Box protein 3 [Gallus 
gallus] 46.4 61.6 (M:61.6) 4 
145 gi|513162834 
PREDICTED: E3 
ubiquitin-protein ligase 
TTC3 [Gallus gallus] 226.8 61.2 (M:61.2) 4 
146 gi|363737435 
PREDICTED: 1-
phosphatidylinositol 4,5-
bisphosphate 
phosphodiesterase eta-1 
isoform X4 [Gallus 
gallus] 188.8 61.1 (M:61.1) 5 
147 gi|513166963 
PREDICTED: C2 
domain-containing 
protein 3 isoform X6 
[Gallus gallus] 256.9 61.0 (M:61.0) 4 
148 gi|118085134 
PREDICTED: 
cytoplasmic dynein 2 
heavy chain 1 isoform 
X2 [Gallus gallus] 491.7 61.0 (M:61.0) 3 
149 gi|513165698 
PREDICTED: protein 
furry homolog isoform 
X2 [Gallus gallus] 343.8 60.9 (M:60.9) 5 
150 gi|513211222 
PREDICTED: HORMA 
domain-containing 
protein 2 isoform X7 
[Gallus gallus] 38.6 60.9 (M:60.9) 3 
151 gi|226823291 
hydrocephalus inducing 
homolog [Gallus gallus] 564.4 60.6 (M:60.6) 4 
152 gi|513178325 
PREDICTED: LOW 
QUALITY PROTEIN: 
filamin-A-interacting 
protein 1 [Gallus gallus] 137.9 60.1 (M:60.1) 4 
153 gi|513228901 
PREDICTED: Nipped-B 
homolog-like isoform X7 
[Gallus gallus] 291.1 60.1 (M:60.1) 4 
154 gi|513176211 
PREDICTED: mitogen-
activated protein kinase 
kinase kinase 4 isoform 
X3 [Gallus gallus] 178.5 59.9 (M:59.9) 4 
155 gi|344925838 
FYVE and coiled-coil 
domain-containing 
protein 1 [Gallus gallus] 176.8 59.9 (M:59.9) 3 
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156 gi|513162041 
PREDICTED: pleckstrin 
homology-like domain, 
family B, member 2 
isoform X3 [Gallus 
gallus] 147.7 59.8 (M:59.8) 4 
157 gi|10241574 teneurin-2 [Gallus gallus] 310.6 59.8 (M:59.8) 4 
158 gi|389616152 
TBC1 domain family 
member 1 [Gallus gallus] 134.2 59.8 (M:59.8) 3 
159 gi|513188188 
PREDICTED: 
uncharacterized protein 
LOC423333 isoform X7 
[Gallus gallus] 193.9 59.7 (M:59.7) 4 
160 gi|513202856 
PREDICTED: pleckstrin 
homology domain-
containing family G 
member 4B isoform X1 
[Gallus gallus] 125.1 59.6 (M:59.6) 4 
161 gi|513192909 
PREDICTED: ATP-
binding cassette sub-
family A member 12 
[Gallus gallus] 428.2 59.6 (M:59.6) 5 
162 gi|2463529 
DNA 
topoisomeraseII_beta 
[Gallus gallus] 183.1 59.5 (M:59.5) 4 
163 gi|513183646 
PREDICTED: 
protocadherin Fat 4 
[Gallus gallus] 543.7 59.4 (M:59.4) 4 
164 gi|513170392 
PREDICTED: lysine-
specific histone 
demethylase 1B isoform 
X1 [Gallus gallus] 65.9 59.1 (M:59.1) 4 
165 gi|513210289 
PREDICTED: LOW 
QUALITY PROTEIN: 
probable E3 ubiquitin-
protein ligase HECTD4 
[Gallus gallus] 486.2 59.1 (M:59.1) 3 
166 gi|513229854 
PREDICTED: 
microtubule-associated 
protein 1B isoform X2 
[Gallus gallus] 288.8 58.7 (M:58.7) 4 
167 gi|513172748 
PREDICTED: oxygen-
regulated protein 1 
[Gallus gallus] 390.1 58.6 (M:58.6) 4 
168 gi|513222086 
PREDICTED: suppressor 
of tumorigenicity 14 
protein homolog isoform 94.1 58.4 (M:58.4) 4 
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X16 [Gallus gallus] 
169 gi|513209631 
PREDICTED: dynein 
heavy chain 3, axonemal 
isoform X11 [Gallus 
gallus] 432.9 58.1 (M:58.1) 4 
170 gi|513169783 
PREDICTED: LOW 
QUALITY PROTEIN: 
golgin subfamily A 
member 4 [Gallus gallus] 264.1 57.5 (M:57.5) 3 
171 gi|14278285 
Chain A, Crystal 
Structure Of Avian Atic, 
A Bifunctional 
Transformylase And 
Cyclohydrolase Enzyme 
In Purine Biosynthesis At 
1.75 Ang. Resolution 64.2 57.3 (M:57.3) 4 
172 gi|50733622 
PREDICTED: CD83 
antigen [Gallus gallus] 23.6 57.2 (M:57.2) 3 
173 gi|513178813 
PREDICTED: myelin 
transcription factor 1-like 
isoform X30 [Gallus 
gallus] 111 57.0 (M:57.0) 4 
174 gi|513199927 
PREDICTED: leucine-
rich repeat-containing 
protein 31 isoform X2 
[Gallus gallus] 64.1 56.8 (M:56.8) 3 
175 gi|50593343 
axin protein 1 transcript 
variant 1 [Gallus gallus] 94.8 56.5 (M:56.5) 2 
176 gi|513175430 
PREDICTED: 
baculoviral IAP repeat-
containing protein 6 
[Gallus gallus] 506.2 56.4 (M:56.4) 3 
177 gi|313661353 
rho-associated protein 
kinase 1 [Gallus gallus] 158.6 56.4 (M:56.4) 4 
178 gi|363734028 
PREDICTED: LOW 
QUALITY PROTEIN: 1-
phosphatidylinositol 4,5-
bisphosphate 
phosphodiesterase beta-2 
[Gallus gallus] 138.5 56.4 (M:56.4) 4 
179 gi|462740 
RecName: 
Full=Neuronal cell 
adhesion molecule; 
Short=Nr-CAM; 
AltName: Full=Neuronal 
surface protein Bravo; 141.8 56.2 (M:56.2) 3 
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Short=gBravo; AltName: 
Full=NgCAM-related 
cell adhesion molecule; 
Short=Ng-CAM-related; 
Flags: Precursor 
180 gi|513182151 
PREDICTED: SWI/SNF-
related matrix-associated 
actin-dependent regulator 
of chromatin subfamily 
A member 5 isoform X1 
[Gallus gallus] 116.6 56.0 (M:56.0) 4 
181 gi|513187539 
PREDICTED: cytosolic 
phospholipase A2 epsilon 
isoform X2 [Gallus 
gallus] 91.7 55.9 (M:55.9) 3 
182 gi|513158072 
PREDICTED: LOW 
QUALITY PROTEIN: 
gamma-tubulin complex 
component 6 [Gallus 
gallus] 203.3 55.8 (M:55.8) 4 
183 gi|227016 apolipoprotein AI 28.8 55.7 (M:55.7) 3 
184 gi|513229146 
PREDICTED: 
chondroitin sulfate 
proteoglycan 4-like 
isoform X2 [Gallus 
gallus] 275.9 55.6 (M:55.6) 3 
185 gi|513163146 
PREDICTED: peripheral 
plasma membrane 
protein CASK isoform 
X11 [Gallus gallus] 94.5 55.3 (M:55.3) 3 
186 gi|510936992 
chromodomain-helicase-
DNA-binding protein 2 
[Gallus gallus] 212.7 54.9 (M:54.9) 4 
187 gi|513199109 
PREDICTED: kinesin 
family member 1A 
isoform X5 [Gallus 
gallus] 192.4 54.4 (M:54.4) 4 
188 gi|117380068 
cortactin-binding protein 
2 [Gallus gallus] 177.9 54.4 (M:54.4) 3 
189 gi|513188106 
PREDICTED: 
bromodomain adjacent to 
zinc finger domain 
protein 1A isoform X7 
[Gallus gallus] 168.3 54.3 (M:54.3) 3 
190 gi|513174643 
PREDICTED: ninein-
like protein isoform X10 62.8 54.1 (M:54.1) 4 
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[Gallus gallus] 
191 gi|513193788 
PREDICTED: 
neurobeachin-like 1 
isoform X12 [Gallus 
gallus] 306.2 54.0 (M:54.0) 3 
192 gi|53130528 
hypothetical protein 
RCJMB04_8i12 [Gallus 
gallus] 109.8 53.9 (M:53.9) 3 
193 gi|513172897 
PREDICTED: LOW 
QUALITY PROTEIN: 
regulating synaptic 
membrane exocytosis 
protein 2 [Gallus gallus] 181.8 53.8 (M:53.8) 3 
194 gi|513158188 
PREDICTED: DNA 
helicase B isoform X3 
[Gallus gallus] 116.1 53.7 (M:53.7) 2 
195 gi|76468580 
aldehyde oxidase 2 
[Gallus gallus] 147.7 53.6 (M:53.6) 4 
196 gi|118095631 
PREDICTED: probable 
E3 ubiquitin-protein 
ligase HERC1 isoform 
X8 [Gallus gallus] 532.6 53.0 (M:53.0) 4 
197 gi|513200951 
PREDICTED: S phase 
cyclin A-associated 
protein in the 
endoplasmic reticulum 
isoform X6 [Gallus 
gallus] 154.5 52.8 (M:52.8) 3 
198 gi|513166677 
PREDICTED: atherin-
like [Gallus gallus] 33.5 52.7 (M:52.7) 2 
199 gi|513194247 
PREDICTED: low-
density lipoprotein 
receptor-related protein 2 
isoform X9 [Gallus 
gallus] 521.8 52.5 (M:52.5) 4 
200 gi|14017756 
chick atrial myosin heavy 
chain [Gallus gallus] 221.7 52.3 (M:52.3) 3 
201 gi|513181916 
PREDICTED: probable 
ATP-dependent RNA 
helicase DDX60 isoform 
X1 [Gallus gallus] 210.8 51.9 (M:51.9) 4 
202 gi|513209317 
PREDICTED: 
tetratricopeptide repeat 
protein 18 isoform X1 
[Gallus gallus] 138.2 51.8 (M:51.8) 3 
203 gi|513158974 PREDICTED: 207 51.6 (M:51.6) 3 
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transcription factor 20 
isoform X7 [Gallus 
gallus] 
204 gi|513185632 
PREDICTED: attractin, 
partial [Gallus gallus] 144.3 51.5 (M:51.5) 3 
205 gi|513232435 
PREDICTED: 
proteasome-associated 
protein ECM29 homolog 
isoform X3 [Gallus 
gallus] 203.9 51.4 (M:51.4) 4 
206 gi|513203915 
PREDICTED: polycystic 
kidney disease protein 1-
like 2 [Gallus gallus] 273.3 51.4 (M:51.4) 4 
207 gi|53133498 
hypothetical protein 
RCJMB04_17e23 
[Gallus gallus] 49.4 51.4 (M:51.4) 3 
208 gi|513165204 
PREDICTED: von 
Willebrand factor A 
domain-containing 
protein 8-like [Gallus 
gallus] 213.4 51.3 (M:51.3) 3 
209 gi|513163290 
PREDICTED: maestro 
heat-like repeat-
containing protein family 
member 2B-like isoform 
X9 [Gallus gallus] 141.2 51.2 (M:51.2) 3 
210 gi|513212577 
PREDICTED: protein 
PRRC2B isoform X15 
[Gallus gallus] 245.8 51.1 (M:51.1) 4 
211 gi|483968268 
mRNA turnover protein 
4 homolog [Gallus 
gallus] 28 50.8 (M:50.8) 3 
212 gi|513211075 
PREDICTED: scavenger 
receptor class F member 
2 isoform X2 [Gallus 
gallus] 102.3 50.7 (M:50.7) 3 
213 gi|363731756 
PREDICTED: usherin 
[Gallus gallus] 573.9 50.7 (M:50.7) 3 
214 gi|513171368 
PREDICTED: dynein 
heavy chain 5, axonemal-
like [Gallus gallus] 533.7 50.7 (M:50.7) 4 
215 gi|513178065 
PREDICTED: midasin 
isoform X4 [Gallus 
gallus] 632.3 50.4 (M:50.4) 3 
216 gi|513209920 
PREDICTED: probable 
ATP-dependent RNA 116.8 50.4 (M:50.4) 3 
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helicase DHX37 isoform 
X3 [Gallus gallus] 
217 gi|513221021 
PREDICTED: lysine-
specific histone 
demethylase 1A, partial 
[Gallus gallus] 86.3 50.3 (M:50.3) 3 
218 gi|513194426 
PREDICTED: 
tetratricopeptide repeat 
protein 21B isoform X3 
[Gallus gallus] 157.3 50.2 (M:50.2) 3 
219 gi|53133818 
hypothetical protein 
RCJMB04_20k2 [Gallus 
gallus] 86.2 50.2 (M:50.2) 3 
220 gi|211622 
alpha-3 collagen type VI 
[Gallus gallus] 339.4 50.0 (M:50.0) 3 
221 gi|513200349 
PREDICTED: mediator 
complex subunit 12-like 
isoform X3 [Gallus 
gallus] 237.8 49.6 (M:49.6) 3 
222 gi|293651608 
cytoplasmic linker 
associated protein 2 
[Gallus gallus] 164.8 49.5 (M:49.5) 3 
223 gi|5733818 gephyrin [Gallus gallus] 79.7 49.5 (M:49.5) 3 
224 gi|2330003 
glutamine rich protein, 
partial [Gallus gallus] 112.2 49.5 (M:49.5) 4 
225 gi|513211995 
PREDICTED: FK506-
binding protein 15 
isoform X8 [Gallus 
gallus] 138.3 49.4 (M:49.4) 4 
226 gi|513191098 
PREDICTED: golgi-
specific brefeldin A-
resistance guanine 
nucleotide exchange 
factor 1 isoform X5 
[Gallus gallus] 200.2 49.4 (M:49.4) 3 
227 gi|363728726 
PREDICTED: protein 
dopey-2 [Gallus gallus] 257.7 49.3 (M:49.3) 2 
228 gi|118102546 
PREDICTED: inositol 
1,4,5-trisphosphate 
receptor type 3 isoform 
X2 [Gallus gallus] 304.6 49.3 (M:49.3) 4 
229 gi|50582493 
vitellogenin [Gallus 
gallus] 162.5 49.3 (M:49.3) 3 
230 gi|513175768 
PREDICTED: AT-rich 
interactive domain-
containing protein 4B 146.3 49.2 (M:49.2) 3 
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isoform X2 [Gallus 
gallus] 
231 gi|513224576 
PREDICTED: pleckstrin 
homology domain-
containing family A 
member 6 isoform X27 
[Gallus gallus] 114.2 49.2 (M:49.2) 3 
232 gi|20140635 
RecName: 
Full=Transferrin receptor 
protein 1; Short=TR; 
Short=TfR; Short=TfR1; 
Short=Trfr 85.6 49.0 (M:49.0) 4 
233 gi|363738939 
PREDICTED: SH3 and 
PX domain-containing 
protein 2B isoform X3 
[Gallus gallus] 96.4 48.8 (M:48.8) 3 
234 gi|513171922 
PREDICTED: growth 
regulation by estrogen in 
breast cancer-like 
isoform X13 [Gallus 
gallus] 194.6 48.7 (M:48.7) 3 
235 gi|146219852 
breast cancer 2, early 
onset [Gallus gallus] 377.5 48.7 (M:48.7) 3 
236 gi|53136870 
hypothetical protein 
RCJMB04_35e7 [Gallus 
gallus] 94.1 48.5 (M:48.5) 3 
237 gi|513223426 
PREDICTED: 
nucleoporin 210kDa-like 
isoform X7 [Gallus 
gallus] 188.4 48.5 (M:48.5) 2 
238 gi|513179755 
PREDICTED: tudor 
domain-containing 
protein 6 [Gallus gallus] 172.7 48.4 (M:48.4) 4 
239 gi|513190759 
PREDICTED: activating 
signal cointegrator 1 
complex subunit 1 
isoform X7 [Gallus 
gallus] 40.8 48.1 (M:48.1) 3 
240 gi|513184258 
PREDICTED: NF-X1-
type zinc finger protein 
NFXL1 isoform X3 
[Gallus gallus] 84.4 47.9 (M:47.9) 4 
241 gi|363735853 
PREDICTED: 
alkyldihydroxyacetoneph
osphate synthase, 
peroxisomal [Gallus 70.7 47.8 (M:47.8) 3 
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gallus] 
242 gi|513232874 
PREDICTED: Dmx-like 
1 isoform X4 [Gallus 
gallus] 272.6 47.8 (M:47.8) 3 
243 gi|186703014 PNPLA7 [Gallus gallus] 147.6 47.7 (M:47.7) 3 
244 gi|513239041 
PREDICTED: maestro 
heat-like repeat-
containing protein family 
member 2B-like isoform 
X5 [Gallus gallus] 128.8 47.6 (M:47.6) 3 
245 gi|60099181 
hypothetical protein 
RCJMB04_32g20 
[Gallus gallus] 138 47.5 (M:47.5) 3 
246 gi|513178375 
PREDICTED: regulating 
synaptic membrane 
exocytosis protein 1 
isoform X12 [Gallus 
gallus] 174 47.4 (M:47.4) 3 
247 gi|363733842 
PREDICTED: LOW 
QUALITY PROTEIN: 
regulator of G-protein 
signaling 12 [Gallus 
gallus] 166.4 47.4 (M:47.4) 4 
248 gi|313747559 
A-kinase anchor protein 
8-like [Gallus gallus] 80.4 47.1 (M:47.1) 4 
249 gi|513229372 
PREDICTED: A 
disintegrin and 
metalloproteinase with 
thrombospondin motifs 6 
isoform X10 [Gallus 
gallus] 109.6 47.1 (M:47.1) 3 
250 gi|513200909 
PREDICTED: 
chondroitin sulfate 
proteoglycan 4 isoform 
X5 [Gallus gallus] 266.8 47.0 (M:47.0) 3 
251 gi|513229093 
PREDICTED: integrin 
alpha-2 [Gallus gallus] 129.6 47.0 (M:47.0) 3 
252 gi|513164384 
PREDICTED: LOW 
QUALITY PROTEIN: 
E3 SUMO-protein ligase 
RanBP2 [Gallus gallus] 336.3 46.9 (M:46.9) 3 
253 gi|241982727 
protein ELYS [Gallus 
gallus] 252.5 46.8 (M:46.8) 3 
254 gi|513221255 
PREDICTED: splicing 
factor, proline- and 
glutamine-rich isoform 68.7 46.7 (M:46.7) 3 
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X6 [Gallus gallus] 
255 gi|513176328 
PREDICTED: 
androglobin [Gallus 
gallus] 182.1 46.6 (M:46.6) 3 
256 gi|313851036 
cytoskeleton-associated 
protein 5 [Gallus gallus] 225.2 46.6 (M:46.6) 3 
257 gi|513191260 
PREDICTED: LOW 
QUALITY PROTEIN: 
WD repeat- and FYVE 
domain-containing 
protein 4 [Gallus gallus] 357.7 46.5 (M:46.5) 3 
258 gi|60098943 
hypothetical protein 
RCJMB04_16d21 
[Gallus gallus] 88.6 46.4 (M:46.4) 3 
259 gi|50742516 
PREDICTED: TGF-beta-
activated kinase 1 and 
MAP3K7-binding 
protein 2 isoform X2 
[Gallus gallus] 76.7 46.4 (M:46.4) 3 
260 gi|349732129 
rho GTPase-activating 
protein 29 [Gallus gallus] 151.7 46.2 (M:46.2) 3 
261 gi|513200221 
PREDICTED: leucine-, 
glutamate- and lysine-
rich protein 1 isoform 
X21 [Gallus gallus] 77.7 46.2 (M:46.2) 3 
262 gi|534285973 
Chain A, Crystal 
Structure Of Chicken 
Galectin 2 14.9 46.2 (M:46.2) 3 
263 gi|53129447 
hypothetical protein 
RCJMB04_5l15 [Gallus 
gallus] 86.5 46.0 (M:46.0) 3 
264 gi|513225769 
PREDICTED: protein 
TANC2 isoform X19 
[Gallus gallus] 205.4 46.0 (M:46.0) 3 
265 gi|118082738 
PREDICTED: nucleolar 
protein 12 [Gallus gallus] 24.9 45.9 (M:45.9) 2 
266 gi|513226968 
PREDICTED: tRNA-
dihydrouridine(47) 
synthase [NAD(P)(+)]-
like [Gallus gallus] 89.5 45.9 (M:45.9) 2 
267 gi|513163173 
PREDICTED: probable 
ubiquitin carboxyl-
terminal hydrolase FAF-
X isoform X3 [Gallus 
gallus] 289.5 45.8 (M:45.8) 2 
268 gi|363727703 PREDICTED: apoptotic 142.2 45.8 (M:45.8) 2 
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protease-activating factor 
1 isoformX4 [Gallus 
gallus] 
269 gi|513192043 
PREDICTED: von 
Willebrand factor A 
domain-containing 
protein 2 isoform X4 
[Gallus gallus] 76.8 45.7 (M:45.7) 3 
270 gi|363733636 
PREDICTED: LOW 
QUALITY PROTEIN: 
DNA-directed RNA 
polymerase I subunit 
RPA1 [Gallus gallus] 192.5 45.5 (M:45.5) 3 
271 gi|513200631 
PREDICTED: LOW 
QUALITY PROTEIN: 
unconventional myosin-
IXa [Gallus gallus] 301.4 45.5 (M:45.5) 3 
272 gi|513171872 
PREDICTED: LOW 
QUALITY PROTEIN: 
erythrocyte membrane 
protein band 4.1-like 3 
[Gallus gallus] 158.4 45.5 (M:45.5) 2 
273 gi|513199614 
PREDICTED: DIS3 
mitotic control homolog 
(S. cerevisiae)-like 2 
isoform X2 [Gallus 
gallus] 126.4 45.3 (M:45.3) 3 
274 gi|513163748 
PREDICTED: FERM 
and PDZ domain-
containing protein 4 
isoform X3 [Gallus 
gallus] 194.3 45.3 (M:45.3) 3 
275 gi|1096715 DNA methyltransferase 172.8 45.2 (M:45.2) 3 
276 gi|513192529 
PREDICTED: LOW 
QUALITY PROTEIN: 
kinesin-like protein 
KIF20B [Gallus gallus] 207 45.1 (M:45.1) 2 
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ABSTRACT 
Eggshell membranes (ESM) contain a variety of proteins and peptides which help in the 
development of embryo and provide protection to it. Many of the peptides and proteins 
associated with ESM have antimicrobial, immune-modulatory, and adjuvant properties. We 
hypothesized that the membrane byproducts from egg, provided as post hatch nutritional 
supplements to chickens, may improve their performance and immunity. To explore its effect, 
we fed 3 groups of broiler chicks with feed containing 0, 0.2% and 0.4% ESM from day 1 post 
hatch through 14 days and regular feed thereafter. The birds were individually weighed at the 
onset of the experiment and at weekly intervals until the termination at third week when they 
were bled and euthanized. The relative weights of liver, spleen, bursa, and heart, hematology 
profiles, clinical chemistry variables including serum IgM, IgG and corticosterone concentrations 
measured. The chickens in the ESM treated groups showed a statistically significant increase in 
BW with no impact on relative organ weights. Compared with controls, the WBC and 
lymphocyte percentage increased in chickens fed 0.4% ESM whereas the monocyte percentage 
decreased at both levels of ESM.  Except for the serum protein which increased in ESM fed birds 
no other metabolic clinical chemistry variables showed any significant change. Both IgM and 
IgG(Y) levels were elevated and corticosterone levels reduced in chickens fed ESM 
supplemented diets. Our results suggest that ESM supplements during the early phases of growth 
may improve immunity and stress variables, and enhance their growth performance without any 
detrimental effect on other physiological parameters.  
Key words: egg shell membrane, chicken, growth, immunity, stress 
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INTRODUCTION 
Eggshells are byproducts of the poultry industry, which consist largely of calcareous outer shells 
underlined by proteinaceous membranes and the proteins that adsorb to these membranes from 
egg white (Hincke, et al., 2012; Mann, 2007; Mine and Kovacs-Nolan, 2006). The shell 
membranes (ESM) are fibrous structural proteins made up of collagens and keratins that are 
generally resistant to conventional gastric proteases. However there are also numerous other 
proteins and peptides with antimicrobial, antioxidant, and immune-modulatory properties such as 
lysozyme, ovotransferrin, ovalbumin, globulins, ovomucins, and defensins present in these 
membranes (Miksík, et al., 2007).  Many of these proteins are functionally similar to some milk 
proteins which confer post-natal protection to newborns, help maturation of gut, and shape their 
microbiome (Lawrence and Pane, 2007; Rose and Hincke, 2009). Antimicrobial peptides not 
only provide protection against a wide range of microbes including bacteria and fungi but also 
can function as adjuvants enhancing immunity against foreign antigens (Brown and Hancock, 
2006).  In view of the need for alternatives to antibiotics in meat animal production (Seal, et al., 
2013; Thacker, 2013), exploring the potential of egg byproducts to improve immunity and 
disease resistance in poultry is logical. We hypothesized that the factors present in the ESM may 
help modulate immunity and performance of chickens if provided as post hatch nutrient 
supplements which is the objective of this study. 
MATERIALS AND METHODS 
Preparation of eggshell and ESM   
Unfertilized fresh eggs removed of albumen and yolk were washed by mild scrubbing inside of 
the shell under running water and peeled to obtain membranes. The membranes were washed by 
stirring with excess water for 2-3 hours, lyophilized, and finally ground to powdery flakes using 
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a commercial blender. To determine the membrane yield, the individual eggs and their 
membranes were processed separately. For preliminary trials, ESM and whole shells with or 
without membranes were ground separately, and used as supplements to evaluate their effects on 
chicken performance using BW and relative organ weights as the variables.  The above 
preparations were mixed with the grower diet formulated per NRC specification (NRC, 1994) 
using a feed mixer. The amount of eggshell and ESM were set to the concentrations of 5% whole 
shell, 4.8% shell without membrane, and 0.2% ESM based on the observation that a large egg 
yields approximately 5-6 g shell and 0.2-0.25 g of ESM. Based on those initial trials, subsequent 
studies were done using only the ESM preparations at 0.2 and 0.4% levels, respectively  
ESM and feed analysis  
The nitrogen (N), calorie, and selective mineral content of ESM supplemented feed were 
analyzed in the Central Analytical Laboratory of the University of Arkansas using randomly 
sampled ESM powder and feed.  Dumas N analyzer, bomb calorimeter, and inductively coupled 
plasma spectroscopy (ICP) were used for respective analyses. 
Chicken treatments 
Studies were approved by the University of Arkansas, Institutional Animal Care and Use 
Committee. In all trials day-old male broiler chicks from local hatchery (Cobb) were used.  In the 
preliminary trial, the birds were divided into 3 groups consisting of 16 birds each, placed in 2 
replicate battery cages, and provided ad libitum access to feed and water. The chickens were 
provided specified diets from day 1 through 14 and regular diets thereafter till the termination of 
experiments. The follow up and final trial reported here was done using ESM at 2 
concentrations, 0.2% and 0.4%, respectively. Birds were monitored daily for mortality and 
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welfare. The BW of the chickens were measured at the beginning and at weekly intervals 
thereafter.  All birds were necropsied at three weeks of age. Blood collection and organ weight 
On day 21, the chickens were weighed and 6 from each of the replicate cages were bled by 
cardiac puncture; the blood was collected in Vaccutainer tubes containing EDTA for hematology 
and clot accelerator for serum clinical chemistry analyses. The chickens were killed by cervical 
dislocation and the weights of liver, heart, spleen, and bursa recorded, and calculated as 
percentage of BW. The blood with clot accelerator were kept at room temperature for 2 hours, 
centrifuged at 2,500g to separate serum, and stored in aliquots at -20 °C until the assays were 
done.  
 
Hematology 
Hematology measurements were done with EDTA anti-coagulated blood within 2 h of bleeding 
using a Cell-Dyn 3500 blood analysis system (Abbott Diagnostics, Abbott Park, IL), 
standardized for avian blood. The white blood cell (WBC), heterophil (H), lymphocyte (L), 
monocyte (M), eosinophil (E), basophil (B), red blood cell (RBC), and thrombocyte counts, 
hemoglobin, hematocrit, mean corpuscular volume (MCV), microhematocrit (MCH), red blood 
cell distribution width (RDW) values were measured, and the heterophil to lymphocyte ratios 
(H/L) calculated.  
 
Serum chemistry, corticosterone, IgG, and IgM determination  
The serum was used to determine clinical chemistry variables using a clinical chemistry analyzer 
(Ciba Corning Diagnostics Corp; Medfield MA). The parameters included protein, glucose, 
cholesterol, calcium, phosphorous, magnesium, triglycerides, blood urea nitrogen (BUN), 
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alanine aminotransferase (ALT), aspartyl aminotransferase (AST), gamma glutamyl transferase 
(GGT), creatinine, creatine kinase, and alkaline phosphatase. Serum corticosterone levels were 
measured using a Detect X enzyme immunoassay kitTM purchased from Arbor Assays (Ann 
Arbor, MI). Serum samples from 12 birds in each group were diluted 1:20 using the assay buffer 
provided in the kit, and the immunoassay done per instructions in the kit. The concentrations of 
corticosterone in serum samples were calculated from a standard curve obtained using the 
supplied standard. The results were expressed as nanograms of corticosterone per ml. Similarly, 
the IgM and IgG concentrations of the sera were determined in triplicates using reagents 
obtained from Bethyl Laboratory (Montgomery, TX), following the suggested instructions. Eight 
well strips (BD Falcon) were coated with either goat anti chicken IgM or IgG antibodies and the 
assays performed per respective instructions using sera diluted to 1:20,000 for IgM and 1:5000 
for IgG as determined in preliminary assays. The goat anti chicken IgM- or IgG-horse radish 
peroxidase (HRP) were used as secondary antibodies respectively. The HRP enzyme activity 
was measured using tetramethylbenzidine (TMB) substrate as the end point. The concentrations 
of antibodies in the sera were calculated from their respective standard curves obtained using a 
reference calibrator serum supplied in the kit. The results were reported as mg/ml serum. 
 
Statistical analyses 
The relative organ weights were calculated as percentage of whole BW. All results were 
evaluated using Duncan's multiple range test using SAS software (SAS, 2009) and a P-value of 
<0.05 considered significant.  
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RESULTS 
The preliminary trial with shell with or without membranes caused a substantial reduction in the 
BW while ESM alone supported growth (not shown). Similarly, the relative weights of both 
heart and liver increased significantly in groups receiving feed with shell containing preparations 
indicating their toxic effects. The chickens receiving feed supplemented with ESM only did not 
show any change in relative organ weights (not shown). The results of the final trial are shown 
later. 
The analysis of ESM showed the N content ~86 % of total mass. When ESM added at 0.2% or 
0.4% levels to feed, showed negligible differences compared with the total protein, caloric, or 
elemental content of regular diet (Table 1).  
Mortality, health, and BW  
Chickens fed control or ESM supplemented diets showed no mortality during the trial. The birds 
in overall appeared healthy and alert with no signs of sickness or lethargy. The BW showed 
increased differences in birds fed 0.4% ESM supplemented diet starting from first week of 
growth (Fig 1). At final week both treatments showed statistically higher BW relative to the 
controls. The BW and relative organ weight changes are shown in Table 2.  There were no 
changes in relative heart, liver, spleen, and bursa weights of birds fed ESM supplemented diet 
compared with controls.  
Blood Differential count  
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There was a significant increase in WBC, lymphocyte, RBC, and HCT values, and a decrease in 
monocyte counts of chickens fed 0.4% ESM compared with controls. In chickens receiving 0.2% 
ESM there was no significant change in blood cell counts except for monocytes which decreased 
as compared with control birds (Table 3). 
Serum clinical chemistry, corticosterone, IgM, and IgG assays 
Except for the total protein content of serum there were no changes in any of the clinical 
chemistry parameters including AST, ALT, GGT, BUN, uric acid, Ca, or P (Table 4).  IgM and 
IgG content showed significant increases in the sera of chickens fed both 0.2% and 0.4% levels 
of ESM (Fig 2).  The corticosterone levels on the contrary, showed significant reduction in the 
sera of birds fed 0.4% ESM supplemented diet and numerically lower at 0.2% level (Fig 3).  
 
DISCUSSION 
Salvaged egg byproducts from defective eggs have been shown to improve livestock 
performance based on their nutritive values (Al-Harthi, et al., 2011; Schmidt, et al., 2007).  But 
the use of eggshell membranes as feed supplements has been little explored. Considering the 
large numbers of immunomodulatory proteins and peptides that are present in shell membrane 
(Cordeiro and Hincke, 2011; Miksík, et al., 2007; Mine, 2007), we hypothesized that ESM may 
have beneficial effects on the physiology of chickens. Inclusion of ESM in the diet not only 
caused a moderate to significant weight gain but also elevated both serum IgM and IgG levels 
indicative of modulation of humoral immunity. There was no change in relative weights 
suggestive of any negative or inflammatory effect of ESM. The changes in some blood cell 
parameters such as WBC and lymphocyte counts that were increased with 0.4% ESM fed birds 
along with their antibody (IgM and IgG) response, may suggest a stimulation of their adaptive 
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immune response. Although the monocyte counts decreased at both treatment levels, the 
heterophil counts and H/L ratio showed only numerical decrease at 0.4% levels of ESM.  Stress 
is a major factor that decreases monocyte counts. Our results showed that the blood 
corticosterone levels were reduced in chickens fed ESM diets suggesting a lower levels of stress 
in these birds although the mechanism for its decrease is not understood. Stress and 
inflammation can also cause a loss of BW and present other signs of sickness such as lethargy 
that was not observed in ESM fed birds. Low levels of stress can also imply better feeding 
behavior (Bunnett, 2005) that would contribute to increase in BW. The sickness was also not 
evident from clinical chemistry variables such as the AST, ALT, and GGT values which are 
linked to hepatic dysfunction and poultry myopathy (MacRae, et al., 2006).  Similarly, there was 
no elevation in the levels of blood urea nitrogen (BUN), uric acid, and creatinine that would 
indicate kidney dysfunction or creatine kinase which is a sign of muscle dysfunction. The 
increases in blood lymphocyte, IgG, and IgM levels indicate a modulation of immunity as 
compared with control birds. IgM is a natural antibody produced by B1 lymphocytes that fights 
infection, prevents inflammation, reacts with a variety of foreign antigens including pathogen 
associated molecules, activates complement, foreruns, and stimulates IgG response (Boes, 2000; 
Ehrenstein and Notley, 2010; Grönwall and Silverman, 2014). Similarly, an increase in the levels 
of IgG in ESM fed chickens also suggests a modulation of adaptive immune response. These 
antibodies play vital roles for protection against a variety of microbial pathogens (Jeurissen, et 
al., 2000; Sharma, 1997). Whether the antibody response to ESM is transient or it establishes a 
lasting resistance to certain infection needs to be verified. 
The shell membrane is a highly crosslinked matrix that contains many proteins and peptides such 
as defensins which can potentially behave as adjuvants (Brown and Hancock, 2006; Zhang, et 
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al., 2010).  It can also bind and carry foreign antigens to provide vaccine-like effects. 
Lactotransferrin, same as ovotransferrin in ESM, was shown to help maturation of dendritic cells 
of intestine and improve gut immunity (Spadaro, et al., 2008; Spadaro, et al., 2014). Chickens 
fed genetically engineered rice, expressing lactoferrin and lysozyme, showed improvement of 
gastrointestinal function with antibiotic-like effects (Humphrey, et al., 2002). Lysozyme was also 
shown to have similar effects in pig (Oliver and Wells, 2013).   
One of the major imperatives of meat-animal production is to improve immunity (disease 
resistance) without sacrificing growth while abstaining from the use of antibiotics. The ESM 
supplement appears to have beneficial effect in chickens while it reduces stress and modulates 
immunity without sacrificing the growth potential of the birds. 
ACKNOWLEDGEMENTS 
We thank Scott Zornes and Sonia Tsai for technical assistance and Wally McDonner for animal 
care and technical assistance.  
  
  92 
Table 1. Protein, calorie and selective elemental content of regular and ESM supplemented  
Variables Control Feed Control Feed 
+ESM 0.2% 
Control Feed 
+ESM 0.4% 
Protein (%) 22.1 22.2 22.2 
Calories/kg 4252 4221 4212 
Calcium (ppm) 11531 11524 11037 
Magnesium (ppm) 1552 1602 1619 
Sodium (ppm) 1511 1469 1339 
Phosphate (ppm) 8074 7852 7668 
Sulfur (ppm) 2284 2347 2357 
Zinc (ppm) 134 115 116 
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Table 2. BW and the relative organ weights of chicken fed diets with and without ESM (n=16)  
Parameters Control +ESM 0.2% +ESM0.4% 
Body weight 
(grams) 
905.38±18.35b 
 
967.50±12.97a 958.00±16.89a 
 
Relative heart 
weight (%) 
0.50±0.01a 0.54±0.02a 0.54±0.01a 
Relative liver 
weight (%) 
2.21±0.07a 2.46±0.20a 2.25±0.05a 
Relative spleen 
weight (%) 
0.08±0.01a 0.10±0.01a 0.11±0.01a 
Relative bursa 
weight (%) 
0.16±0.01a 0.17±0.01a 0.20±0.01a 
Values with different superscripts in a row are significantly different (P<0.05).  
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Fig 1.  Effect of ESM supplement on weekly BW (n=16). *denotes statistically significant 
differences (p< 0.05) compared with the control fed chickens. The BW of chickens fed both 
levels of ESM supplemented diets showed statistically significant increases at 3-wk of age 
indicated by **.   
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Table 3.  Hematology profiles of chickens fed with and without ESM supplemented feed 
(n=12) 
Variables 
 
Control 
 
+ESM 0.2% +ESM 0.4% 
White blood cell 
(WBC) (x103/µL) 
28.61±2.87b 35.45±2.25b,a 37.5±2.30a  
 
 
Heterophil (%) 14.83±1.30a 11.96±1.22a,b 11.2±1.19a,b 
Lymphocyte (%) 74.81±2.02b 80.0±1.77b,a 81.6±1.55a 
 Monocyte (%) 8.02±0.84a 5.53±0.70b 
 
4.95±0.37b 
 Eosinophil (%) 0.02±0.01a 0.02±0.01a 0.02±0.00a 
Basophil (%) 2.34±0.12a 2.50±0.14 a 2.17±0.18a 
Red blood cell (RBC) 
(× 106/µL) 
2.08±0.02b 2.09±0.03b 2.2±0.03a 
 Thrombocyte (k/µL) 13.36±0.65a 11.81±0.70a,b 9.93±0.39b 
 
Heterophil/Lymphocyte 
(H/L) 
0.21±0.03a 0.16±0.02a 0.14±0.02a,b 
Values with different superscripts in a row are significantly different (P<0.05) 
Table 4.  Clinical chemistry variables of serum from 3 wk-old chickens fed with or without ESM 
(n=12) 
Hemoglobin (g/dL) 
 
   7.00±0.10a 6.92±0.09a 7.06±0.08a 
  
 
 
Hematocrit (%) 52.78±0.67b 52.65±0.77b 55.67±0.68a 
 
Mean corpuscular 
volume (MCV) (fL) 
254.06±1.66a 252.33±0.82a 257.40±1.68a 
Red cell distribution 
width (RDW) (%) 
11.76±0.16a 11.79±0.11a 11.91±0.14a 
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Parameters 
 
Control 
 
+ESM 0.2% +ESM 0.4% 
Albumin (g/dL) 
 
0.98±0.03b 1.03±0.08b 1.05±0.02b,a 
Alkaline phosphate 
(U/L) 
757.83±139.78a 958.75±186.52a 797.58±168.70a 
Alanine transferase 
(U/L) 
2.61±0.51a   2.08±0.57a 2.65±0.37a 
Aspartate 
aminotransferase(U/L) 
189.60±4.64a 194.02±6.16a 193.63±5.46a 
Blood urea nitrogen  
(mg/µL) 
1.12±0.09a    1.12±0.11a 1.19±0.43 a 
Calcium (mg/dL) 8.80±0.16a,b    9.11±0.21a  8.47±0.13b     
Cholesterol (mg/dL) 107.50±3.27a     110.50±5.89a      109.17±3.46a      
Creatinine kinase 
(U/L) 
177.08±22.97a      150.75±25.56a      267.25±61.65a      
Creatinine (mg/dL) 0.31± 0.02a 0.27±0.02a 0.28±0.02a 
Gamma-glutamyl 
transferase (U/L) 
14.41±5.13a 14.25±0.70a 14.9±0.57a 
Glucose (mg/dL) 230.41±5.13a 240.08±5.90a 238.17±0.06a 
Phosphorous (mg/dL) 4.33±0.08a 
 
4.46±0.23a 4.45±0.06a 
Low density 
lipoprotein (mg/dL) 
115.50±13.03a      119.75±10.34a     133.33±10.13a      
Total protein (g/dL) 2.23±0.04c 
      
2.85± 0.09b     3.18±0.04a    
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Triglycerides (mg/dL) 54.17±4.75a    62.58± 6.58a 
     
62.75±6.91a 
Uric Acid (mg/dL) 5.87±0.23a 6.23±0.29a 
 
5.97±0.32a 
       
Magnesium (mEq/L) 1.60±0.05a     1.60±0.05a      1.67±0.03a    
Iron  (µg/dL) 84.40±3.97a     86.55±7.12a 
 
      
82.50±3.70a      
Values with different superscripts in a row are significantly different (P<0.05) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2. Comparison of serum IgM and IgG levels of chickens fed control, 0.2%, and 0.4% ESM 
supplemented diets. The IgM and IgG levels were measured as mg/ml ± SEM (n=12 each). 
Values with different superscripts are significantly different (P<0.05).  
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Fig 3.  Serum corticosterone levels of chickens fed diets supplemented with or without ESM. The 
concentration of corticosterone was measured as ng/ml and shown as mean ± SEM.  Values with 
different superscripts are significantly different (P<0.05).  
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IV. Protein profiles of hatchery derived egg shell  membrane
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Abstract 
Eggshell membranes protect growing embryo are interlaced around the albumen and form a 
meshwork, which can trap the invading bacteria and prevent it from further penetrating in the 
egg. The microstructures present on egg membranes are formed of these fibrous proteins, which 
are knotted together to form a net to obstruct the passage of microorganisms. We hypothesize 
that eggshell membranes from hatched eggs will be richer in fetal proteins and their 
characterization possibly might shed light into their biological relevance in providing physical 
and chemical defense to the growing embryo. We want to explore the eggshell membranes in the 
context of waste material left after the eggs are hatched.  We extracted the proteins and peptides 
by two methods and analyzed them with mass spectrometry techniques. The proteins and 
peptides from hatched eggshell membranes (HESM) were extracted with methanol and also with 
a chaotropic agent. Both the extracts were subjected to in solution digestion, the protein and 
peptide profiles were determined by LC-MS/MS. The results from hatched egg membranes 
showed the presence of not only the presence of proteins (ovalbumin, ovocledin, lysozyme) 
which is found in unfertilized egg membranes but also many new proteins such as zona pleucida, 
filamin, lumican which can be major players in the growth, and development of the embryo.  
Introduction 
Egg shells from hatchery waste have been considered to be useful for biological and biomedical 
applications (Abeyrathne, et al., 2013; Kovacs-Nolan, et al., 2005) . The empty egg shells largely 
consist of the outer calcareous matrix and underlying membranes that are not only proteinaceous 
but laced with many proteins of embryonic origins as well as a variety of microbial and hatchery 
contaminants (Das, et al., 2002; Mine, et al., 2003).  The embryonic proteins and peptides may 
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be useful to bring about specific physiological modulation; however, their potential has not been 
tested. Previously, we found that shell membranes prepared from unfertilized eggs when fed to 
chickens post hatch for 2 weeks affected their growth performance, and immunity (Makkar, et 
al., 2015b) these membranes were abound with numerous antimicrobial and cell associated 
peptides (Makkar, et al., 2015a). Following those studies we observed that hatchery egg shell 
membrane (HESM) fed to post hatch chickens not only improved growth performance but also 
protected the chickens against lipopolysaccharide (LPS) induced anorexia/cachexia 
(unpublished). Considering that the differences between 2 membrane preparations can be 
considerable such as the unfertilized egg shell membrane may have only certain types of proteins 
and peptides inherently acquired from reproductive tract, whereas the HESM may have been 
differentially enriched with proteins of embryonic, blood, feather, and microbial origins, we were 
interested to determine their protein profile.  The results of these studies are described in the 
current report.   
Chemicals and reagents.  All reagents and devices such as C18 Nu tips (Glysci.com), 
Spectra/Por membranes (Spectrumlabs.com), BCA protein assay kit, Pierce C18 spin columns, 
MS grade trypsin (Fisher Scientific.com), peptide  calibration standard II (m/z 500-16000, 
Bruker Daltonics, Bremen, Germany), and 2-iodoacetamide (IAA) (MP Biomedicals, OH) were 
purchased from their respective vendors. All other reagents and supplies including 1, 4-
dithiothreitol (DTT), 2, 5-dihydroxybenzoic acid (DHB), were purchased from Sigma Aldrich 
(St. Louis, MO).  
Material and methods 
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Empty eggshell with membranes were obtained from a local hatchery and allowed to dry at room 
temperature under the hood. The membranes were separated manually and ground to a powdered 
form using an IKA mill (find specification). The membrane powders were extracted with 4 M 
guanidine hydrochloride (GdHCl) containing 20 mM EDTA, and 50 mM Na-acetate, pH 5.8 and 
70% methanol containing 0.1% acetic acid stirred in 20 volumes of respective solutions 
overnight at 4o C.  The extracts were centrifuged at 21,000 g for 15 min, and the supernatant 
dialyzed against excess 50 mM ammonium carbonate solution with 3 changes using 1,000 Da 
Spectra/Por membranes. The protein concentrations of both the extracts were measured using 
BCA protein assay kit. The extracts were concentrated by vacuum evaporation by means of a 
speed vac or lypholization and approximately 50 µg of both were reduced, alkylated and trypsin 
digested and desalted with C18 columns and subjected to LC/MS/MS.  Each of these extractions 
was done in 2 trials and the studies were repeated twice. 
LC-MS/MS analysis of methanol and guanidine extracted proteins. The protein 
concentrations of GdHCL was adjusted to 5mg/ml. Approximately 50 µg of GdHCl extracted 
proteins was subjected to reduction and alkylation, and digested with trypsin at the protein: 
trypsin ratios of 50:1 for 24 h at 37oC .  The tryptic digest was desalted with Pierce C18 spin 
columns and chromatographed on a capillary C18 column (150 x 0.1 mm, 3.5 µm particle size, 
300 Å pore size, Zorbax SB) attached to an Agilent 1200 series HPLC, interfaced with a Bruker 
Amazon-SL quadrupole ion trap mass spectrometer, and captive spray source. Tryptic peptides 
were separated at a solvent flow rate of 1.6 µL/min with 0 to 40 % gradients of 0.1% FA (solvent 
A) and ACN in 0.1% FA solvent B (solvent B). Each time the samples were run three times as
technical repeats and the results from 2 replicate studies were processed using Skyline software 
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(https://skyline.gs.washington.edu/labkey/project/home/begin.view) for peptide dominance and 
scores automatically without introducing any manual bias. The same strategy was applied to the 
methanol extract of HESM.  
LC-MS/MS analyzed proteins. Peaks were picked in the LC-MS/MS (MSn) chromatogram 
using Bruker default settings.  Bruker Proteinscape bioinformatics suite coupled with MASCOT 
2.1 was used to search NCBI Gallus protein database for identification. The parent ion mass 
tolerance and fragment ion mass tolerance were both set at 0.6 Da. A MASCOT decoy database 
search was performed with all the datasets.  A score threshold of 45 or more was used as a high 
probability match for protein identifications. The proteins with only <1% false discovery rate 
(FDR) and at least 1unique peptide were reported.  Functional annotation for these proteins was 
performed using Gene Ontology tool powered by PANTHER (http://geneontology.org)  
Results 
The guanidine HCl extract of HESM showed the presence of more than 100 proteins (Table 1) 
and 47 proteins (Table 2) in the methanol. Along with ovoalbumin, ovolcledin which are present 
in ESM, the membranes from fertilized eggs also contains tubulin, annexin, collagen, titin, 
desmin in abundance. Several chaperon proteins such as heat shock 10, 60 and 70 are also found. 
Proteins associated with antimicrobial properties such as lysozyme, gallinacin, keratin, cystatin 
are also reported. Some of the proteins are unique in methanol extract, which are not found in 
gunadine HCl extract such as gallinacin 9, thymosin beta 4, septins.  The functional annotation 
by PANTHER shows that most of the proteins are involved in metabolic and cellular processes 
in terms of their biological relevance. In terms they are mainly involved of their molecular 
function Structural, binding and catalytic activity. We also found 50 proteins of bacterial origin, 
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which gives us a clue that these membranes acts as a trap for bacteria and prevent their egression 
inside the egg and acts as both physical and chemical barrier for the growing embryo.  
Discussion 
Cordieri et.al also reported the presence of fibronectin, vitellogenin, apolipoproteins in fertilized 
ESM (Cordeiro and Hincke, 2015)  . The fertilized membranes are more rich in cytoskeleton 
proteins such as stratifin, fibronectin, annexin. Fibronectin plays very important role in 
embryogenesis and it is involved in the cell migration, attachment and differentiation during the 
process of growth of an embryo. (Nicosia, et al., 1993) (Risau and Lemmon, 1988).  
Defensins are an important category of antimicrobial peptides that contains highly conserved 
cysteine residues. They are important arsenals of our innate immune system cells and are 
multifunctional in nature. The chemotactic properties of defensins helps in the recruitment of the 
immune cells to the site of infection, eliminate the pathogens and modulate the immune system. 
(Guaní-Guerra, et al., 2010; Hazlett and Wu, 2011; Jäger, et al., 2012). Gallin, a member of 
defensin family found in egg white and now also reported in membranes have potent 
antimicrobial activity against E.coli  (Gong, et al., 2010). 
Actin, mimecan, apolipoprotein, annexin, lumican are involved in developmental process. 
Mimecan is unique to fertilized membranes and is extracellular matrix glycoprotein, involved in 
the formation of tissues (Funderburgh, et al., 1997). Lumican another extracellular protein is 
clinically significant in term of providing transparency to the cornea by aligning with collagen 
fibrils (Kao, et al., 2006; Wang, et al., 2014). Lum knock out mice are reported to have 
abnormality in skin, heart tissues and cornea (Chakravarti, 2002) 
Thioredoxin, lactate dehydrogenase, serpin are major players in catalytic activity. Thioredoxins 
are antioxidants and help to prevent oxidative stress (Lu and Holmgren, 2014; Nordberg and 
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Arnér, 2001). Serpins are protease inhibitors and also important constituents of blood clotting 
and inflammation processes (Devlin and Bottomley, 2005; Rau, et al., 2007). Proteins are actual 
functional molecules and indicators of pathological condition or pharmacological process and 
can be good candidates to target for drug designing.  Understanding the constituent proteins and 
peptides may shed light into their functions associated with the development and protection of 
the embryo and improve egg quality.  
The biological interpretation of the proteomic dataset in itself is a big challenge. Therefore 
analysis of each single protein by referring to the literature is a limiting factor, in finding the 
insights of the functional aspect of these proteins. (Fredrickson, et al., 2013) (Thompson, et al., 
2012). But still with the annotation software’s we can broadly classify these proteins into 
categories based on their roles in growth, development and several other metabolic functions. 
Functional analysis of HESM proteins showed that majority of them is involved in cellular 
process, regulation and also development process.  
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Table 1: Proteins identified in methanol extract by LC-MS/MS 
ID DED Description esDescrDescription scores mw #Peptides 
ENSGALP00000000275 
Ovalbumin  [Source:UniProtKB/Swiss-
Prot;Acc:P01012] 629.9 42.9 11 
ENSGALP00000000325 
Ovomucoid  [Source:UniProtKB/Swiss-
Prot;Acc:P01005] 338.1 22.6 7 
ENSGALP00000000726 
Ovocleidin-116 
[Source:UniProtKB/Swiss-
Prot;Acc:F1NSM7]  225 76.8 2 
ENSGALP00000000876 
orosomucoid 1 (ovoglycoprotein) 
precursor  [Source:RefSeq 
peptide;Acc:NP_989872] 167 22.3 3 
ENSGALP00000001532 
peptidyl-prolyl cis-trans isomerase 
FKBP1A  [Source:RefSeq 
peptide;Acc:NP_989661] 163.5 8.9 3 
ENSGALP00000002523 
Lysozyme C  
[Source:UniProtKB/Swiss-
Prot;Acc:P00698] 129.2 16.2 2 
ENSGALP00000005544 
keratin 8, type II [Source:HGNC 
Symbol;Acc:HGNC:6446] 119.1 42.1 2 
ENSGALP00000006093 
Gallus gallus SH3 domain binding 
glutamic acid-rich protein like 
(SH3BGRL), mRNA. [Source:RefSeq 
mRNA;Acc:NM_001012574] 109.6 12.9 2 
ENSGALP00000006097 
Ubiquitin-fold modifier 1  
[Source:UniProtKB/Swiss-
Prot;Acc:Q5ZMK7] 102.1 9 1 
ENSGALP00000008163 
Gallinacin-9  
[Source:UniProtKB/Swiss-
Prot;Acc:Q6QLR1] 85.7 7.3 2 
ENSGALP00000009976 
Ovocalyxin-36 precursor  
[Source:RefSeq 
peptide;Acc:NP_001026032] 83.7 58.3 1 
ENSGALP00000010763 
Gallus gallus diazepam binding inhibitor 
(GABA receptor modulator, acyl-CoA 
binding protein) (DBI), mRNA. 
[Source: RefSeq 
mRNA;Acc:NM_204576] 69.8 9.6 2 
ENSGALP00000012729 
Gallinacin-10  [Source: 
UniProtKB/Swiss-Prot;Acc:Q6QLQ9] 62.6 7.1 2 
ENSGALP00000013908 
keratin, type I cytoskeletal 19  [Source: 
RefSeq peptide;Acc:NP_990340] 62.3 46 3 
ENSGALP00000014919 
Usher syndrome 1C [Source: HGNC 
Symbol;Acc:HGNC:12597] 51.9 100.1 1 
ENSGALP00000016177 Uncharacterized protein [Source: 50.9 21 1 
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UniProtKB/TrEMBL;Acc:E1C8H4] 
ENSGALP00000016632 
thymosin, beta 4  [Source:RefSeq 
peptide;Acc:NP_001001315] 47.8 5 2 
ENSGALP00000017755 
collagen, type XVI, alpha 1 [Source: 
HGNC Symbol;Acc:HGNC:2193] 42 156.6 1 
ENSGALP00000018601 
signal peptidase complex subunit 1 
homolog  [Source: RefSeq 
peptide;Acc:NP_001165115] 37.9 27.2 1 
ENSGALP00000019412 
zinc finger BED domain-containing 
protein 4  [Source: RefSeq 
peptide;Acc:NP_001186470] 37.8 132.4 2 
ENSGALP00000019758 
alpha-D-globin (HBAD), mRNA. 
[Source: RefSeq 
mRNA;Acc:NM_001004375] 37.3 15.7 1 
ENSGALP00000019988 
utrophin [Source: HGNC 
Symbol;Acc:HGNC:12635] 36.5 398.6 2 
ENSGALP00000020194 
fatty acid-binding protein, heart  
[Source: RefSeq 
peptide;Acc:NP_001026060] 34.6 14.8 1 
ENSGALP00000024777 
nociceptin precursor  [Source: RefSeq 
peptide;Acc:NP_001171980] 34.4 21.4 1 
ENSGALP00000025120 
polycystic kidney and hepatic disease 1 
(autosomal recessive) [Source: HGNC 
Symbol;Acc:HGNC:9016] 32.7 440 1 
ENSGALP00000025439 
serine peptidase inhibitor, Kazal type 2 
(acrosin-trypsin inhibitor) [Source: 
HGNC Symbol;Acc:HGNC:11245] 26.7 6 1 
ENSGALP00000026777 
probable arginyl-tRNA synthetase, 
mitochondrial  [Source: RefSeq 
peptide;Acc:NP_001264948] 25.2 65.3 1 
ENSGALP00000026846 
transforming, acidic coiled-coil 
containing protein 1 [Source: HGNC 
Symbol;Acc:HGNC:11522] 24.5 86.4 2 
ENSGALP00000026863 
elaC ribonuclease Z 2 [Source :HGNC 
Symbol;Acc:HGNC:14198] 24.2 94.2 1 
ENSGALP00000027483 
Fibroblast growth factor 2  [Source: 
UniProtKB/Swiss-Prot;Acc:P48800] 22.8 16.2 1 
ENSGALP00000027541 
nuclear receptor coactivator 2 [Source: 
HGNC Symbol;Acc:HGNC:7669] 21.5 44.7 1 
ENSGALP00000030659 
WD repeat-containing protein 36  
[Source:RefSeq 
peptide;Acc:NP_001038099] 21.2 98.2 1 
ENSGALP00000031518 
large tumor suppressor kinase 1 
[Source:HGNC 
Symbol;Acc:HGNC:6514] 21.2 127.7 1 
ENSGALP00000031725 septin 3 [Source:HGNC 20.5 40 1 
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Symbol;Acc:HGNC:10750] 
ENSGALP00000035930 
High mobility group protein B1  
[Source:UniProtKB/Swiss-
Prot;Acc:Q9YH06] 20 24.9 1 
ENSGALP00000036403 
tRNA (adenine-N(1)-)-
methyltransferase non-catalytic subunit 
TRM6  [Source:RefSeq 
peptide;Acc:NP_001026212] 19.8 54.2 1 
ENSGALP00000038283 
fibrinogen silencer binding protein 
[Source:HGNC 
Symbol;Acc:HGNC:43653] 19 36.4 1 
ENSGALP00000038735 
SH3 domain binding glutamate-rich 
protein like 3 [Source:HGNC 
Symbol;Acc:HGNC:15568] 18.8 10.5 1 
ENSGALP00000038904 
UPF3 regulator of nonsense transcripts 
homolog B (yeast) [Source:HGNC 
Symbol;Acc:HGNC:20439] 18.4 56.9 1 
ENSGALP00000038912 
mutated in colorectal cancers 
[Source:HGNC 
Symbol;Acc:HGNC:6935] 18.3 112.6 1 
ENSGALP00000039913 
Polyubiquitin-B Ubiquitin 
[Source:UniProtKB/Swiss-
Prot;Acc:P0CG62] 15.5 109.6 1 
ENSGALP00000040476 
neuregulin 2 [Source:HGNC 
Symbol;Acc:HGNC:7998] 15 65.5 1 
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Table 2: Proteins identified in guanidine HCL extract of eggshell membranes by LC-MS/MS   
Protein id Description Score Mw # Peptides 
ENSGALP00000010
405 
ovotransferrin precursor 
[Source:RefSeq 
peptide;Acc:NP_990635] 2328.2 77.8 45 
ENSGALP00000036
403 
Ovalbumin [Source:UniProtKB/Swiss-
Prot;Acc:P01012] 1751.1 42.9 28 
ENSGALP00000039
176 
Actin, cytoplasmic type 5 
[Source:UniProtKB/Swiss-
Prot;Acc:P53478] 1470.9 41.8 29 
ENSGALP00000005
654 
fibronectin precursor [Source: RefSeq 
peptide;Acc:NP_001185641] 1383 
273.
1 33 
ENSGALP00000019
372 
protein-glutamine gamma-
glutamyltransferase 4 [Source:RefSeq 
peptide;Acc:NP_001006368] 1307.4 78.9 28 
ENSGALP00000016
648 
 
1267.7 23.9 17 
ENSGALP00000015
988 
Actin, alpha cardiac muscle 1 [Source: 
UniProtKB/Swiss-Prot;Acc:P68034] 1267.2 42 24 
ENSGALP00000006
093 
keratin, type I cytoskeletal 19 [Source: 
RefSeq peptide;Acc:NP_990340] 1110.2 46 28 
ENSGALP00000005
836 
keratin, type I cytoskeletal 14-like 
[Source: RefSeq 
peptide;Acc:NP_001264913] 904.6 50 23 
ENSGALP00000016
632 
keratin 8, type II [Source: HGNC 
Symbol;Acc:HGNC:6446] 870.4 42.1 17 
ENSGALP00000006
090 
keratin, type I cytoskeletal 14 
[Source:RefSeq 
peptide;Acc:NP_001001311] 845.1 51 20 
ENSGALP00000015
687 
collagen alpha-2(I) chain precursor 
[Source:RefSeq 
peptide;Acc:NP_001073182] 805.3 
128.
8 19 
ENSGALP00000038
912 
Gallus gallus alpha-D-globin (HBAD), 
mRNA. [Source:RefSeq 
mRNA;Acc:NM_001004375] 776.9 15.7 13 
ENSGALP00000005
971 
Annexin A2 
[Source:UniProtKB/Swiss-
Prot;Acc:P17785] 740.3 38.6 17 
ENSGALP00000016
177 
Lysozyme C 
[Source:UniProtKB/Swiss-
Prot;Acc:P00698] 712.1 16.2 11 
ENSGALP00000035
593 
Hemoglobin subunit beta 
[Source:UniProtKB/Swiss- 712.1 16.5 12 
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Prot;Acc:P02112] 
ENSGALP00000016
651 
Uncharacterized protein 
[Source:UniProtKB/TrEMBL;Acc:H9
KZP6] 701.3 28 16 
ENSGALP00000019
031 
serum albumin precursor 
[Source:RefSeq 
peptide;Acc:NP_990592] 673.2 64 17 
ENSGALP00000038
904 
Gallus gallus hemoglobin, alpha 1 
(HBAA), mRNA. [Source:RefSeq 
mRNA;Acc:NM_001004376] 668.8 15.4 13 
ENSGALP00000018
373 
decorin precursor [Source:RefSeq 
peptide;Acc:NP_001025918] 654.7 39.6 15 
ENSGALP00000014
107 
vimentin [Source:RefSeq 
peptide;Acc:NP_001041541] 641.7 53.2 14 
ENSGALP00000035
339 
Gallus gallus ATP synthase, H+ 
transporting, mitochondrial F1 
complex, beta polypeptide (ATP5B), 
nuclear gene encoding mitochondrial 
protein, mRNA. [Source:RefSeq 
mRNA;Acc:NM_001031391] 538.6 52.9 10 
ENSGALP00000035
591 
epsilon globin [Source:RefSeq 
peptide;Acc:NP_001026660] 522.6 16.4 11 
ENSGALP00000006
098 
keratin, type I cytoskeletal 15 [Source: 
RefSeq peptide;Acc:NP_001001312] 486.5 47.9 15 
ENSGALP00000043
135 
titin [Source:HGNC 
Symbol;Acc:HGNC:12403] 456.8 
3397
.7 27 
ENSGALP00000041
526 
Gallus gallus histone cluster 1, H4-VI, 
germinal H4 (similar to human histone 
cluster 1, class H4 genes) (HIST1H46), 
mRNA. [Source: RefSeq 
mRNA;Acc:NM_001037845] 449 11.4 6 
ENSGALP00000022
528 
zona pellucida sperm-binding protein 1 
precursor [Source: RefSeq 
peptide;Acc:NP_990014] 443.2 99.7 10 
ENSGALP00000003
737 
alpha-enolase [Source: RefSeq 
peptide;Acc:NP_990451] 397.4 47.3 8 
ENSGALP00000003
695 
keratin 6A [Source: RefSeq 
peptide;Acc:NP_001001313] 397 57 9 
ENSGALP00000038
799 
Tropomyosin alpha-1 chain [Source: 
UniProtKB/Swiss-Prot;Acc:P04268] 392.9 32.9 12 
ENSGALP00000010
210 
myeloid protein 1 precursor [Source: 
RefSeq peptide;Acc:NP_990809] 388.4 35.2 7 
ENSGALP00000042
171 
transgelin 2 [Source: HGNC 
Symbol;Acc:HGNC:11554] 382 29 8 
ENSGALP00000023
278 
Glyceraldehyde-3-phosphate 
dehydrogenase [Source: 366.1 34.9 8 
  114 
UniProtKB/Swiss-Prot;Acc:P00356] 
ENSGALP00000032
184 
annexin A1 [Source: RefSeq 
peptide;Acc:NP_996789] 334 38.5 9 
ENSGALP00000002
368 
Zona pellucida sperm-binding protein 3 
Processed zona pellucida sperm-
binding protein 3 [Source: 
UniProtKB/Swiss-Prot;Acc:P79762] 331.6 46.7 3 
ENSGALP00000025
606 
Elongation factor 1-alpha 1 
[Source:UniProtKB/Swiss-
Prot;Acc:Q90835] 328.2 50.1 10 
ENSGALP00000037
266 
Gallus gallus histone cluster 1, H1.01 
(similar to human histone cluster 1, 
class H1 genes) (HIST1H101), mRNA. 
[Source: RefSeq 
mRNA;Acc:NM_001040642] 326.7 22.5 7 
ENSGALP00000041
690 
peptidyl-prolyl cis-trans isomerase A 
[Source: RefSeq 
peptide;Acc:NP_001159798] 323.2 15.9 6 
ENSGALP00000011
510 
Apolipoprotein A-I Proapolipoprotein 
A-I [Source: UniProtKB/Swiss-
Prot;Acc:P08250] 320.7 30.7 8 
ENSGALP00000042
590 
keratin 18, type I [Source:HGNC 
Symbol;Acc:HGNC:6430] 318.3 19 5 
ENSGALP00000018
370 
Lumican [Source: UniProtKB/Swiss-
Prot;Acc:P51890] 317 38.6 8 
ENSGALP00000009
563 
Annexin [Source: 
UniProtKB/TrEMBL;Acc:E1C8K3] 313.8 36.7 8 
ENSGALP00000017
755 
Ovocleidin-116 [Source: 
UniProtKB/Swiss-Prot;Acc:F1NSM7] 312.2 76.8 6 
ENSGALP00000019
120 
heat shock 70 kDa protein [Source: 
RefSeq peptide;Acc:NP_001006686] 300.9 69.9 11 
ENSGALP00000013
964 
tubulin beta-3 chain [Source: RefSeq 
peptide;Acc:NP_001074329] 272.9 49.8 7 
ENSGALP00000002
197 
gelsolin precursor [Source: RefSeq 
peptide;Acc:NP_990265] 272.4 85.8 10 
ENSGALP00000005
544 
Ovomucoid [Source: 
UniProtKB/Swiss-Prot;Acc:P01005] 269.7 22.6 5 
ENSGALP00000018
265 
Serpin H1 [Source: UniProtKB/Swiss-
Prot;Acc:P13731] 264.9 45.7 1 
ENSGALP00000043
256 
Fructose-bisphosphate aldolase C 
[Source: UniProtKB/Swiss-
Prot;Acc:P53449] 257.2 39.3 7 
ENSGALP00000028
845 
keratin 4, type II [Source:HGNC 
Symbol;Acc:HGNC:6441] 256.4 58.7 8 
ENSGALP00000010
510 
heat shock cognate 71 kDa protein 
[Source: RefSeq 255.4 70.8 2 
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peptide;Acc:NP_990334] 
ENSGALP00000023
396 
Triosephosphate isomerase [Source: 
UniProtKB/Swiss-Prot;Acc:P00940] 231.3 26.6 4 
ENSGALP00000023
085 
Gallus gallus actinin, alpha 4 
(ACTN4), mRNA. [Source :RefSeq 
mRNA;Acc:NM_205126] 217.2 71.6 5 
ENSGALP00000018
742 
creatine kinase B-type [Source: RefSeq 
peptide;Acc:NP_990641] 216.4 40.2 8 
ENSGALP00000005
607 
proline/arginine-rich end leucine-rich 
repeat protein [Source: HGNC 
Symbol;Acc:HGNC:9357] 210.9 42.9 6 
ENSGALP00000018
424 
desmin [Source: HGNC 
Symbol;Acc:HGNC:2770] 204.5 48.8 6 
ENSGALP00000034
108 
Pyruvate kinase PKM [Source: 
UniProtKB/Swiss-Prot;Acc:P00548] 200.1 57.8 6 
ENSGALP00000021
743 
Histone H2B [Source: 
UniProtKB/TrEMBL;Acc:F1NF30] 193 13.5 1 
ENSGALP00000014
097 
destrin [Source: RefSeq 
peptide;Acc:NP_990859] 189.9 18.4 7 
ENSGALP00000023
926 
Uncharacterized protein [Source: 
UniProtKB/TrEMBL;Acc:E1C6R9] 182.5 19.9 4 
ENSGALP00000020
275 
Beta-galactoside-binding lectin 
[Source: UniProtKB/Swiss-
Prot;Acc:P07583] 176.9 
  ENSGALP00000017
578 
anterior gradient 2 [Source: HGNC 
Symbol;Acc:HGNC:328] 173.9 19.8 4 
ENSGALP00000039
133 
14-3-3 protein epsilon [Source: 
UniProtKB/Swiss-Prot;Acc:Q5ZMT0] 173.4 26.6 3 
ENSGALP00000025
593 
collagen alpha-1(XII) chain precursor 
[Source: RefSeq 
peptide;Acc:NP_990352] 171.6 
339.
6 1 
ENSGALP00000010
853 
 
161.2 
452.
4 3 
ENSGALP00000042
357 
H2A histone family, member X 
[Source: HGNC 
Symbol;Acc:HGNC:4739] 159.5 15 3 
ENSGALP00000042
528 
cold-inducible RNA-binding protein 
[Source:RefSeq 
peptide;Acc:NP_001026518] 159.5 18..6 2 
ENSGALP00000008
163 
orsomucoid 1 (ovoglycoprotein) 
precursor [Source:RefSeq 
peptide;Acc:NP_989872] 158.4 22.3 3 
ENSGALP00000018
498 
heat shock protein 90kDa alpha 
(cytosolic), class A member 1 [Source: 
HGNC Symbol;Acc:HGNC:5253] 157.7 83.2 3 
ENSGALP00000041 tropomyosin beta chain [Source: 157.6 28.7 7 
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937 RefSeq peptide;Acc:NP_990777] 
ENSGALP00000001
474 
78 kDa glucose-regulated protein 
[Source: UniProtKB/Swiss-
Prot;Acc:Q90593] 155.8 72 5 
ENSGALP00000025
280 
Thioredoxin [Source: 
UniProtKB/Swiss-Prot;Acc:P08629] 155.4 11.7 4 
ENSGALP00000006
240 
collagen alpha-3(VI) chain precursor 
[Source:RefSeq 
peptide;Acc:NP_990865] 155.2 
339.
4 5 
ENSGALP00000019
399 
Transgelin [Source: UniProtKB/Swiss-
Prot;Acc:P19966] 147.2 22.3 5 
ENSGALP00000033
366 
Ribonuclease homolog 
[Source:UniProtKB/Swiss-
Prot;Acc:P30374] 143.2 15.9 1 
ENSGALP00000020
967 
ovalbumin-related protein Y [Source: 
RefSeq peptide;Acc:NP_001026172] 141.6 43.8 5 
ENSGALP00000028
277 
Histone H2A.Z [Source: 
UniProtKB/Swiss-Prot;Acc:Q5ZMD6] 139.7 13.6 3 
ENSGALP00000040
188 
S100 calcium binding protein A12 
[Source: HGNC 
Symbol;Acc:HGNC:10489] 138.4 18.5 4 
ENSGALP00000036
122 
14-3-3 protein theta [Source: 
UniProtKB/Swiss-Prot;Acc:Q5ZMD1] 138.3 27.8 1 
ENSGALP00000002
888 
vitellogenin-2 precursor [Source: 
RefSeq peptide;Acc:NP_001026447] 136.8 205 6 
ENSGALP00000019
033 
Alpha-fetoprotein [Source: 
UniProtKB/TrEMBL;Acc:E1BV96] 133.9 71.1 6 
ENSGALP00000040
672 
stratifin [Source: HGNC 
Symbol;Acc:HGNC:10773] 133.4 27.7 4 
ENSGALP00000010
852 
Uncharacterized protein [Source: 
UniProtKB/TrEMBL;Acc:F1NZY2] 133.1 
233.
4 2 
ENSGALP00000026
846 
Gallinacin-10 [Source: 
UniProtKB/Swiss-Prot;Acc:Q6QLQ9] 127.7 7.1 2 
ENSGALP00000043
172 
Cystatin [Source: UniProtKB/Swiss-
Prot;Acc:P01038] 123.6 16.3 2 
ENSGALP00000041
913 
Myosin regulatory light chain 2, 
smooth muscle major isoform 
[Source:UniProtKB/Swiss-
Prot;Acc:P02612] 117.8 19.8 4 
ENSGALP00000000
876 
fatty acid-binding protein, heart 
[Source:RefSeq 
peptide;Acc:NP_001026060] 116.4 14.8 4 
ENSGALP00000038
626 
L-lactate dehydrogenase A chain 
[Source:RefSeq 
peptide;Acc:NP_990615] 116.2 36.5 4 
ENSGALP00000011 60S acidic ribosomal protein P0 114.8 34.6 2 
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717 [Source:RefSeq 
peptide;Acc:NP_990318] 
ENSGALP00000011
961 
phosphatidylethanolamine-binding 
protein 1 [Source: RefSeq 
peptide;Acc:NP_001185571] 113.9 20.9 4 
ENSGALP00000000
062 
Uncharacterized protein [Source: 
UniProtKB/TrEMBL;Acc:H9KYP2] 113.8 67.8 5 
ENSGALP00000043
361 
Uncharacterized protein [Source: 
UniProtKB/TrEMBL;Acc:R4GMA5] 113.2 26.7 2 
ENSGALP00000043
060 
Mimecan [Source: UniProtKB/Swiss-
Prot;Acc:Q9W6H0] 110.1 33.2 3 
ENSGALP00000013
267 
rab GDP dissociation inhibitor beta 
[Source: RefSeq 
peptide;Acc:NP_990335] 106.7 50.7 3 
ENSGALP00000034
078 
Nucleoside diphosphate kinase 
[Source: UniProtKB/Swiss-
Prot;Acc:O57535] 104 17.3 4 
ENSGALP00000019
365 
annexin A5 [Source: RefSeq 
peptide;Acc:NP_001026709] 103.3 36.2 5 
ENSGALP00000026
126 
60S ribosomal protein L8 [Source: 
RefSeq peptide;Acc:NP_001264657] 102.2 28 4 
ENSGALP00000005
520 
aldehyde dehydrogenase 9 family, 
member A1 [Source: HGNC 
Symbol;Acc:HGNC:412] 101.7 57.1 3 
ENSGALP00000000
316 
major vault protein [Source: RefSeq 
peptide;Acc:NP_001006336] 96.5 93.7 6 
ENSGALP00000036
963 
ribosomal protein L15 [Source: HGNC 
Symbol;Acc:HGNC:10306] 95.8 24.1 2 
ENSGALP00000020
094 
Histone H5 [Source: UniProtKB/Swiss-
Prot;Acc:P02259] 95.4 20.7 3 
ENSGALP00000014
317 
isocitrate dehydrogenase 1 (NADP+), 
soluble [Source: HGNC 
Symbol;Acc:HGNC:5382] 93.3 46.9 2 
ENSGALP00000008
498 
transketolase [Source:HGNC 
Symbol;Acc:HGNC:11834] 91.9 68.4 3 
ENSGALP00000039
326 
60S ribosomal protein L19 [Source: 
RefSeq peptide;Acc:NP_001026100] 85.7 23.2 2 
ENSGALP00000014
912 
Protein S100-A11 [Source: 
UniProtKB/Swiss-Prot;Acc:P24479] 85 11.4 1 
ENSGALP00000013
574 
Protein disulfide-isomerase A3 
[Source: UniProtKB/Swiss-
Prot;Acc:Q8JG64] 84.9 56.1 4 
ENSGALP00000016
361 
ribosomal protein S3A [Source:RefSeq 
peptide;Acc:NP_001075886] 84.7 29.8 4 
ENSGALP00000040
606 
CD99 antigen precursor [Source: 
RefSeq peptide;Acc:NP_001185580] 79.3 18.2 2 
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ENSGALP00000006
938 
annexin A6 [Source: RefSeq 
peptide;Acc:NP_990061] 77.5 75.2 2 
ENSGALP00000040
966 
Uncharacterized protein [Source: 
UniProtKB/TrEMBL;Acc:R4GG07] 74.1 13.2 1 
ENSGALP00000007
490 
moesin [Source: HGNC 
Symbol;Acc:HGNC:7373] 73.8 68.5 3 
ENSGALP00000038
677 
Gallus gallus phosphoglycerate mutase 
1 (brain) (PGAM1), mRNA. [Source: 
RefSeq mRNA;Acc:NM_001031556] 73.4 23.7 3 
ENSGALP00000029
440 
Vitelline membrane outer layer protein 
1 [Source: UniProtKB/Swiss-
Prot;Acc:P41366] 69.1 20.2 1 
ENSGALP00000024
468 
40S ribosomal protein S15 [Source: 
UniProtKB/Swiss-Prot;Acc:P62846] 68 16.9 2 
ENSGALP00000032
611 
vitellogenin-1 precursor [Source: 
RefSeq peptide;Acc:NP_001004408] 67.6 
210.
6 3 
ENSGALP00000003
455 
peptidyl-prolyl cis-trans isomerase B 
precursor [Source: RefSeq 
peptide;Acc:NP_990792] 66.6 16.2 2 
ENSGALP00000029
968 
60S ribosomal protein L3 [Source: 
RefSeq peptide;Acc:NP_001006241] 65.8 26.1 3 
ENSGALP00000025
929 
hydroxyacyl-coenzyme A 
dehydrogenase, mitochondrial [Source: 
RefSeq peptide;Acc:NP_001264826] 64.9 34.4 2 
ENSGALP00000001
013 
60S ribosomal protein L22 
[Source:RefSeq 
peptide;Acc:NP_989472] 64.7 14.6 2 
ENSGALP00000007
680 
60S ribosomal protein L6 [Source: 
RefSeq peptide;Acc:NP_989483] 64 33.9 2 
ENSGALP00000021
618 
L-lactate dehydrogenase B chain 
[Source: UniProtKB/Swiss-
Prot;Acc:P00337] 61.6 36.3 3 
ENSGALP00000038
462 
protein TENP [Source: RefSeq 
peptide;Acc:NP_990357] 61.3 47.4 2 
ENSGALP00000011
689 
protein disulfide-isomerase precursor 
[Source: RefSeq 
peptide;Acc:NP_001185639] 61.1 55.8 4 
ENSGALP00000003
431 
nucleophosmin [Source: RefSeq 
peptide;Acc:NP_990598] 60.5 30.3 2 
ENSGALP00000041
639 
ribosomal protein S26 [Source: HGNC 
Symbol;Acc:HGNC:10414] 59 18 2 
ENSGALP00000008
131 
vinculin [Source: HGNC 
Symbol;Acc:HGNC:12665] 58.9 
114.
3 1 
ENSGALP00000024
078 
WD repeat-containing protein 1 
[Source: RefSeq 
peptide;Acc:NP_001004402] 58.5 66.5 1 
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ENSGALP00000023
089 
ribosomal protein, large, P2 [Source: 
HGNC Symbol;Acc:HGNC:10377] 57.8 14.2 1 
ENSGALP00000007
476 
protein SET [Source: RefSeq 
peptide;Acc:NP_001025862] 57.7 32.1 1 
ENSGALP00000012
462 
ribosomal protein S25 [Source: HGNC 
Symbol;Acc:HGNC:10413] 57.5 13.7 1 
ENSGALP00000000
509 
heterogeneous nuclear 
ribonucleoprotein M [Source: RefSeq 
peptide;Acc:NP_001026103] 53 76 4 
ENSGALP00000014
298 
60S ribosomal protein L12 [Source: 
RefSeq peptide;Acc:NP_001264608] 52.2 17.7 1 
ENSGALP00000027
030 
60S ribosomal protein L31 [Source: 
RefSeq peptide;Acc:NP_001264684] 52.2 14.7 2 
ENSGALP00000027
665 
acetyl-CoA acetyltransferase, 
mitochondrial [Source: RefSeq 
peptide;Acc:NP_001264708] 51.9 44.1 2 
ENSGALP00000039
447 
heat shock protein beta-1 [Source: 
RefSeq peptide;Acc:NP_990621] 51.9 21.8 1 
ENSGALP00000025
745 
Uncharacterized protein [Source: 
UniProtKB/TrEMBL;Acc:F1P304] 50.8 24.5 3 
ENSGALP00000039
530 
heterogeneous nuclear 
ribonucleoprotein H [Source: RefSeq 
peptide;Acc:NP_989827] 50.4 56.5 2 
ENSGALP00000038
435 
protein-glutamine gamma-
glutamyltransferase 2 [Source: RefSeq 
peptide;Acc:NP_990779] 49.5 77.7 1 
ENSGALP00000002
333 
Uncharacterized protein [Source: 
UniProtKB/TrEMBL;Acc:F1NPG6] 47.6 93.8 2 
ENSGALP00000006
284 
heterogeneous nuclear 
ribonucleoprotein H3 [Source: RefSeq 
peptide;Acc:NP_001012610] 46.3 36.6 2 
ENSGALP00000021
314 
caldesmon [Source: RefSeq 
peptide;Acc:NP_989489] 44.7 86.4 2 
ENSGALP00000026
392 
ribosomal protein S7 [Source:HGNC 
Symbol;Acc:HGNC:10440] 43 22.3 2 
ENSGALP00000026
123 
ATP-dependent RNA helicase DDX3X 
[Source: RefSeq 
peptide;Acc:NP_001025971] 42.8 72.6 1 
ENSGALP00000027
012 
lysozyme g precursor [Source: RefSeq 
peptide;Acc:NP_001001470] 42.2 23.3 3 
ENSGALP00000019
979 
Uncharacterized protein [Source: 
UniProtKB/TrEMBL;Acc:F1NI80] 41.2 41.1 1 
ENSGALP00000010
800 
actin-related protein 2/3 complex 
subunit 4 [Source :RefSeq 
peptide;Acc:NP_001244213] 41.1 19.7 8 
ENSGALP00000025 Carbonic anhydrase 2 [Source: 41.1 29 1 
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525 UniProtKB/Swiss-Prot;Acc:P07630] 
ENSGALP00000039
575 
guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-1 [Source: 
RefSeq peptide;Acc:NP_001012853] 40.8 37.3 2 
ENSGALP00000028
211 
glycerol-3-phosphate dehydrogenase 1 
(soluble) [Source: HGNC 
Symbol;Acc:HGNC:4455] 40.2 38.6 1 
ENSGALP00000014
746 
Gallus gallus heat shock 10kDa protein 
1 (chaperonin 10) (HSPE1), nuclear 
gene encoding mitochondrial protein, 
mRNA. [Source: RefSeq 
mRNA;Acc:NM_205067] 39.6 12.1 2 
ENSGALP00000035
996 
superoxide dismutase [Source:RefSeq 
peptide;Acc:NP_990395] 39.3 15.7 1 
ENSGALP00000012
481 
60S ribosomal protein L4 [Source: 
RefSeq peptide;Acc:NP_001007480] 38.6 46.7 2 
ENSGALP00000006
308 
ribosomal protein L23a [Source:HGNC 
Symbol;Acc:HGNC:10317] 38.3 17.6 2 
ENSGALP00000010
414 
heterogeneous nuclear 
ribonucleoprotein G [Source:RefSeq 
peptide;Acc:NP_001073196] 38 41.5 2 
ENSGALP00000001
914 
chloride intracellular channel 4 
[Source:HGNC 
Symbol;Acc:HGNC:13518] 31.5 27.7 1 
ENSGALP00000041
423 
glutathione peroxidase 1 
[Source:RefSeq 
peptide;Acc:NP_001264782] 31.4 17.9 1 
ENSGALP00000008
802 
40S ribosomal protein S2 
[Source:RefSeq 
peptide;Acc:NP_001264093] 31 30.7 1 
ENSGALP00000013
122 
60 kDa heat shock protein, 
mitochondrial 
[Source:UniProtKB/Swiss-
Prot;Acc:Q5ZL72] 30.8 60.9 1 
ENSGALP00000009
511 
60S ribosomal protein L5 
[Source:UniProtKB/Swiss-
Prot;Acc:P22451] 30.7 33.9 2 
ENSGALP00000006
222 
calreticulin 3 [Source:HGNC 
Symbol;Acc:HGNC:20407] 29.8 48 1 
ENSGALP00000041
109 
capping protein (actin filament), 
gelsolin-like [Source:HGNC 
Symbol;Acc:HGNC:1474] 29.5 72.4 1 
ENSGALP00000033
411 
ribosomal protein S21 [Source:HGNC 
Symbol;Acc:HGNC:10409] 28.8 9.1 1 
ENSGALP00000029
993 
rho GDP-dissociation inhibitor 2 
[Source:RefSeq 28.1 23.2 1 
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peptide;Acc:NP_001264293] 
ENSGALP00000035
366 
isocitrate dehydrogenase 
[Source:RefSeq 
peptide;Acc:NP_001026770] 26.7 50.4 1 
ENSGALP00000035
959 
carbonyl reductase [Source:RefSeq 
peptide;Acc:NP_001025966] 24.4 30.3 1 
ENSGALP00000041
772 
Protein syndesmos 
[Source:UniProtKB/Swiss-
Prot;Acc:Q9IAY5] 23.5 33.8 1 
ENSGALP00000003
373 
40S ribosomal protein S17 
[Source:UniProtKB/Swiss-
Prot;Acc:P08636] 20 9.5 1 
ENSGALP00000037
222 
Heterogeneous nuclear 
ribonucleoprotein D-like [Source: 
UniProtKB/Swiss-Prot;Acc:Q5ZI72] 17.3 33.4 1 
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Table 3: Proteins identified in bacterial database 	 Accession	 Protein	 MW	[kDa]	 Scores	 #Peptides	1	 gi|294828133	 histidine	kinase/response	regulator	hybrid	protein	[Leptospira	interrogans	serovar	Lai	str.	56601]	
116.9	 77.8	 4	
2	 gi|517357534	 serine/threonine	protein	kinase	[Streptomyces	sp.	HmicA12]	 67.9	 65.8	 2	3	 gi|655245428	 protein	kinase	[Nocardioides	sp.	J54]	 72.9	 63.7	 2	4	 gi|124514345	 Precorrin-4	C11-methyltransferase	[Leptospirillum	rubarum]	 29.5	 56.8	 2	5	 gi|206742631	 soluble	lytic	murein	transglycosylase	[Thermodesulfovibrio	yellowstonii	DSM	11347]	
73.8	 55.6	 2	
6	 gi|292642245	 SWIM	zinc	finger	domain	protein	[Enterococcus	faecium	PC4.1]	 42.4	 54.1	 2	7	 gi|695172258	 aminotransferase	[Sphingomonas	taxi]	 33.6	 49.5	 1	8	 gi|345633807	 LuxR	family	transcriptional	regulator	[Streptomyces	zinciresistens	K42]	 24.0	 48.9	 1	9	 gi|19705092	 hypothetical	protein	FN1787	[Fusobacterium	nucleatum	subsp.	nucleatum	ATCC	25586]	 73.8	 44.1	 1	10	 gi|124515012	 putative	hydrolase,	haloacid	dehalogenase-like	family	[Leptospirillum	rubarum]	 24.5	 43.7	 1	11	 gi|422886479	 cold	shock-like	protein	[Alcaligenes	sp.	HPC1271]	 7.5	 42.3	 1	12	 gi|618782811	 ribonucleotide-diphosphate	reductase	subunit	alpha	[Pseudomonas	aeruginosa	M10]	 107.0	 38.8	 1	13	 gi|311693188	 ATPase	components	of	ABC	transporters	with	duplicated	ATPase	domains	[Marinobacter	adhaerens	HP15]	
24.5	 71.7	 2	
14	 gi|297550774	 serine/threonine	protein	kinase	 73.8	 65	 2	
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with	TPR	repeats	[Ktedonobacter	racemifer	DSM	44963]	15	 gi|405587154	 transcription	termination	factor	Rho	[Bergeyella	zoohelcum	CCUG	30536]	 65.9	 63.3	 2	16	 gi|618771208	 F0F1	ATP	synthase	subunit	alpha	[Pseudomonas	aeruginosa	M10]	 55.4	 61	 1	17	 gi|588290902	 prolyl-tRNA	synthetase	[Thalassolituus	oleivorans	R6-15]	 63.9	 55.7	 2	18	 gi|114739665	 isocitrate	dehydrogenase,	NADP-dependent	[Hyphomonas	neptunium	ATCC	15444]	 45.6	 52.6	 1	19	 gi|755437351	 der	GTPase	activator	family	protein	[Yersinia	kristensenii]	 21.2	 49.5	 1	20	 gi|394456251	 hypothetical	protein	O71_08395	[Pontibacter	sp.	BAB1700]	 45.3	 45.8	 1	21	 gi|452006359	 mutant	NtrC-like	activator	[Pseudomonas	stutzeri	NF13]	 51.1	 45	 1	22	 gi|618789844	 oxidoreductase	[Pseudomonas	aeruginosa	M10]	 26.2	 44.4	 1	23	 gi|328474119	 GTP-binding	protein	LepA	[Vibrio	parahaemolyticus	10329]	 65.9	 43.1	 1	24	 gi|651910070	 hypothetical	protein	[Butyrivibrio	sp.	AC2005]	 52.1	 40.4	 1	25	 gi|311694265	 glutathione	synthase/ribosomal	protein	S6	modification	enzyme	[Marinobacter	adhaerens	HP15]	 58.3	 43.8	 1	26	 gi|546198376	 MULTISPECIES:	ribosomal	protein	L25,	Ctc-form	[Bacteria]	 20.7	 43.8	 1	27	 gi|726045696	 acetyltransferase	[Candidatus	Scalindua	brodae]	 17.6	 43.4	 1	28	 gi|452009578	 hypothetical	protein	B381_02321	[Pseudomonas	stutzeri	NF13]	 32.3	 32.1	 1	29	 gi|258592528	 putative	Histidine	kinase	[Candidatus	Methylomirabilis	oxyfera]	 86.4	 85.2	 3	30	 gi|516628378	 MULTISPECIES:	F0F1	ATP	synthase	subunit	alpha	[Bacteria][Archaea]	 55.6	 84.4	 4	31	 gi|292642035	 hypothetical	protein	CUO_2557	[Enterococcus	faecium	PC4.1]	 97.6	 80.2	 3	32	 gi|695170760	 2-keto-4-pentenoate	hydratase	[Sphingomonas	taxi]	 35.8	 78.4	 3	33	 gi|380733894	 serine/threonine	protein	kinase	[Corallococcus	coralloides	DSM	 126.9	 77	 3	
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2259]	34	 gi|292637908	 NADH:ubiquinone	oxidoreductase,	Na(+)-translocating,	A	subunit	[Bacteroides	xylanisolvens	SD	CC	2a]	
55.7	 70.5	 2	
35	 gi|114737610	 putative	helicase	[Hyphomonas	neptunium	ATCC	15444]	 42.9	 69.2	 3	36	 gi|288328957	 tetratricopeptide	repeat	protein	[Prevotella	sp.	oral	taxon	317	str.	F0108]	 67.0	 62.7	 2	37	 gi|618792792	 selenocysteine	synthase	[Pseudomonas	aeruginosa	M10]	 49.7	 62	 2	38	 gi|300402166	 DNA	mismatch	repair	domain	protein	[Escherichia	coli	MS	84-1]	 67.9	 62	 2	39	 gi|394454349	 tex-like	protein	[Pontibacter	sp.	BAB1700]	 83.4	 54.4	 1	40	 gi|695170101	 phosphoadenosine	phosphosulfate	reductase	[Sphingomonas	taxi]	 27.7	 51.1	 1	41	 gi|618777703	 ATP-binding	protein	[Pseudomonas	aeruginosa	M10]	 38.4	 49.7	 1	42	 gi|291518125	 Uncharacterized	protein	conserved	in	bacteria	[Butyrivibrio	fibrisolvens	16/4]	 9.1	 46.6	 1	43	 gi|726045751	 hypothetical	protein	SCABRO_01635	[Candidatus	Scalindua	brodae]	 23.3	 46.2	 1	44	 gi|292643035	 ribonuclease	HIII	[Enterococcus	faecium	PC4.1]	 33.9	 45.2	 1	45	 gi|618771210	 F0F1	ATP	synthase	subunit	beta	[Pseudomonas	aeruginosa	M10]	 49.5	 45	 1	46	 gi|691636805	 hypothetical	protein	IA69_10970	[Massilia	sp.	JS1662]	 99.2	 44.7	 1	47	 gi|726045041	 hypothetical	protein	SCABRO_02256	[Candidatus	Scalindua	brodae]	 15.4	 44.6	 1	48	 gi|635597237	 uncharacterized	protein	conserved	in	bacteria	[Comamonadaceae	bacterium	B1]	 45.0	 43.7	 1	49	 gi|114740197	 putative	fimbrial	assembly	protein	[Hyphomonas	neptunium	ATCC	15444]	 26.7	 42.5	 1	50	 gi|667096584	 lytic	transglycosylase	 20.7	 41	 1	
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[Xanthomonas	vasicola	pv.	vasculorum	NCPPB	895]	
 
Figure 1:  Functional annotation of proteins by Protein Analysis through Evolutionary 
Relationships (PANTHER) a) biological process b) Molecular Functions 
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Abstract 
Eggshells are significant part of hatchery waste which consist of calcium carbonate crust, 
membranes, and proteins and peptides of embryonic origins along with other entrapped 
contaminants such as microbes. We hypothesized that using this product as a nutritional additive 
in poultry diet may confer better immunity to the chickens in the paradigm of mammalian milk 
that enhances immunity. Therefore, we investigated the effect of hatchery eggshell membranes 
(HESM) as a short term feed supplement on growth performance and immunity of chickens 
under bacterial lipopolysaccharide (LPS) challenged condition. Three studies were conducted to 
find the effect of HESM supplement on post hatch chickens. In the first study, the chickens were 
fed either a control diet or diets containing 0.5% whey protein or HESM as supplement and 
evaluated at 5 weeks of age using growth, hematology, clinical chemistry, plasma 
immunoglobulins, and corticosterone as variables. The second and third studies were done to 
compare the effects of LPS on control and HESM fed birds at 5 weeks of age where the HESM 
was also treated with ethanol to inactivate bacterial factors, and the effects of LPS evaluated at 4 
and 24 h of treatment. HESM supplement caused a numerical but nonsignificant weight gain in 2 
experiments and consistently decreased the blood corticosterone levels. LPS caused a significant 
loss in body weight at 24 h following its administration but the HESM supplemented birds 
showed significantly less body weight loss compared with the control fed birds. The WBC, 
heterophil/lymphocyte ratio, and the levels of IgG were low in chickens fed HESM supplement 
diet compared with the control fed group.  LPS challenge increased the expression of pro-
inflammatory cytokine gene IL-6 but the HESM fed birds showed its effect curtailed also, 
favored the up-regulation of some anti-inflammatory genes compared with control fed chickens. 
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Post hatch supplementation of HESM appears to modulate immunity, and increase their 
resistance to endotoxin.  
 
Key words:  Hatchery eggshell membrane, chicken, lipopolysaccharide, gene expression, 
corticosterone 
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Introduction  
Eggshells which constitute a significant part of hatchery waste consist of calcareous crust, shell 
membranes, proteins and peptides of embryonic origins, and entrapped contaminants including 
microbes [1, 2]. Proteomic analysis of the eggshell membranes (ESM) have shown the presence 
of over 200 proteins and peptides belonging to structural, antimicrobial, and cell-regulatory 
genre [3-5] with the hatchery eggshell membrane (HESM) enriched with many blood derived 
proteins (Makkar et al., in preparation). We hypothesized that HESM as a feed supplement may 
be beneficial to post hatch poultry in the paradigm of mammalian milk, which contain many 
similar proteins and peptides such as lactoferrin, lysozyme, albumin, and other factors that help 
gastrointestinal development and help development of immunity in neonates [6, 7].  However, 
the functional stability of these proteins to harsh processes such as, drying, decontamination, and 
passage through the gastrointestinal tract is not known.  Reports in the literature have shown the 
biological effects of different enzymes, antibodies, recombinant cytokines, and other bioactive 
protein additives in animal feed [8-13]. Previously, we showed that nutritional supplement of 
eggshell membrane (ESM) from fresh unfertilized eggs given to the chickens during first 2 
weeks post hatch, improved growth, increased serum immunoglobulins, and reduced several 
stress variables such as plasma corticosterone, heterophils, and heterophil/lymphocyte ratios[14]. 
The growth supportive effects of fetal proteins have also been demonstrated in other 
experimental models [15, 16], The muco-adhesive membrane particles may also act as carriers of 
microbial antigens along with other adjuvant-like proteins and peptides [17, 18] that help to 
develop resistance or tolerance to pathogens. Hence, the objective of this research was to explore 
the effect of HESM supplements on the performance of post hatch chickens stressed with 
endotoxin during the grow-out period. 
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Materials and Method 
Preparation of HESM and its sterilization  
Empty eggshells collected from a hatchery were dried at room temperature and the membranes 
separated from the shells and pulverized to powders and flakes with an IKA mill (Cole Parmer). 
The protein nitrogen content of the membrane powder before and after mixing with feed were 
estimated by Duma’s nitrogen analyzer using duplicate samples [14].  Three feeding experiments 
were conducted: study 1 utilized intact HESM while the studies 2 and 3 utilized HESM flakes 
sterilized with ethanol to reduce bacterial and endotoxin contaminants.  In studies with ethanol 
sterilization, the HESM flakes were treated with 3 volumes (w/v) of reagent grade ethanol, 
enough to wet the flakes, and then air dried in a chemical hood without decantation.  The effect 
of this treatment was evaluated using bacterial colony count assays [19] and the production of 
nitrite by HTC macrophages due to endotoxin [20].  Briefly, duplicate samples of untreated and 
ethanol treated HESM powders were extracted with sterile saline at the concentrations of 100 
mg/ mL at room temperature for 2 h and centrifuged at 21,000 g. Respective supernatants were 
serially diluted and 100 µl of each sample was plated on agar plates in triplicate, and incubated 
for 24 h at 37oC to evaluate for bacterial growth. The same extracts were also evaluated for 
endotoxin activities using nitrite production by the HTC chicken macrophages following 24 h of 
stimulation and compared with Salmonella LPS (1µg/ml) used as a positive control [20].  
Experimental Schedule 
The animal study protocols were approved by the Institutional Animal Care and Use Committee 
(IACUC) of the University of Arkansas.  Newly hatched Cobb 500 male chicks were raised on 
floor pens at a density of 8 square feet /bird with 23:1 light: dark schedule and provided feed 
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formulated per National Research Council [21] specification and ad libitum water.  The HESM 
was added at 0.5% level to broiler starter diet based on previous experiments.  In Study 1 the 
effects of crude HESM and a comparable level of whey protein powder were tested on the 
growth performance and general physiological parameters of 5-wk-old chickens as described 
later.  In Studies 2 and 3, the HESM powder was ethanol sterilized and used as the feed 
supplement where the effects of Salmonella typhimurium lipopolysaccharide was evaluated 
following 24 or 4 h of treatment. In all the experiments, the chickens were fed diets containing 
the supplement for 14 days post hatch then switched to un supplemented diet for the rest of the 
time until necropsy. The birds were monitored daily for mortality, welfare and evaluated weekly 
for body weight (BW), and feed consumption. The BW of the birds were measured before LPS 
injection and prior to necropsy when necessary.   
In Study 1, 72 one day-old chicks were divided into 3 groups each with 24 birds in two replicate 
pens. The three groups received diets as follows: 1) control feed with no supplement, 2) feed 
containing 0.5% whey protein powder as a secondary control to find whether the effect was due 
to protein supplement alone, and 3) feed containing 0.5% HESM.  Prior to necropsy, 6 birds 
from each pen (12/group) were bled by cardiac puncture, blood collected using EDTA containing 
Vacutainer as well as rapid serum tubes (BD Falcon) for hematology and clinical chemistry 
assays respectively [14]. 
Studies 2 and 3 were done with ethanol sterilized HESM.  Growth performance of the birds 
along with differnt physiological changes including the effects of Salmonella typhimurium LPS 
(cat # HC4060 Sigma-Aldrich, St. Louis, MO) were determined.  In Study 2, the day-old 
chickens were allocated into 2 groups and given feed with or without 0.5% HESM as described 
above then switched to regular feed through 5 weeks of age.  On day 34, 12 birds in each group 
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were injected intramuscularly in the thigh with LPS at the concentration of 1 mg/kg BW in saline 
and the rest received equal volumes of saline. The effect of LPS was monitored visually for 5 h 
following injection with the BW measured before and after 24 h of injection.  Prior to necropsy, 
12 chickens/group were bled for hematology and clinical chemistry assays.  At necropsy, the 
weights of selective organs from all the birds were recorded. 
In Study 3, the effect of LPS on splenic expression of selective genes associated with different 
immune function were determined. Chickens from control and HESM groups received either 
saline or LPS injection as described earlier.  Four h after the injection 6 chickens from each 
group were killed and the spleens placed in liquid nitrogen for RNA extraction, and the rest 
killed after 24 h to record BW and organ weights.  
Necropsy 
The liver, heart, spleen, and bursa weights from all birds were used to calculate the percentage 
relative to BW.  In Study 2, a cm length of ileum below the pancreatic loop was excised from 
each of  six control and HESM fed birds and fixed in Carnoy’s fluid for ~5 h, transferred to 70% 
alcohol then processed for histology.  Six micron paraffin sections were stained with periodic 
acid Schiff (PAS) hematoxylin staining and examined for villus health, mucous secretion, and 
gross abnormality by visual observation. The sections were photographed in BX Olympus 
microscope. 
 
Hematology 
Blood cell counts along with hemoglobin content, mean corpuscular volume (MCV), hematocrit, 
microhematocrit (MCH), red blood cell distribution width (RDW) values were measured using 
EDTA anticoagulated blood by the use of Cell-Dyn 3500 blood analysis system (Abbott 
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Diagnostics, Abbott Park, IL) standardized for avian blood and the heterophil to lymphocyte 
ratios (H/L) calculated.   
 
Serum assays 
The serum metabolic parameters were assayed using a clinical chemistry analyzer (Ciba Corning 
Diagnostics Corp, Medfield, MA). Corticosterone concentrations were measured by Detect X 
enzyme immunoassay kitTM (Arbor Assays, Ann Arbor, MI) using predetermined dilutions of 
sera [14].  The IgM, IgG, and IgA concentrations were similarly, determined using respective 
assay kits from Bethyl Laboratory (Montgomery, TX) with the serum diluted to 1:1000 with the 
manufacturer supplied buffer for IgA, 1:50,000 for IgG, and 1:20,000 for IgM, respectively.  The 
concentrations of antibodies in the sera were calculated from their respective standard curves.  
 
Gene expression 
 
The expressions of inflammation regulatory genes such as pro-inflammatory (IL-1β, IL-6, IFN-
γ), anti-inflammatory (IL-4, IL-10, IL-12), and immunosuppressive, wound repair supportive 
factors (TGF-β3 and vascular endothelial growth factor (VEGF) [22-24] were determined using 
splenic tissue RNA and quantitative RT-PCR.  Six frozen spleens from each treatment group 
were split into 4 quarters and ~ 100 mg of tissues from equivalent region of each spleen were 
extracted with Tri Reagent (Sigma-Aldrich) to prepare RNA. Complementary DNA (cDNA) was 
synthesized using 1 µg of RNA and qScript™ cDNA SuperMix (Quanta biosciences) following 
manufacturer's protocol. Quantitative real-time PCR was performed using SYBR® Green PCR 
Master mix (Life technologies) in an ABI 7500 Real-Time PCR system (Applied Biosystems, 
Carlsbad, CA).  A 25 µl reaction containing 5 µl cDNA (1 µg of RNA equivalent) and primers 
specific against chicken IL-1β, IL-4, IL-6, IL-10, IFN-γ, TGF-β3, VEGF and IL-12 
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(Supplementary Table 1) were subjected to PCR with initial denaturation at 95°C for 10 minutes 
followed by 40 PCR cycles as follows: 95 °C for 15 s, 58 °C for 1 min. Expression of target 
genes were analyzed by the 2−ΔΔCt method [25] with 18S RNA used as reference gene.   
 
Statistical analyses 
All results were evaluated using Duncan's t test using SAS software [26] and a P-value of <0.05 
considered to be significant.The results are shown as mean±SEM.  
Results 
HESM 
The average protein content of HESM was determined to be approximately 88% (w/w)  the 
addition of which did not significantly alter the protein content of feed  (Control: 25.1% and 
HESM: 25.3%, n=2 samples/group). The number of bacterial colonies showed a significant 
reduction from 30,000 / ml in untreated HESM extract to less than 5 colonies in ethanol treated 
HESM. Similarly, the ethanol treatment reduced the endotoxin content of HESM judged by a 
significantly low level of nitrite production by the HTC cells (Figure. 1) 
Effect on BW, mortality  
In Study 1, there were no significant differences in body weight (BW) or relative organ weights 
of the birds given HESM supplemented feed compared with either control or whey protein 
supplemented groups (Supplementary Table 2).  In both Studies 2 and 3, the birds fed HESM 
supplement diet showed a slight but statistically nonsignificant increase in BW and no 
differences in relative organ weights compared with control group. Cumulative mortality rate in 
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all 3 experiments combined, showed no differences between control and HESM fed chicks 
(Table 1).  
LPS effect 
LPS treated chickens showed symptoms of sickness indicated by lack of activity, eyelid closure, 
and feed avoidance within 3 h of treatment and decreases in BW by 24 h. The relative liver 
weights were significantly increased and bursa weights decreased in LPS treated groups although 
this effect was not seen with heart and spleen. The chickens that received HESM showed 
comparatively less (p≤ 0.05) BW loss relative to control fed birds (Table 1, Figure. 2).  
Hematology and serum chemistry 
The results from Study 2 and the effect of LPS are shown in Table 2.  HESM treatment per se 
had no effect on lymphocyte (L), monocyte (M), heterophil (H), or basophil (B) percentages, and 
H/L ratios. On LPS treatment, there was an increase in percentages of heterophil, monocyte, and 
basophils, and H/L ratios, and a reduction in lymphocyte counts in both groups. The relative 
decrease in heterophil and increase in the lymphocyte counts resulted in a significant decrease of 
H/L ratios in HESM group compared with controls and challenged with LPS (Table 2). There 
were few other changes including increased hematocrit in HESM birds and treated with LPS. 
HESM produced a moderate decrease in serum protein, calcium, and magnesium levels some of 
which increased upon LPS treatment.  LPS caused a decrease in serum iron and increase in 
triglycerides in both groups (Table 3).  The cholesterol and HDL levels were down regulated in 
serum of control birds as compared to HESM when challenged with LPS.  Neither alanine nor 
the aspartate amino transferases were affected by HESM indicating the lack of liver toxicity.  
Serum immunoglobulins and corticosterone 
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In Study 1 there was no changes in serum IgM levels of chickens fed whey protein or intact 
HESM but the IgG levels decreased with HESM (Supplementary Table 3). Similar trend was 
observed in the 2nd study that upon LPS treatment increased the serum IgM while the IgG level 
remained unchanged in HESM fed birds.  Neither treatment had any effect on serum IgA (Table 
4). The corticosterone was consistently lower in both studies in HESM fed birds but with LPS 
treatment, it increased moderately reaching to the same levels as control birds (Table 4). 
 
Gene expression 
The splenic gene expression results are shown in Table 5. Chickens fed regular diet and 
challenged with LPS had a significant increase in IL-6 gene expression compared with HESM 
fed group (Figure 3). The anti-inflammatory gene IL-10 showed a significant increase in the 
HESM group when challenged with LPS (Figure 4).  The IL-4 gene was downregulated in 
HESM birds but on LPS treatment its expression was significantly higher compared with control 
fed chickens (Figure 5). There was no change in the expressions of IFN-g or IL-12. But the TGF-
β expression showed a significant decrease by LPS treatment in both control and HESM fed 
groups whereas the VEGF downregulated in HESM birds regardless of LPS treatment.   
 
Histology 
There were no differences in the overall health of intestine between the control and HESM diet 
fed birds judged by villus morphology, muscularis, and mucus deposition (Supplementary Figure 
1). 
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Discussion   
Our results show that feeding HESM is beneficial to chickens particularly in decreasing stress 
levels and improving resistance to LPS-induced changes.  These results are consistent with our 
previous report where the egg shell membranes (ESM) from fresh unfertilized eggs improved the 
performance of 3 week old chickens with respect to body weight and downregulated 
corticosterone and other stress parameters[14].  In the previous study with ESM we observed an 
increase in the levels of IgG and IgM at 3 weeks but in the present study the IgM levels appeared 
not to be affected which may be due to later sampling time of 5 weeks when the early response 
to antigens tend to subside [27-29].  However, the cause of IgG downregulation in HESM fed 
birds is not understood.  
Weight loss is a hallmark of endotoxemia in both mammals and birds which is mediated 
through several pro inflammatory cytokines such as IL-1, IL-6, and TNF-α [30-33]. These 
cytokines not only cause hypophagia but also promote protein catabolism [34]. The HESM 
appears to curb the effect of endotoxin promoting weight loss also modifies the splenic 
expression of cytokine genes that are associated with inflammation [35-39].  Similarly, there was 
a persistent downregulation of corticosterone and other stress markers such as heterophil to 
lymphocyte ratios [40] in HESM fed birds that could account for their better performance. 
Glucocorticoids can  not only  be anti-anabolic but also immunosuppressive [41]. Lower stress 
can improve feeding and decrease  susceptibility to pathogens in  poultry [42]. However, the 
mechanism by which the ESM lower the stress parameters is not understood since the effect 
appears to persist beyond the period of discontinuation of feeding HESM. Hypothetically a 
decreased serum level of adrenal steroids can be expected upon endocrine exhaustion occurring 
under conditions such as chronic endotoxemia. However, it is not the case in this study because 
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the HESM was not only deplete of endotoxin but also, the chickens fed on it showed any sign of 
sickness judged from their BW, intestinal pathology and blood profiles. 
 
Although the expression of IL-6, was upregulated by LPS treatment in both feed groups, it was 
significantly low in birds fed HESM. Similarly, there were also the upregulation of IL-4 and IL-
10, both of which are considered as anti-inflammatory cytokines implicated in the development 
of immune tolerance [43, 44]. Anti-inflammatory effect of natural ESM has been reported in 
experimental models of joint inflammation where the effects were attributed to the proteoglycan 
content of the preparation [45, 46].  Similar findings were reported by Shi et.al in mice where the 
effect of hydrolysate of eggshell membrane provided protection against dextran sodium sulfate 
induced intestinal inflammation [47]. The TGF-β expression was lower in both feed groups 
injected with LPS while the VEGF showed consistently lower expression in HESM birds. Since 
these growth factors help tissue repair and angiogenesis, associated with the resolution of 
inflammation, [23] their downregulation during early phases of inflammation is likely. However, 
the decrease in VEGF expression in birds fed HESM treatment is not understood. Whether the 
patterns of expressions of pro and anti-inflammatory cytokines have any relevance in curbing the 
body weight loss in HESM fed chickens is not known.  Evidently, a modified immune response 
due to HESM confers resistance to endotoxin induced changes.  As the susceptibility to infection 
can increase in immunocompromised individual likewise, it may confer tolerance to disease in 
immune strengthened birds. 
 
There were no significant differences in IgM or IgA levels of chickens fed either control or 
HESM diet with or without LPS challenge. By contrast, the IgG levels were reduced in birds fed 
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HESM that did not substantially change even after LPS treatment. Hypogammaglobinemia with 
normal IgM and IgA have been noted in human patients with physical trauma such as burn and 
nephrosis [48]. But the chickens fed HESM had neither physical trauma nor their clinical 
chemistry showed any indication of dysregulated kidney function such as hypoalbumenemia and 
hyperlipidemia that can be associated with nephrotic conditions. The HESM induced down 
regulation of serum corticosterone is consistent with our previous results with ESM [14]. We 
presume that post hatch exposure to HESM which is laden with different regulatory proteins and 
peptides and the remnants of bacterial and parasite contaminants possibly, condition the neuro-
immune system lowering the disposition of birds to stress and higher tolerance to LPS.  In newly 
hatched birds as in mammalian neonates, the immune and neuroendocrine system is immature 
and prone to epigenetic conditioning. At this stage not only the maternal but also other 
biodiverse factors such as diets, and microbes provide signals that can shape immunity and 
establish tolerance and resistance to pathogens [49-52]. There is increasing evidence showing 
that the neonatal exposure to stress, diets and microbiome have long term effect on immunity, 
health, and wellbeing of individuals [53, 54].  Besides, the enteric system houses the second 
largest density of neurons that could be impacted by bioactive factors thereby can influence 
immunity; for example, it is now known that the immune functions of lymphoid organs such as 
spleen can be prone to control through neural output of autonomic system and T cell regulation is 
subject to cholinergic output [55, 56]. Thus, the bioactive embryonic factors in HESM 
modulating the immune response of chickens is a possibility.  Also, it is now well recognized 
that maternal factors such as milk along with exposure to microbiome are important factors for 
establishing disease resistance and post-natal conditioning in mammals [57]. The plethora of 
proteins and peptides present in the eggshell membrane could simulate those effects in chickens.  
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From the foregoing discussion it is clear that HESM supplementation of feed is beneficial to post 
hatch poultry and it curtails the harming effects of LPS. Whether the effects are due to the 
bioactive proteins and peptides or some other factors is not known. Very little is known as to 
whether and how food associated bioactive proteins influence immunity because most 
omnivorous birds and mammals rely on some sort of raw proteins and peptides for their early 
nutrition which could provide epigenetic conditioning of immune system and build their 
resistance against common infections. The postnatal immune system being immature but plastic 
it certainly provides opportunity for nutritional modulation for building better immunity [58] In 
conclusion, our results show that HESM supplement can be a sustainable feed additive to 
improve immunity and health physiology of poultry.  
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Table 1. Body weight (BW) and the relative organ weights (% BW) of 5-week-old chicken fed 
diets with sterilized HESM and challenged with LPS for 24 h: Studies 2 and 3 combined 
(n=32-36).  
           Saline       
 
 
 
 
 
                LPS  
Parameters Control HESM Control HESM 
BW (g) 2238.27±33.38a 
 
2327.23±40.77a 
 
2021.30±37.02c 2135.38±28.55b 
Heart 0.52±0.01a 0.51±0.01a 0.52±0.01a 0.52±0.01a 
Liver 2.63±0.04b 2.48±0.06b 3.41±0.08a 3.30±0.09a 
Spleen 0.12±0.01a 0.12±0.00 a 0.13±0.01a 0.13±0.01a 
 
Mortality (%)* 9±1.53a 14.33±3.48a 
 
- - 
Values with different superscripts in a row are significantly different (P<0.05). *Results   based 
on 3 experiments   
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Table 2.Hematology profiles of chickens fed with or without HESM containing feed and treated 
with LPS: Study 2 (n=12) 
               Saline      
Saline 
 
 
 
 
 
                LPS  
Parameters Control    HESM  Control   HESM  
WBC (103/µL) 49.76±1.42 a  46.01±1.75 b  54.09± 3.12 a 
 
45.60±3.0b  
Heterophil (H) (%) 11.44±0.36c 12.62±0.46c 30.85±2.35a 22.94±3.14b  
Lymphocytes (L) (%) 83.81±0.65a 82.31±0.70a 
 
61.80±2.22c 69.92±3.10b 
 (H/L) 0.14±0.01c 0.15±0.01c 0.50±0.06a 0.32±0.05b 
Monocytes (M) (%) 2.32±0.18 b 
 
2.75±0.28b 
 
4.31±0.33a 
 
4.01±0.26a  
Eosinophil (E) (%) 0.02±0.01a  0.01±0.00 a 0.02±0.00 a 0.02±0.00a  
Basophil (B) (%) 1.99±0.17b 2.3±0.18b 2.99±0.19a 3.03±0.17a  
Red blood cell (× 
106/µL) 
2.18±0.04a 2.18±0.04a 
 
2.24±0.03a 
 
2.33±0.02a 
Hemoglobin (g/dL) 
 
6.77±0.09b 6.80±0.085b 
 
  
 
 
6.92±0.062b 7.17±0.073a 
Hematocrit (%) 59.26 ±1.15b 60.27±0.98b 
 
60.11±0.68b 63.02±0.65a 
Mean corpuscular 
volume (MCV)(fL) 
271.23±1.73b 276.16±1.69a 267.32±1.58b 271.07±1.16b  
Thrombocyte (k/µL) 0.03±0.03a 0.00±0.00a 
 
0.64±0.44a 0.003±0.00 a  
Values with different superscripts in a row are significantly different (P ≤ 0.05).  
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Table 3.. Serum clinical chemistry variables of 5 week-old chickens fed with regular diet or the 
diet supplemented with 0.5%  HESM and challenged with LPS:  Study 2 (n=12).   
                  Saline             
               
                  LPS   
                 
 
Parameters Control    HESM  Control   HESM  
Albumin (g/dL) 1.15± 0.02a,b 1.08± 0.02 b 1.17± 0.02a 1.19± 0.03a 
Glucose(mg/dL)    213.15±4.18a 216.15± 3.64 a 199.08± 4.14b 212.85± 5.63a 
Inorganic 
phosphate 
(mg/dL) 
3.31±0.16b 3.28± 0.13b 3.28± 0.17b 4.01± 0.21a 
Total 
protein(g/dL) 
3.12± 0.06a 2.76± 0.04b 3.15 ± 0.05a 3.22± 0.01a 
Alkaline 
phosphate (U/L) 
193.77± 24.24a,b  226.31± 28.60a  139.77 ± 14.90b 192.85±24.93a,b 
Alanine 
aminotransferase 
(U/L) 
3.85 ± 0.62a 2.49± 0.49a 2.75± 0.44a 3.85± 0.56a 
Aspartate 
Aminotransferas
e (U/L) 
309.45±17.4a 348.67±29.45 a 324.95±18.49a 380.83±24.72a 
Blood urea 
nitrogen (mg/µL) 
1.61± 0.13a 1.05± 0.15 a 1.33± 0.08 a 1.30± 0.08a 
Magnesium 
(mEq/L) 
1.90± 0.05a  1.58± 0.04 b  1.73± 0.05 a ,b     1.68± 0.11b  
Calcium (mg/dL) 10.53± 0.23a 7.99± 0.26 c  10.28± 0.29a 9.40± 0.27 b  
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Cholesterol 
(mg/dL) 
165.15± 6.91a 166.00± 4.16a 138.54±4.05b 161.31 ± 6.20a 
Creatinine 
kinase(U/L) 
546.8±83.43a,b 821.9 ± 166.59a 288.9± 36.06b 388.7± 46.39b 
Triglycerides 
(mg/dL) 
55.00± 4.86 b 51.07± 3.28b 93.00± 5.49a 86.31± 6.93a 
High density 
lipoprotein 
(mg/dL) 
45.15± 2.81a 44.77± 1.28 a 35.69± 1.24 b  41.23± 1.61a 
Iron (µg/dL) 99.54± 4.94 a 93.85± 4.80 a 55.46± 5.18 b 57.77± 9.27 b 
Values with different superscripts in a row are significantly different (P ≤ 0.05). 
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Table 4.. Serum IgG, IgM, IgA, and corticosterone levels of chickens fed regular NRC diet or 
diets supplemented with ethanol sterilized HESM and challenged with LPS for 24 h.: Study 1 
(n=12)   
             Saline                     LPS    
Parameters    Control  
 
HESM    Control        HESM  
IgM (mg/ml) 2.84±0.30b.a 
 
       
1.93±0.24b 
      
3.83±0.40a 
 
3.50±0.47a 
      IgG (mg/ml) 4.78±0.68a 
 
 
1.23±0.17b 
 
3.53±0.53a 
 
 
0.98±0.17b 
 
IgA (mg/ml) 0.56±0.15a 
 
       
0.54±0.22a 
      
1.18±0.17a 
 
0.81±0.39a 
      Corticosterone  7.74±0.95a 5.01±0.53b 6.7±0.60a,b 6.58± 0.96a,b 
 
 
 
Values with different superscripts in a row are significantly different (P ≤ 0.05). 
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Table 5.  Study 3. The expression of splenic genes quantified by RT-PCR in birds fed with and 
without HESM and injected with LPS or saline (n=6) 
              Saline                      LPS  
Parameters Control HESM Control HESM 
IL-1 1.00± 0.24b,a 0.75±0.11b 1.32±0.25b,a 1.83±0.61a 
IL-6 1.00±0.24b 1.08±0.17b 3.52±0.37a 2.42±0.49b 
IL-10 1.00± 0.10b,c 0.89±0.19c 2.3±0.34b 4.26±0.95a 
IFN-γ 1.00±0.28a 0.99±0.26a 0.68±0.13a 1.15±0.31a 
TGF-β 1.00±0.20a 0.97±0.14a 0.28±0.04b 0.30±0.04b 
 
IL-12 
 
1.00±0.13a 1.43±0.32a 1.13±0.26a 1.64±0.19a 
 
VEGF 
 
1.00±0.13a 
 
0.32±0.08 b 
 
0.86±0.11 a 
 
0.31±0.04b 
 
IL-4 1.00±0.13b,c 0.67±0.12c 1.76±0.32b 2.82±0.68a 
Values with different superscripts in a row are significantly different (P<0.05). 
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Figure legends 
Figure 1. Nitrite production at 24 h by the HTC chicken macrophage in response to different 
treatments.  
Figure 2. Effect of HESM on body weight of 5 week old birds, challenged with LPS for 24h 
n=(32-26). Values with different superscripts are significantly different.  
Figure 3. Comparison of splenic IL-6 gene expression in chickens fed control and HESM diet 
and challenged with LPS or Saline for 4 h (n=6). Values with different superscripts are 
significantly different (p≤0.05).  
Figure 4. Splenic IL-10 gene expression comparison of chickens fed control or HESM 
supplemented diet and treated with LPS or Saline for 4 h (n=6). Values with different 
superscripts are significantly different (p≤0.05).  
Figure 5 Comparison of splenic IL-4 gene expression in chickens fed control and HESM diet and 
challenged with LPS or Saline for 4 h (n=6). Values with different superscripts are significantly 
different (p≤0.05). 
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Supplementary Table 1.  PCR primers and accession numbers of candidate genes for 
chicken cytokine and other proteins  
Target 
genes 
Accession 
number 
Primer sequences Length of 
product (bp) 
IL-1β NM_204524.1 SF：CGAGGAGCAGGGACTTTGC 
SR：GAAGGTGACGGGCTCAAAAA 
71 
IL-6 NM_204628.1 SF：GCTTCGACGAGGAGAAATGC 
SR:GGTAGGTCTGAAAGGCGAACAG 
63 
IL-10 NM_001004414.2 SF：CGCTGTCACCGCTTCTTCA 
SR：CGTCTCCTTGATCTGCTTGATG 
63 
IFN-γ NM_205149 SF：AAAGCCGCACATCAAACACA 
SR：GCCATCAGGAAGGTTGTTTTTC 
64 
TGF-β3 NM_205454.1 SF：TGCGGCCAGATGAGCAT 
SR：TGCACATTCCTGCCACTGA 
55 
18S rRNA NC_006088.3 SF：TCCCCTCCCGTTACTTGGAT 
SR：GCGCTCGTCGGCATGTA 
 
 
60 
IL-12 NC-46430425 SF:TGCCCAGTGCCAGAAGGA 
 
SR:TCAGTCGGCTGGTGCTCTT 
57 
VEGF-A GI 160358852 SF:AAATTCACAGACTCACGTTGCAA 
SR: ATCTGCAAGTGCGCTCGTTT 
61 
IL-4 NM_0010079.1 SF: GCTCTCAGTGCCGCTGATG 
SR: GAAACCTCTCCCTGGATGTCAT 
60 
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Supplementary Table 2. Study 1. Body weight (BW) and the relative organ weights (% BW) of 
5 week-old chicken fed diets containing 0.5% whey protein powder or 0.5% HESM (n=20-
23).  
Parameters Control 0.5% whey 
protein 
0.5% HESM 
BW (g) 2153.95±45.97a 
  
 
2219.65±37.20a 
 
2148.00±37.74a 
Heart 0.56±0.02a 0.53±0.02a 0.57±0.02a 
Liver 2.20±0.04a 2.18±0.05a 2.3±0.06a 
Spleen 0.11±0.01a 0.12±0.01a 0.11±0.01a 
Bursa (%) 0.15±0.01 a 
  
  
  
 
0.16±0.02a 0.16±0.01a 
    
                   Values with different superscripts in a row are significantly different (P<0.05).  
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Supplementary Table 3. Study 1. Comparison of serum IgG, IgM, and corticosterone levels of 
chickens fed with regular NRC diet or 0.5% whey protein, or HESM supplemented diet. The 
results are shown as mean ± SEM. (n=12/ group)   
Parameters Control 
 
0.5% whey 
protein 
0.5% HESM 
IgG (mg/mL) 1.20±0.07a 1.07±0.06a 0.82±0.07b 
IgM (mg/mL) 2.69±0.24a 2.54±0.30a 2.60±0.22a 
Corticosterone 
(ng/mL) 
5.75±0.77a 4.26±0.33a,b 3.81±0.41b,c 
 
        Values with different superscripts in a row are significantly different (P ≤ 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  159 
Supplementary Figure 1. Histology of intestine sections of control and HESM fed birds 
(magnification X400) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Control HESM 
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VI. CONCLUSION
The immune system of a newly hatched chick is functionally immature and plastic. It can be 
primed and modulated by numerous ways, which can make it more resilient to fight infections in 
later life. Pre and postnatal life is critical time for the immune system for epigenetic 
programming for development of resistance and tolerance and the nutritional modulation can be 
a major option to this end.  In mammals for example, the mother’s milk that contains a plethora 
of defense proteins, peptides, and growth factors provide such programming boosting resistance 
against microbes, provide probiotic factors for microbiome, and anti-infective benefits to the 
immature gut.  The diets in birds living in wild may consist of fresh worms, insects, fish or food 
which can provide such programming which the domesticated poultry raised under controlled 
conditions may not have that exposure. Using eggshell membrane matrix and following its 
composition and biological effects our data suggest that the factors associated with this 
physiological modulation that provides protection of chicks against LPS induced changes. 
Using ESM from both fresh unfertilized as well as from hatchery egg membranes, we found that 
it contain more than 270 proteins, which are not only antimicrobial in nature, but they are also 
associated with cell signaling, development process, and immune system regulation processes 
(chapter2/4) largely of embryonic and hematological origins. The rejuvenation potential of body 
fluid factors of young animals was shown using parabiotic mice (   ) suggesting that these factors 
can influence physiology.  In extrapolating the concept we think that ESM factors which contain 
many antimicrobial, cell organizing, and cell signaling proteins perhaps produce the effects 
through neuroendocrine immune organizational pathways (chapters 3 and 5). 
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These experiments can be foundational to explore the idea that post hatch modulation of 
physiology and immunity using allogeneic or xenogeneic bioactive factors and microbes may 
confer life time resistance and tolerance to poultry against pathogens. 
With respect to ESM, this byproduct can be reusable and saleable without causing any 
biosecurity issues. This research would help for utilization of hatchery waste eggshell 
membranes in a potentially valuable and profitable manner. 
